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Yao-Sheng Tung 
The key to effective treatment of neurological diseases resides in the safe opening of 
the blood-brain barrier (BBB), a specialized structure that impedes the delivery of 
therapeutic agents to the parenchyma. Despite the fact that several approaches have been 
successful in overcoming the BBB impermeability, none of them can induce localized BBB 
opening noninvasively except for focused ultrasound (FUS) in conjunction with 
microbubbles. The physical mechanism behind the opening, however, has not been 
identified. Insight into the mechanism can be critical for delineating the safety profile for in 
both small and large animals alike. Therefore the purpose of this dissertation is to first 
determine the physical mechanism of FUS-induced BBB opening in mice and then 
translate this approach to non-human primates. 
To accomplish this goal, an in vivo transcranial cavitation detection system was 
developed and tested, built in phantoms and in vivo, to monitor the behavior of the 
microbubbles in the FUS bean, and to determine the type of cavitation, i.e., the activation 
of bubbles in an acoustic field, during BBB opening. We showed that the inertial cavitation 
(IC), a collapse of a bubble, which can vary from a fragmentation of the bubble to shock 
wave and liquid jets depending on the pressure, thereby damaging the endothelial cells of 
the brain capillaries, was not required to induce BBB opening in mice. With this system, 
  
the role of microbubble properties, including the diameter and shell components, in the 
BBB opening were determined. When the BBB opens with stable cavitation (SC), i.e., 
relatively moderate amplitude changes in the bubble size, the bubble diameter is similar to 
the capillary diameter (i.e., at 4-5, 6-8 µm) while with inertial cavitation it is not (i.e., at 1-2 
µm). The bubble may thus have to be in closer proximity to the capillary wall to induce 
BBB opening without IC. The BBB opening properties, such as volume and permeability, 
however, were not affected by the shell component of the microbubbles in mice. The 
connection between the physical and physiological mechanism was then investigated to 
identify the lowest peak rarefactional pressure BBB opening threshold at 1.5 MHz (0.18 
MPa). A sufficiently long pulse (pulse length = 0.5 ms) was required for the SC to induce 
BBB opening at the lowest pressure. However, the tight junctions, the main formation of 
the BBB, were found not to be disrupted after sonication at both low (0.18 MPa) and high 
(0.45 MPa) pressures. Therefore, the transcellular pathway may be the main route of the 
FUS-induced BBB opening. Finally, the cavitation-guided BBB opening system was used 
to induce reversible BBB opening in non-human primates. This is a major step towards 
clinical feasibility. In conclusion, a transcranial cavitation detection system was developed, 
in order to characterize the physical mechanism, the role of the microbubbles, and the 
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Most neurological disorders and neurodegenerative diseases, such as Alzheimer's 
disease (AD), Parkinson's disease (PD), multiple sclerosis (MS) and amyotrophic lateral 
sclerosis (ALS), remain difficult to treat. To date, only 5% of the more than 7000 small-
molecule drugs available can currently treat Central Nervous System (CNS) diseases 
because of the impermeability of the blood-brain barrier (BBB)1. The BBB is a specialized 
structure found between the capillary lumen and the brain parenchyma that only allows 
passive diffusion of lipid-soluble molecules with a molecular weight smaller than 400 Da2. 
Distinct from the general capillaries, the BBB consists of the tight junctions (TJs) between 
endothelial cells in CNS capillaries that restrict the passage of solutes. As a result, 
pharmacological agents cannot reach their desired targets, thus rendering therapeutically 
potent drugs clinically ineffective. Mechanical stress induced by the activation of 
microbubbles in an acoustic field is currently the only noninvasive approach to temporarily 
induce localized BBB opening, without damaging the surrounding tissues3. Since 2001 
when the first microbubble-enhanced BBB opening using focused ultrasound (FUS) was 
reported, numerous reports have been published on the methodology and application. Our 
group has also recently achieved the delivery of therapeutic compounds, i.e., the Brain-
Derived Neurotrophic Factor (BDNF) and neurturin (NTN), to the murine hippocampus4. 
The physical mechanism behind this approach, however, is still not entirely known. 
In order to achieve the goal of developing a FUS technique that will allow 
pharmacological agents to cross the BBB under well controlled and safe conditions, it is 
necessary to have a very clear understanding of the mechanisms and determination of the 




there are many indications as to the various mechanisms involved such as the dilation of 
vessels, temporary ischemia, mechanically induced opening of the tight junctions, and the 
activation of various transport mechanisms have been reported5-7, the trigger cause 
induced by the microbubbles, however, is unclear. Therefore, the primary objective of 
this dissertation is to reveal the physical mechanism (i.e., bubble behavior of trigger 
cause) of BBB opening using a novel device in phantoms and in vivo. Meanwhile, 
theoretical models are applied to predict the type of oscillation of the acoustically-driven 
microbubbles. Once the physical mechanism is identified, a secondary objective entails 
the translation of the BBB opening system to non-human primates to verify the feasibility 
and mechanism in large animals. 
 
1.2 Overview and significance 
Acoustic cavitation, which refers to acoustically driven bubble activity, is considered to 
be the main cause of BBB opening since it does not occur without injecting preformed 
microbubbles at a given acoustic setting. At low acoustic pressures, acoustically driven 
bubble oscillations were shown to increase the permeability of surrounding cell 
membranes8. At high acoustic pressures, inertial cavitation, i.e., the collapse of bubbles, 
releases high energy and may generate high temperatures, high pressures, and high velocity 
jets that may damage the surrounding structures9. Therefore, knowing the pressure 
threshold for inducing inertial cavitation is important for controlling the potential side-
effects. As of now, possible physical mechanisms for BBB opening via FUS and 
microbubbles include inertial cavitation, which may induce pores on the membrane of 




microstreaming surrounding the microbubbles that may induce shear stress or repeated 
stretch affecting the tight junctions or the permeability of the endothelial cells11.  
Until recently the interaction among the microbubbles, the FUS beam, and the brain 
capillaries have not been thoroughly investigated. Imaging techniques, such as magnetic 
resonance imaging (MRI) and fluorescence imaging, have been used to confirm the FUS-
induced BBB opening. In order to study the physical effects responsible for BBB opening, 
a passive cavitation detector (PCD) can be used to acquire the acoustic response stemming 
from the microbubble and tissue, thereby monitoring the bubble behavior during BBB 
opening. In addition, assessing the bubble behavior is necessary for establishing a well-
controlled safety window during BBB opening. Since inertial cavitation may cause damage 
to the vessel structure surrounding the microbubbles, it should be prevented for FUS-
induced BBB opening. Therefore, in order to determine the cavitation type during BBB 
opening, an in vivo transcranial PCD system was designed and built. The PCD system 
provides an alternative way to monitor the target and estimate the volume of BBB opening. 
Since the BBB opening is dependent on the microbubble size and the acoustic 
parameters12, we hypothesize that the physical effect responsible for BBB opening can be 
unveiled by changing the microbubble properties and acoustic parameters based on our in 
vivo transcranial PCD system. The optimal parameters can thereby be determined for a safe 
and efficient BBB opening. The feasibility of BBB opening in non-human primates is also 
investigated for the future clinical treatment of neurodegenerative diseases with the 
proposed technology.  
Furthermore, cavitation effects have been reported in several therapeutic ultrasound 




intensity focused ultrasound (HIFU)16, histotripsy17, and lithotripsy18, etc.. Since the bubble 
oscillation cannot be observed in vivo, an in vivo cavitation detection system may prove 
pivotal in determining the role of cavitation in different fields. As a result, the development 
of an in vivo cavitation detection system will have high medical significance. 
This dissertation is structured as follows. First, the basics of the blood-brain barrier 
physiology and current brain drug delivery methods are summarized. Second, the basics 
behind FUS and microbubbles, as well as previous studies on the FUS-induced BBB 
opening including optimization, delivery of therapeutic compounds, safety assessment and 
the possible mechanism, will be described in Chapter 2. In order to reveal the physical 
mechanism of the FUS-induced BBB opening, the method of a transcranial PCD system 
during BBB opening is described (Chapter 3). This system offers the possibility to study 
the physical mechanism by adjusting the microbubble design and carefully selecting the 
acoustic parameters. The permeability measurement and safety inspection will be 
implemented in order to study the mechanism associated with distinct microbubble 
diameters and shell materials (Chapter 4). The theoretical model of bubble behavior will 
also be implemented with a vessel phantom validation (Chapter 4). After describing the 
role of microbubbles in the BBB opening mechanism, the connection between the physical 
and physiological mechanisms will be investigated to provide insight into the physiological 
response to the microbubble activity during BBB opening (Chapter 5). Finally, an in vivo 
transcranial cavitation system in monkeys will be described in order to achieve real-time 
cavitation-guided BBB opening in non-human primates (Chapter 6). The main conclusions 









Chapter 2  
Noninvasive and Localized Blood-
Brain Barrier Opening Using Focused 






Identification of the physical mechanism of FUS-induced BBB opening requires a full 
understanding of the BBB physiology, focused ultrasound, and microbubbles. In this 
chapter, we will first provide basic concepts of the BBB physiology and summarize current 
brain drug delivery methods (section 2.2). The FUS, microbubbles, and previous reports on 
FUS-induced BBB opening will then be provided in detail in section 2.3. Finally, the 
different types of physiological and physical mechanisms will be introduced in section 2.4.  
In terms of physical mechanism, the types of cavitation and cavitation detection will also 
be summarized. 
 
2.2 The Blood-Brain Barrier 
The main limiting factor towards the development of novel treatments of neurological 
and neurodegenerative diseases is the blood-brain barrier (BBB): more than 98% of small-
molecule drugs and nearly all large-molecule drugs do not cross this anatomic barrier1,19. 
The BBB is a complex regulatory system within the neurovascular unit, which controls the 
flow of nutrients and chemicals into and out of the brain parenchyma maintaining the brain 
homeostasis necessary for proper neuronal firing20. The BBB hinders the effective systemic 
delivery of neurological agents and biomarkers to the brain through a combination of 
passive, transport and metabolic barriers. Determining factors for the passage of molecules 
across the BBB are lipid solubility, charge and molecular size (threshold range spans 
between 50 Da and 400 Da)2. Therefore, potential therapeutic agents, such as growth 




kDa)25,26,  do not efficiently cross the BBB when administered systemically. Such delivery 
and efficacy are critical in inducing therapeutic effects and triggering biological pathways.  
The difference between the general capillaries and the brain capillaries is depicted in 
Fig. 2.1. Most molecular traffic, which occurs via intercellular transport and pinocytosis in 
the general capillaries, is forced to take an intercellular route across the BBB through the 
tight junctions. Therefore, the BBB acts as a physical barrier impeding paracellular transfer 





Figure 2.1 – A schematic diagram of the major differences between (a) general capillaries 
and (b) brain capillaries. The endothelium of brain capillaries has the tight junction 
between the cells, as well as lacks intercellular clefts, fenestrations, and pinocytosis. This 






Several techniques exist to circumvent the BBB, such as intracranial injections, mixing 
or attaching agents to BBB-modifying chemicals, and the chemical alteration of agents to 
be delivered through endogenous transport systems1,20. However, these techniques are 
either invasive, drug-specific or are plagued by very poor spatial specificity. Even the latest 
advances in brain gene therapy28 provide cell specific drug delivery but not region specific.  
Global breaching of the BBB can be a risky process, as it increases influx of all molecules 
and therapeutic agents in untargeted areas of the brain29 even if this approach has been 
proven to be successful for some applications such as metastatic lung cancer30. A controlled 
and safe opening of the BBB would enable the passage of pharmacological agents across 
the interstitial space that could enhance the neuronal activity in the aforementioned brain 
diseases, without causing permanent physiologic or anatomical damage. An ideal method 
would ensure drug-independent, reversible, localized and noninvasive delivery through the 
BBB to minimize potential hazards. Several methods currently available for opening the 
BBB are listed in Table 2.1. Except FUS, none of them can induce localized BBB opening 
noninvasively. 
 
Table 2.1 Techniques shown to induce BBB opening and their advantages 
Method Noninvasive Localized 
Direct injection 
(e.g., intracerebral, intracerebroventricular)   
Hyperosmotic solutions 
(e.g., mannitol)   
Chemical modification of molecules 
(e.g., lipidization, endogenous transport systems)   





2.3 FUS-induced BBB opening 
2.3.1 Focused ultrasound 
“Ultrasound” defines the acoustic wave, with a frequency higher than the human 
audible frequency (> 20 kHz), generated from a transducer which converts the electrical 
stimulus into mechanical vibrations. Distinct from the conventional diagnostic ultrasound, 
a curved-shaped transducer is driven at frequencies between 200 kHz and 5 MHz to 
generate a high energy, compared with the intensity near the surface of the transducer, at 
the focus. The concept of FUS is illustrated in Fig. 2.2. Therefore, FUS can be used in the 
therapeutic applications which require localized and noninvasive treatment. Since the 
temperature at the focus can reach over 70°C, which leads to protein denaturation, at high 
acoustic pressures, this technique has been widely used in ablation of tumors31-33. This is 
most widely known as high-intensity focused ultrasound (HIFU). Compared with HIFU, 
however, the FUS in conjunction with microbubbles can induce BBB opening at relative 
low pressures (< 1 MPa). This approach is introduced in detail in section 2.3.3. 
Figure 2.2 – Illustration of the focused ultrasound. The rarefactional pressure map shown 
in the XY-plane and XZ-plane demonstrates the ellipsoidal focus of the FUS transducer 





Microbubbles, also known as ultrasound contrast agents (UCA), are gas-filled bubbles. 
They are prevented from dissolving by a stabilizing shell. They are used in the clinic to 
help improve the ultrasound image contrast of blood vessels and blood cavities. In general, 
microbubbles have a typical size distribution centered around 3 to 4 µm in diameter. They 
are stabilized against dissolution by a coating that consists of a lipid, protein (albumin), or 
polymer shell. The basic illustration of a microbubble is depicted in Fig. 2.3. In general, the 
shell thickness of the lipid, protein, and polymer shell is around 3 nm, 15-20 nm, and 100-










Besides initially used merely as the contrast agent for ultrasonic imaging, microbubbles 
have recently been shown critical in therapeutic ultrasound applications, such as HIFU16, 
sonothrombolysis35, and BBB opening3,36. The interaction between microbubbles and 
ultrasound can significantly enhance the effect of FUS. In HIFU, the effect of microbubble 
concentrations on the lesion volume and focal shift has been investigated. It has been 
shown that the lesion volume can be enhanced to 12 times higher than the one without 
microbubble administration, but with an acceptable shift of focus16. Previous research 
found that microbubbles could not only enhance the effectiveness of the thrombolytic 
agents in the presence of ultrasound, but microbubbles also had the potential to reduce the 
dose of the thrombolytic agents in the treatment of vascular thrombotic disease, and reduce 
the side effects of the thrombolytic therapy37. Unlike HIFU, in FUS-induced BBB opening, 
the BBB is not opened in the absence of the microbubble administration. The description of 
three mainly commercial microbubbles, including Definity®, Optison®, and Sonovue®, 
used in the BBB opening are listed in Table 2.2.  
 
 
Table 2.2 Three main microbubbles used in BBB opening. The data of Optison and 
Definity is obtained from the package insert. The data of Sonovue is from Molecular 
Imaging and Contrast Agent Database (MIDAC) 
Microbubble Shell Gas Concentration (numbers / mL) 
Mean 
Diameter (µm) 
Definity® Lipid Perfluoropropane 1.2 x 1010 1.1 - 3.3 
Optison® Albumin Perfluoropropane 5-8 x 108 3.0 - 4.5 





2.3.3 BBB opening using FUS and microbubbles 
FUS-induced BBB opening was first observed using HIFU, accompanied with lesion 
formation38.  It was also reported that abnormal permeability of the human blood-brain 
barrier can be induced by 300 kHz insonation, used for somothrombolysis, in one patient 
with severe cerebral small vessel disease39. A remarkable side effect was observed in this 
patient undergoing perfusion-MRI. Although the patient with cerebral small vessel disease 
may already have an impaired BBB (vascular leakage), it has to be tentatively regarded as a 
negative effect of this technique on the cerebral endothelium39. In 2001, with intravenous 
administration of microbubbles, the BBB was opened in vivo at acoustic pressures and duty 
cycles low enough that significant thermal effects may be avoided3,40. To date, several 
different aspects of this technique have been investigated, including different animal 
models, the optimization of experimental conditions, varied-sized compound delivery, 
safety assessment, physiological mechanism, and physical mechanism, which will be 
summarized in the following sections. 
 
2.3.3.1 Animal models for BBB opening 
The first BBB opening using FUS and microbubbles was implemented in rabbits with 
craniotomy3. Following this study, BBB opening has been achieved in additional species, 
such as, mice41, rats42, and pigs43. Since the craniotomy is invasive and time-consuming, 
the reversible BBB opening using transcranial FUS was then achieved in rats and 
rabbits44,45. Our group has also shown that the BBB can be reproducibly opened using 
transcranial FUS in a specific subcortical region associated with neurodegenerative disease, 




generate models of human Alzheimer’s disease to allow a better understanding of the 
mechanisms leading to initiation and progression of the disease, which would identify 
potential therapeutic targets and permit testing of drugs of real clinical potential46. Thus, the 
Alzheimer’s-model mouse (AD mouse) is an appropriate model for FUS induced BBB 
opening47. Furthermore, in order to have clinical translation of this technique, the feasibility 
of FUS-induced BBB opening in non-human primates (NHP) has been accomplished by 
our group and will be described in most detail in Chapter 636,48. The summary of all animal 
models and main contribution are listed in Table 2.3. 
 
Table 2.3 Animal models used in FUS-induced BBB opening 
Animal Microbubble Main contribution 
Mice40,41  Optison® Reproducible opening located at hippocampus  
AD mice47 Optison®/Definity® Successful opening in AD mice 
Rats42 Optison® Transcranial BBB opening in rats  
Rabbits3 Optison® BBB opening with/without craniotomy 
Pigs43 In-house First BBB opening in large animals 
Monkeys36,48 In-house  First BBB opening and Cavitation-guided BBB opening in NHPs 
 
 
2.3.3.2 Investigation of experimental conditions 
After successfully opening the BBB in different models, the efficacy, efficiency, and 
the corresponding experimental conditions have been widely investigated. First, different 
acoustic parameters, such as frequency, peak rarefactional pressure (PRP), pulse length 




Several frequencies, e.g., 28 kHz49, 260 kHz45, 500 kHz48, 690 kHz44, 1 MHz50, 1.5 MHz41, 
1.63 MHz3, and 2.64 MHz51, have been applied for opening the BBB. The PRP threshold 
for BBB opening was shown to increase with the applied sonication frequency. The 
threshold, however, remained constant when compared to the mechanical index (MI)51. The 
PRP threshold was also shown to decrease with PL while the PRF did not affect the 
threshold52. In addition, our group has demonstrated feasibility of BBB opening using a 
pulse length of  3 cycles (2 µs) at 1.5 MHz PL-based pulse, and capable of delivering a 
high dose of dextran homogenously throughout the targeted region53. Furthermore, a 
sonication duration lower than 180 s in duration is associated with a low probability of 
irreversible damage to the brain tissue at a PRP of 0.38 MPa54.  
Second, distinct microbubble concentration and types have been investigated in several 
studies. The microbubble concentration has shown no effect on the contrast enhancement 
of dextran or MRI images within the range among 50, 100, and 250 µL/kg at 0.5 MPa12,52, 
but was shown to affect the Evans Blue (EB) delivery at 1.2 MPa55. In terms of 
microbubble properties, our group has shown that the PRP threshold for the smaller (1-2 
µm in diameter) microbubbles is higher than that of the larger ones (4-5 and 6-8 µm)56,57. 
Larger microbubbles were observed having bigger opening volume, but having higher 
chance of inducing damage57.  
Third, because MRI was used in most studies for BBB opening confirmation, distinct 
parameters were applied in terms of optimization. A susceptibility-weighted MRI was first 
used to detect hemorrhage during BBB opening42. Both gradient echo and spin echo 
sequences were deemed reliable in indicating the degree of BBB opening58. The timing of 




been obtained. The spin-echo T1W images at 10 minutes post–contrast enhancement 
showed the best correlation with EB staining in both quantity of EB extravasation and 
spatial distribution59. In addition, MRI signal intensity change not only could be used to 
detect BBB opening during sonication, but could also be used to estimate the concentration 
of EB in the target tissue over the whole duration of BBB disruption after sonication60.  
Reversibility, i.e., the duration of BBB opening, has also been reported in several 
studies. In general, using commercial microbubbles, such as Optison®, Sonovue®, and 
Definity®, the opened BBB will close in 24 hours if the PRP is lower than 1 MPa. In our 
recent findings, however, the duration of BBB opening can be controlled between 1 and 5 
days by selecting corresponding pressures (0.30 - 0.60 MPa), pulse length (100 - 10,000 
cycles) and microbubble diameters (1-2, 4-5, and 6-8 µm)61. In addition, repeated BBB 
openings are being implemented to investigate the effect of the second BBB opening. With 
the 40 min interval, the MR contrast enhancement and histological examination of the 
second sonication was shown different from a single sonication50.  The investigations in 
different experimental parameters were summarized in Table 2.4. 
 
Table 2.4 Investigations on the experimental parameters 
Parameter 1
st author, 




The PRP threshold was lower with 10 ms PL, compared 
with 0.1 and 1 ms PL. 
Choi, 201012 The PLs of 0.033, 0.1, 0.2, 1.0, 2.0, 10, 20, and 30 ms at 0.46 MPa were evaluated. 
Choi, 201153 The 3 cycles PL was capable of inducing homogenous BBB opening. 
O’Reilly, 
201262 
The BBB has been disrupted using closely-timed 3-ms 
pulses, at repetitions rates as slow as 1 Hz 
Duration Chopra, 201054 








No significant difference, in terms of MRI contrast 
enhancement, was observed among 0.5, 1, 2, and 5 Hz. 
Choi, 201012 The BBB was not opened at 0.1-Hz PRF. No difference was observed among 5, 10, and 25-Hz PRF. 





Optison® produced a larger effect than Definity® for the 
same acoustic pressure amplitude. 
Choi, 201056 PRP threshold of the 1-2-µm diameter bubbles was higher than the 4-5-µm diameter bubbles. 
Tung, 201157 The physical mechanism is bubble-size dependent. 




®) The amount of EB was significantly greater 
with 60 or 90 uL/kg than with 0 or 30 uL/kg at  1.2 MPa 
McDannold, 
200852 
(Optison®) No difference was observed among 50, 100, 
and 250 uL/kg at 0.50 MPa. 
Yang, 200965 (Sonovue
®) A dose of 300 and 450 uL/kg induced greater 
EBs amount and longer opening duration than a 150 uL/kg. 
Choi, 201012 Fluorescence intensity was not significantly different among 10, 50, and 250 uL/kg with Definity® at 0.46 MPa. 
MRI 
Liu, 200842 
susceptibility–weighted imaging is more sensitive than 
standard T2-weighted and contrast-enhanced T1-weighted 
MRI techniques in detecting hemorrhages 
Vlachos, 
201066 Comparison of two permeability models for BBB opening 
Yang, 201060 MRI signal intensity change could be used to estimate the concentration of EB.  
Weng, 201059 
The spin-echo T1W images at 10 minutes post–contrast 
enhancement showed the better correlation with EB 
staining than the gradient-echo T1W images. 
Weng, 201158 Both gradient echo and spin echo sequences were all reliable in indicating the degree of BBB opening. 
Howles, 
201067 
This technique enables in vivo functional mapping of the 




(Optison®), the opened BBB is closed in 5 hrs at 0.40 MPa 
and at 260 kHz in rabbits. 
Wang, 200968 (Sonovue®), the opened BBB is closed in 8 hrs at 0.80 MPa 
and at 1.1 MHz in rabbits. 
Xie, 200843 (In-house MBs), the opened BBB is closed in 3 hrs at 0.25 
MPa and at 1 MHz in pigs. 
Samiotaki, 
2012 
(Mono-dispersed in-house MBs), the opened BBB is closed 





2.3.3.3 Delivery of large compounds through the opened BBB 
The aim of optimization for experimental conditions was to successfully delivery drugs 
into the brain parenchyma. To date, except for the agents used for BBB opening 
confirmation, such as Ominiscan40, Magnevist69, Superparamagnetic iron oxide70, 99mTc-
DTPA71, Evans Blue (EB)72, Trypan Blue73, Congo Red73, fluorescence tagged dextran74, 
and horseradish peroxidase6, different agents have been shown across the BBB via the 
interaction between FUS and microbubbles.  
FUS-induced BBB opening has been used for the delivery of various therapeutic 
agents. The deposition of doxorubicin (DOX), named as a strong candidate for 
chemotherapy of the central nervous system, has been increased due to the FUS-induced 
BBB opening75,76.  BCNU, used in the treatment of several types of brain cancer, has also 
been successfully delivered to the brain tumors of rats77-79. Higher PRP (> 1 MPa) was 
usually applied for tumor treatment. For neurodegenerative disease treatment, however, 
successful delivery is more difficult because lower PRP is usually used to prevent the 
occurrence of ablation. Our group has achieved the delivery of brain-derived neurotrophic 
factor (BDNF) which can encourage the growth and differentiation of new neurons4. In 
addition, the delivery of neuron stem cells from the blood to targeted brain structures was 
also demonstrated80. This provided an alternative to cell therapy. 
Antibody-based anticancer agents are promising chemotherapeutic agents. Among 
these agents, Herceptin (trastuzumab), a humanized anti-human epidermal growth factor 
receptor 2 (HER2c-erbB2) monoclonal antibody, was successfully delivered into the 
murine brain81. In addition, anti-Aβ antibodies, used to reduce the Aβ plaque involved with 




rabbit anti-human dopamine D4 receptor antibody, which recognizes the 3rd extracellular 
domain (Ac-176-185) of the human dopamine D4 receptor, has also been delivered in the 
murine brain83. Furthermore, the expressions of exogenous gene pBDNF-EGFP were 
observed in the cytoplasm of some neurons, and BDNF expressions were markedly 
enhanced by the combination of ultrasound and pBDNF-EGFP-loaded microbubbles84. The 
large agents and corresponding size were summerized in Table 2.5.   
 
Table 2.5 Molecules used in the FUS-induced BBB opening 
Compound Name Size 
MRI or SPECT 
contrast agent 
Omniscan40 573 Da 
Magnevist69 938 Da 
Superparamagnetic iron oxide (SPIO)70 50 nm 
99mTc-DTPA71 492 Da 
Dye and 
fluorescence agent 
Evans Blue72 960 Da 
Trypan Blue73 916 Da 
Congo Red73 697 Da 
Dextran74 3 kDa, 7 kDa, 2 MDa 
Horseradish peroxidase6 40 kDa 
Therapeutic 
compounds 
Doxorubicin75,76 544 Da 
BCNU77-79 214 Da 
BDNF4  27 kDa 
Neuron Stem cell80 -- 
Antibody 
Herceptin81  148 kDa 
Anti Aβ82 -- 
D4 rabbit receptor-targeting83 42 kDa 
Gene delivery exogenous gene pBDNF-EGFP84 -- 
Nano particle 
Magnetic nanoparticles85 74-83 nm 




2.3.3.4 Safety assessment 
In order to prevent the permanent damage on the healthy brain tissue, safety assessment 
is necessary. Most studies mainly concentrated on hematoxylin and eosin (H&E) analysis, 
which provided the information of red blood cell (RBC) extravasations and damaged 
neurons identified based on characteristics of dark neurons in the sections. These neurons 
had shrunken and triangulated cell bodies, eosinophilic peri-karyal cytoplasm and pyknotic 
basophilic nuclei. TUNEL is also a common method for detecting DNA fragmentation that 
results from apoptotic signaling cascades87. In addition, vanadium acid fuchsin (VAF)-
toluidine blue staining is used to visualize ischemic neurons in the parenchyma in the 
sonicated areas88. Based on these histological analyses after FUS-induced BBB opening, 
the PRP threshold for vascular wall damage, hemorrhage, and eventually necrosis was 6.3 
MPa. No ischemia or apoptosis was observed even if the PRP was 12.7 MPa, which 
induced 1.7 °C temperature rise89. 
Besides the histological analysis, MRI can be used as the damage identification. The 
susceptibility–weighted imaging (MR-SWI) has been shown more sensitive for possible 
tissue hemorrhage associated with BBB opening in a rat model. Also, temperature changes 
were measured with MRI by exploiting the temperature-dependence of the proton resonant 
frequency (PRF). Changes in the PRF were estimated with phase-difference images using a 
fast spoiled gradient echo (FSPGR) sequence90. Therefore, MRI is able to identify thermal 
effect during BBB opening, but no significant thermal effect has been observed so far. 
Permeability assessment can also provide the dynamic information of the molecular 
diffusion. Our group has investigated the permeability after FUS-induced BBB opening 




diameter of microbubbles. The permeability after BBB opening was found to increase by at 
least a 100-fold64,66.  Further details will be provided in Chapter 4.  
The safety assessment of the short term (immediately after sonication up to a few 
hours) and long term (few days to several weeks) have been investigated by our group and 
McDonnald et. al91,92. For short survival time periods (30 min and 5 h), it was only the 
lower-pressure amplitudes that showed the least amount of short-term effects (0.3 to 0.46 
MPa at 1.5 MHz)91. No lesions containing ischemic or apoptotic neurons were observed to 
4 weeks after sonication at 0.7 or 1.0 MPa. Thus, using FUS in conjunction with 
microbubbles for targeted BBB opening does not appear to result in widespread damage to 
the neurons (either directly or through ischemia or apoptosis) or delayed effects up to one 
month after sonication92.  
Using the SPIO, it has been shown that the infiltration of phagocytes, i.e. the 
inflammatory response, does not occur using lower PRP (1.1 MPa, compared with 2.45 
MPa)93. Furthermore, during the BBB opening experiments, the effect of anesthesia 
methods was investigated. Over the range of exposure levels tested, MRI contrast 
enhancement was significantly higher for animals anesthetized with ketamine/xylazine. 








2.4 Possible mechanism of FUS-induced BBB opening  
Understanding the mechanism of FUS-induced BBB opening is believed useful for 
optimization and the design of therapeutic agents. Here, we will first summarize the 
physiological response to the stimulus of microbubbles activated in the acoustic filed. The 
possible physical mechanism behind the physiological response will then be introduced. 
 
2.4.1 Physiological mechanism 
Figure 2.4 shows the general pathways for molecules across the BBB. Prior to the FUS-
induced BBB opening, the tight junction (TJ) restricts the paracellular route, thus only 
small (<400 Da) and lipid soluble molecular can transport across the BBB through the 
lipophilic pathway, transport proteins, and endocytosis95. The cellular mechanism of FUS-
induced BBB opening has been first reported in 2004. The data revealed that several 
mechanisms of transcapillary passage are possible after such sonications: 1. transcytosis; 2. 
endothelial cell cytoplasmic openings - fenestration and channel formation; 3. opening of a 
part of tight junctions; and 4. free passage through the injured endothelium7. As shown in 
Fig. 2.4, TJ-related protein includes occluding, claudin-1, claudin-5, and ZO-1. More 
specific, the TJ molecular structure was shown disassembled at 1.1 MPa peak rarefactional 
pressure (PRP) using a 1.5-MHz FUS and Optison® microbubbles, as well as the occludin, 
claudin-1 and ZO-1 was affected up to 4 hours after the sonication6,7. This TJ disruption 
may induce the activation of Akt signaling pathway, which plays a role in regulating 
neuronal cell survival during pathological alteration, in neuronal cells surrounding the 




The gap junctions, which allow transfer of information between adjacent cells and are 
responsible for tissue homeostasis, was observed having reorganization instead of 
destruction or loss of gap-junctional plaques after BBB opening97. In addition, regarding 
the protein about the transcellular route, the expression of caveolin-1 has been shown to be 
increased after FUS-induced BBB opening, which is relevant to the receptor-mediated 
mechanism98. In addition, optical imaging used to observe the response of the brain 
vasculature has shown 1) the activation of vesicular transport was shown more expressed in 
the brain arterioles than in the capillaries5; 2) vasoconstriction99 and 3) different types of 
leakage correlated to distinct PRP during BBB opening, from 0.3 to 0.8 MPa100. However, 
the physical mechanism on the microbubble interaction with ultrasound during BBB 
opening remains to be established.  
Figure 2.4 – Physiological transport across the BBB95. The main routes for molecular 
traffic across the BBB are (a) paracellular aqueous pathway, but restricted by the tight 
junction which is mainly established by the transmembrane proteins (claudins and 
occludin), linked to cytoskeletal actin through ZO-1; (b) the lipid membranes of the 
endothelium offers an effective diffusive route for lipid-soluble agents; (c) transport 
proteins for glucose, amino acids, purine bases, nucleosides, and choline; (d,e) receptor- or 




2.4.2 Physical mechanism – acoustic cavitation 
Cavitation is defined as any stimulated bubble activity. The stimulation may be due to 
flow, decompression, acoustic waves, sudden deposition of electromagnetic or ionizing 
radiation, or heat102. The activity can refer to bubble inception or dynamics. Acoustic 
cavitation refers to the generation, growth and interaction of small gas bubbles in a sound 
field. When exposed to an acoustic field in a fluid, the gas cavity or bubble can either 
oscillate gently at low pressure levels, or oscillate violently, resulting in large growth and 
rapid collapse at higher pressures. Traditionally, we call the former the stable cavitation 
(SC), and the latter the transient or inertial cavitation (IC)102.  
Apfel and Holland calculated the pressure threshold of inertial cavitation in water and 
showed that it increased with frequency103. Most studies on the threshold of cavitation 
effects with microbubbles were based on the assumption of a free bubble104-109. However, 
containment of a bubble within a vessel alters its behavior. Qin and Ferrara simulated the 
interaction between acoustically driven microbubbles in compliant microvessels and found 
that the threshold of bubble fragmentation was higher within more rigid vessels when 
compared to compliant vessels110.  
Rigid bubble motion as a result of the radiation force as well as visualization of radial 
oscillations have been proposed to explain why microbubbles within smaller tubes have a 
higher fragmentation threshold and greater persistence111. The relationship between the 
threshold of fragmentation for ultrasonic contrast agents and the acoustic parameters used 
has also been investigated105. However, cellulose tubes, which have been used in most 
vessel phantom studies, do not have the same properties as physiologic vessels. The 




been investigated to demonstrate the process of bubble collapse into the endothelium and 
repeated expansion of the microbubble within the blood vessels112. It has been shown that 
the inertial cavitation can be correlated with cell damage in rabbit ear vessels113,114. The 
interaction between ultrasound and microbubbles has been shown to increase the 
permeability of the endothelial layer without any cell detachment or damage in vitro115. 
Since optical imaging can only be used to observe the superficial vasculature with the 
craniotomy, a better method has to be implemented in order to identify the type of 
microbubble behavior during BBB opening in the deep regions in absence of the 
craniotomy. In order to study the physical effects responsible for BBB opening, a passive 
cavitation detector (PCD) can be used to acquire the acoustic response stemming from the 
microbubble and tissue during BBB opening116. The frequency response can be classified 
into two categories. The first response is generated by SC, i.e., at harmonic, sub-harmonic 
and ultra-harmonic frequencies. The second response is generated by IC, which will 
produce broadband acoustic emission due to the collapse of microbubbles. In general, 
stable cavitation dose (SCD) and inertial cavitation dose (ICD) are generated by the 
integration of the amplitude at ultra-harmonics and broadband response, respectively, with 
the sonication duration117,118. In this dissertation, we will qualitatively demonstrate the 
frequency and quantitatively calculate the SCD and ICD in order to determine the 
cavitation type which dominate BBB opening. 
The possible physical mechanism for BBB opening and corresponding frequency 
response can hence be depicted in Fig. 2.5. In SC, the stable expansion and contraction may 
be able to change the permeability of endothelial cells. The corresponding frequency 




without the broadband response.   In IC, the collapse of microbubbles induces broadband 
response and the fluid jet may damage surrounding endothelial cells. Our group has 
achieved the in vivo transcranial cavitation detection in mice and provided evidence that the 
BBB opening could be induced at the absence of inertial cavitation, at 0.30 MPa119,120. We 
have also shown that the murine skull does not completely influence the detection of 
inertial cavitation119, which is further described in Chapter 3.  
	
Figure 2.5 – Schematic diagram illustrating the microbubble behavior and cavitation types. 
A microbubble decreases in size during the compressional phase, and expands during the 
rarefactional phase. Low-intensity ultrasound induces a stable oscillation of a microbubble 
in the capillaries, named as stable cavitation where the harmonics (red arrows) and ultra-
harmonics (black arrows) are generated. However, at higher intensities, the microbubble 
grows rapidly for a few cycles. Very soon, the inertial energy of the fluid surrounding the 
microbubble during the compression forcibly collapses the microbubble, generating fluid 









Chapter 3  
Development of a Transcranial 







A comprehensive assessment of the physical mechanism is warranted in order to 
establish a safety window of BBB opening. Till now, the physical mechanism of FUS-
induced BBB opening remains largely uncovered. Not only is the interaction between the 
acoustically driven bubble and brain capillaries unknown but also the effect of the skull on 
the BBB opening threshold has not been thoroughly described. Several studies 
investigating BBB opening require craniotomy3,52,63,92,121. However, craniotomy is a 
difficult and time-consuming process that is associated with brain exposure, morbidity and 
occasional mortality. As a result, Hynynen et al. used low frequency (260 kHz), which 
resulted in lower phase aberration through the skull when opening the BBB 
transcranially44,45. Our group has characterized the FUS beam through the murine skull in 
simulations and ex vivo skull experiments in order to understand the effects of aberration 
and attenuation through the skull corresponding to the hippocampus41. Since Alzheimer’s 
disease occurs in hippocampus, localized transcranial BBB opening in the murine 
hippocampus has been reported40.   
In order to study the bubble behavior during BBB opening, the relationship between 
acoustic cavitation and BBB disruption was previously investigated using a PCD, which 
suggested that inertial cavitation might not be necessary for BBB opening121. The peak-
rarefactional pressure (PRP) threshold of BBB opening and inertial cavitation at 260 kHz 
was 0.29 MPa and 0.40 MPa, respectively, which suggested that inertial cavitation might 
not be necessary for BBB opening. However, that study was performed following 
craniotomy and ignored any effects that the skull may introduce such as a change in the 




BBB opening is necessary for studying the actual mechanism of BBB opening induced by 
FUS and microbubbles without craniotomy.     
The objective of this chapter is to establish a novel system to detect bubble response 
transcranially and to identify the cavitation type during BBB opening in mice in vivo. First, 
a phantom study was carried out to separately assess the effect of the skull, the angle 
dependence, sensitivity and reliability of the PCD setup. The occurrence of inertial 
cavitation during BBB opening in mice in vivo was then investigated using two PCD setups 
to determine the optimal configuration. The spectrogram and inertial cavitation dose (ICD), 
the integration of the spectrum amplitude with time curve, were used to identify the 
threshold of inertial cavitation. MRI and histology were used to determine the BBB 
opening occurrence and macroscopic damage, respectively. 
 
3.2 Materials and Methods 
3.2.1 Phantom validation of the skull effect 
3.2.1.1 Experimental Setup 
The experimental setup of the phantom validation is shown in Fig. 3.1. A single-
element circular focused ultrasound transducer (Riverside Research Institute, New York, 
USA) was driven by a function generator (Agilent Technologies, Palo Alto, CA, USA) 
through a 50-dB power amplifier (ENI Inc., Rochester, NY, USA). The center frequency, 
focal depth, outer radius and inner radius of the FUS transducer were 1.525 MHz, 90 mm, 
30 mm and 11.2 mm, respectively. A single-element diagnostic transducer (center 




(Panametrics, Waltham, MA, USA), was positioned through the opening of the FUS 
transducer. These two transducers were confocally aligned. A cone filled with degassed 
and distilled water was attached to the transducer system. The transducer was then mounted 
on a computer-controlled positioner (Velmex Inc., Bloomfield, NY). The dimensions of the 
focal region were measured and a lateral and axial full-width at half maximum (FWHM) 
intensity were of approximately 1.32 and 13.0 mm, respectively. 
A 5-cm broadband, cylindrically focused hydrophone (Sonic Concepts, Bothell, WA, 
USA) with a cylindrical focal region (height 19 mm, diameter 3.64 mm) was placed at 60º 
(60º-PCD, Fig. 3.1(a)) or 90º (90º-PCD, Fig. 3.1(b)) from the longitudinal axis of the FUS 
beam. The hydrophone holder was adjusted to confocally align the hydrophone and the 
FUS transducer. The acoustic emissions from the microbubbles were acquired by the 
hydrophone followed by a 20-dB amplification (model 5800, Olympus NDT, Waltham, 
MA, USA) and collected using a digitizer (model 14200, Gage Applied Technologies, Inc., 
Lachine, QC, Canada).  
Each sonication set included a pulse length of 100 cycles (67 μs) and a pulse repetition 
frequency (PRF) of 10 Hz. The total sonication duration of a sonication set was 2 s, i.e., 20 
pulses. Acoustic signals emitted from microbubbles were acquired for each pulse. The 
peak-rarefactional pressure amplitude ranged between 0.30 and 0.90 MPa at a 0.15 MPa 





Figure 3.1 – Block diagrams of the experimental setup. The PCD was positioned at a (a) 
60⁰ and (b) 90⁰ relative to the longitudinal axis of the FUS beam. The space between latex 
membrane and phantom was degassed water, and the big water tank was not shown on 
this figure. The overlap between the focal region of PCD and FUS was also illustrated in 
the insets. The cylindrical region was the focal region of PCD and the cigar-shaped 
region was the focal region of FUS. The water tank, in which the phantom was 






The vessel phantom was constructed using acrylamide according to Takegami et al.122 
without the egg protein. The vessel was formed by inserting a polyethylene tube (model 
PE10, Becton Dickinson and Company, Sparks, MD, USA) before the phantom solidified 
and removing it immediately after. The phantom was immersed in a tank filled with 
degassed water (Fig. 3.1). The vessel was positioned 3 mm below the surface of the 
phantom to simulate the location of the vessel targeted in the in vivo application40,41. A 
linear-array transducer (center frequency 7.5 MHz, model 10L5, Terason Ultrasound, 
Burlington, MA) was placed perpendicular to the longitudinal axis of the FUS transducer 
(Fig. 3.1) and was used to map the spatial distribution of microbubbles after sonication. 
 
3.2.1.2 Skull preparation and targeting procedure 
Three brown mice (strain: C57BL/6, sex: male, mass: 20-25g) were euthanized, their 
skulls were extracted and then immersed into a formalin solution. All procedures used on 
the mice were approved by the Columbia University Institutional Animal Care and Use 
Committee. The thickness of the parietal bone was 0.18, 0.20 and 0.23 mm, respectively. 
The intact skull was degassed before each experiment in order to prevent any cavitation 
effects at the skull level that may affect the beam propagation. Based on previous 
experiments, the skull attenuates the pressure amplitude by approximately 18.1% at 1.525 
MHz40. Therefore, the FUS transducer was driven at different voltages to ensure that the 
pressure values were of the same magnitude, with or without skull in place.  
Figure 3.2 illustrates the targeting method through the skull that is also used to open the 
BBB in a subcortical structure such as the hippocampus in vivo40. Since the thickness and 




order to propagate through the thinnest region. A grid-positioning method was used to 
ensure that the focal spot overlapped with the equivalent hippocampus location, which is 
the target in our in vivo studies40,41. First, a raster scan (Fig. 3.2(a)) was performed to 
ensure that the center of the FUS focal spot was placed in the middle of the vessel. Second, 
the FUS transducer was positioned above the skull. A second raster scan was performed to 
locate the region equivalent to the hippocampus location in vivo, i.e., 3 mm below the skull 







Figure 3.2 – The channel phantom below the ex vivo mouse skull was localized using 
raster scan with the pulse-echo transducer as shown. (a) The first raster scan was used to 
find the position of the vessel while (b) the second raster scan of the RF signal amplitude 
was used to find the position of the left parietal bone, where in previous studies was the 
acoustic window through which to sonicate to target the left-hippocampus region (cross 
symbol). The white bar indicates the grid which was yellow shown in (b). [Image of the 
mouse skull available at http://www.digimorph.org.] 




3.2.1.3 microbubble preparation and sonication 
Definity® microbubbles (Bristol-Myers Squibb Medical Imaging, N. Billerica, MA, 
USA.), which constitute perflutren-filled, lipid-shelled microspheres, were used in our 
experiments. These microbubbles had a mean diameter of about 1.1 to 3.3 μm (Table 2.2), 
with 98% having a diameter lower than 10 μm, and a concentration of around 1.2×1010 
bubbles/mL. In this study, the concentration was diluted in degassed phosphate buffered 
saline (PBS) to 2.5×107 (number of bubbles/mL), which approximated what was used in in 
vivo studies40,41. The concentration (number of bubbles/mL) of microbubbles was measured 
by an automatic particle sizer (Accusizer 780A, NICOMP Particle Sizing Systems, Santa 
Barbara, CA), which used a laser light obscuration and scattering technique. In order to 
ensure that the concentration of the microbubbles did not change over time, e.g., caused by 
a decay of microbubbles, a new batch of diluted bubble suspension was used every 10 
minutes. The same diluted bubble suspension was used for 10 independent sonication sets. 
At each pressure amplitude and PCD angle, five sonication sets were performed in the 
presence, and five in the absence, of the skull. A new phantom was used with each different 
skull, each for 15 – 20 sonication sets. Prior to each sonication set, new microbubbles were 
slowly injected into the vessel formed in order to avoid any change in the microbubble size 
distribution and concentration that may be introduced with a fast bubble injection123. 
Following each sonication set, degassed water was used to remove any remaining 





3.2.1.4 Acoustic emission signal acquisition and analysis 
The acoustic emissions acquired by the PCD were sampled at 80 MHz and processed 
using MATLAB® (2007b, Mathworks, Natick, MA). The resulting signals were analyzed 
using four independent methods: the frequency response of the first pulse of each 
sonication was obtained using a 4096-point FFT (Fig. 3.5), a spectrogram of the first pulse 
(Fig. 3.6), and the spectrogram depicted as the frequency response of the signal versus the 
20 sonication pulses applied (Fig. 3.7), the root mean square (RMS) of the PCD’s recorded 
voltage amplitude (VRMS) for each pulse (Fig. 3.8(a)), and the average across all pulses 
(Fig. 3.8(b)). 
In the calculation of the VRMS and ICD, a highpass filter with a cut-off of 4 MHz was 
first applied to the acquired PCD signal. A comb filter was then used to exclude the ± 150 
kHz range at the transducer’s harmonic (nf, n = 1, 2, …,6), subharmonic (f/2) and 
ultraharmonic (nf/2, n = 3, 5, 7, 9) frequencies124. The ICD was defined as the integral of 
the area under the VRMS curve over the entire sonication duration (2 s in this study). In 
order to reduce the noise in the ICD calculation, the VRMS of water at each pressure 
amplitude was also calculated and was subtracted from the results of the bubble experiment 
to obtain the net bubble response.  
Radiofrequency (RF) data from the linear array was acquired using the Terason system 
and processed using MATLAB®. B-mode imaging was then performed using the Hilbert 
function on the acquired RF data. The change in the B-mode imaging contrast due to 










where Ipre is the intensity of the region of interest (ROI) at the FUS focal region before 
sonication and Ipost is the intensity of the ROI after sonication. The dimensions of the ROI 
were equal to 9.0 × 7.2 mm2. 
A Student’s t-test was used to determine whether the ICD dose or intensity ratio was 
different between the two different pressures. A P-value of P < 0.05 was considered to 
represent a significant difference in all comparisons. 
 
3.2.2  In vivo transcranial cavitation detection in mice 
3.2.2.1 Experimental Setup 
The experimental setup of in vivo transcranial cavitation detection is shown in Fig. 3.3. 
All procedures used on the mice were approved by the Columbia University Institutional 
Animal Care and Use Committee. Twenty-six (n=26) adult male mice (strain: C57BL/6, 
weight: 26.1±1.7g, Harlan Sprague Dawley, Indianapolis, IN, USA) were sonicated. The 
number of nice studied in each pressure were showed in Table 3.1. The animals were 
anesthetized with a mixture of oxygen (0.8 L/min at 1.0 Bar, 21̊C) and 1.5-2.0% vaporized 
isoflurane (Aerrane, Baxter Healthcare Corporation, Deerfield, IL) using an anesthesia 
vaporizer (SurgiVet, Inc. Waukesha, WI). In this study, a grid system which could localize 
the sutures of the murine skull was used for the targeting procedure41. The right 
hippocampus was targeted and the PCD was placed on the right-hand side. The focal point 
was placed 3 mm beneath the skull so that the focal region overlapped with the right 









Figure 3.3 – Block diagram of the experimental setup. The PCD was positioned at a (a) 60⁰
and (b) 90⁰ relative to the longitudinal axis of the FUS beam. The space between latex 
membrane and phantom was degassed water, and the big water tank was not shown on this 
figure. The overlap between the focal region of PCD and FUS was also illustrated in the 
insets. The cylindrical region was the focal region of PCD and the cigar-shaped region was 
the focal region of FUS. The water tank, in which the phantom was immersed, is not shown 







Table 3.1 Number of mice with BBB opening / number of mice studied at each pressure 
  Pressure   
System/PCD 0.15 MPa 0.30 MPa 0.45 MPa 0.60 MPa Total 
A / Hydrophone 0/2 3/3 3/3 3/3 11 
B / Hydrophone  0/2 3/3 3/3 3/3 11 
B / 10- MHz P-E  0/1 1/1 1/1 1/1 4 
 
In order to maintain the stability of the microbubbles, a new vial of Definity® 
microbubbles was activated each time using the manufacturer’s instructions and only used 
for the experiments within 24 h after activation. Following activation, a 1:20 dilution 
solution was prepared using 1x phosphate-buffered saline (PBS) and slowly injected into 
the tail vein (1 µl per gram of mouse body weight). Two different FUS transducers were 
used in this study in order to confirm that FUS-induced BBB opening was transducer 
independent. The first FUS transducer (System-A, center frequency: 1.525 MHz; focal 
depth: 90 mm; outer radius: 30 mm; inner radius 11.2 mm, Riverside Research Institute, 
New York, NY, USA) was the same as in the phantom study and the targeted right 
hippocampus was sonicated one minute after bubble injection. The second FUS transducer 
(System-B, center frequency: 1.5 MHz; focal depth: 60 mm; outer radius: 30 mm; inner 
radius 11.2 mm, model: cdc7411-3, Imasonic, Besançon, France) was used to perform 
sonication immediately following bubble administration with the same acoustic parameters 
as System-A. A single-element pulse-echo (P/E) diagnostic transducer (center frequency: 




positioned through the center hole of the FUS transducer so that the foci of the two 
transducers could be properly aligned.  
  Both transducers used pulsed-wave FUS (burst rate: 10 Hz; burst duration: 20 ms; 
duty cycle: 20%) in two 30-s sonication intervals with a 30-s intermittent delay. Peak-
rarefactional acoustic pressures of 0.15, 0.30, 0.45 and 0.60 MPa were used in this study. 
For both transducers, these values were obtained experimentally in degassed water and 
adjusted to account for murine skull attenuation values of 18.1%. The left hippocampus 
was not targeted and was used as the control for MRI examination. The sonication on the 
right hippocampus without microbubbles could provide the baseline of acoustic emission 
acquired by the PCD. It was shown that the sonication without microbubbles at lower 
pressures (< 2 MPa, peak-rarefactional) would not induce BBB opening41. As a result, the 
net bubble response could be calculated after subtraction from the baseline. 
 
3.2.2.2 Magnetic resonance imaging 
A vertical-bore 9.4T MR system (Bruker Biospin, Billerica, MA, USA) was used to 
confirm the blood-brain barrier opening in the murine hippocampus. Each mouse was 
anesthetized using 1-2% of isoflurane gas and was positioned inside a single resonator. The 
respiration rate was monitored throughout the procedure using a monitoring or gating 
system (SA Instruments Inc., Stony Brook, New York, USA). Prior to introducing the 
mouse into the scanner, intraperitoneal (IP) catheterization was performed. Because the 
MR system underwent a software upgrade during the course of the study, two different 
protocols were used for MR imaging. The first protocol was a three-dimensional (3D), T1-




TR/TE=20/4 ms, a flip angle of 25 deg, NEX of 5, a total acquisition time of 6 min and 49 
s, a matrix size of 256×256×16 pixels and a field of view (FOV) of 1.92×1.92×0.5 cm3, 
resulting in a resolution of 75×75×312.5 µm3. The second protocol was a 3D T2*-weighted 
GEFC gradient echo pulse sequence, which acquired horizontal images using 
TR/TE=20/5.2 ms, a flip angle of 10 deg, NEX of 8, a total acquisition time of 8 min and 
12 s, a matrix size of 256×192×16 pixels and a FOV of 2.25×1.69×0.7 cm3, resulting in a 
resolution of 88×88×437.5 µm3. Both protocols were applied approximately 30 min after 
IP injection of 0.30 ml of gadodiamide (Omniscan®, GE Healthcare, Princeton, NJ, USA), 
which allowed sufficient time for the gadodiamide to diffuse into the sonicated region. 
 
3.2.2.3 Histological analysis  
Five hours after sonication, all mice were sacrificed and transcardially perfused with 30 
ml phosphate buffered saline and 60 ml 4% paraformaldehyde. After soaking the brain in 
paraformaldehyde for 24 hours, the skull was removed and the brain was fixed again in 4% 
paraformaldehyde for six days. The post-fixation processing of the brain tissue was then 
performed according to standard histological procedures. The paraffin-embedded 
specimens were sectioned horizontally at 6-µm thickness section. A 1.2-mm layer from the 
top of the brain was first trimmed away. A total of twelve separate levels that covered the 
entire hippocampus were then obtained at 80-µm intervals. At each level, six sections were 





3.2.2.4 Acoustic emission signal acquisition and analysis 
The acoustic emission signals acquired by the PCD were sampled at 25 MHz in the in 
vivo study to accommodate the highest memory limit of the digitizer involved in each case. 
A customized spectrogram function (30-cycles, i.e., 20 µs, Chebyshev window; 95% 
overlap; 4096-point FFT) in MATLAB® (2007b, Mathworks, Natick, MA) was used to 
generate a time-frequency map, which provided the spectral amplitude in time (Fig. 3.4(a)). 
The spectrogram can then clearly indicate how the frequency content of a signal changes 
over time. Therefore, the onset of the broadband response and its duration could be clearly 
demonstrated on the spectrogram.  
In terms of the quantification of the acoustic emission signal acquisition, the filtering 
technique has been described in the section 3.2.1.4. Here, the root mean square (RMS) of 
the spectral amplitude (VRMS) could be obtained from the spectrogram through filtering 
(Fig. 3.4). Fig. 3.4(a) depicts the spectrogram after high-pass filtering with a 4-MHz cutoff 
and Fig. 3.4(b) showed the corresponding VRMS. To maximize the broadband response 
compared to the sonication without microbubbles, only the first 50 µs of sonication (from 
0.095 ms to 0.145 ms, denoted by the two dash lines in Fig. 3.4 were considered in the ICD 
calculation, which was performed by integrating the VRMS variation within an interval of 
0.75 µs (i.e., calculating the area below the VRMS curve between 0.095 ms and 0.145 ms). 
In order to remove the effect of the skull in the ICD calculation, the VRMS in the case 
without microbubbles was also calculated and was subtracted from the results with the 
microbubbles to obtain the net bubble response. A Student’s t-test was used to determine 
whether the ICD was statistically different between different pressure amplitudes. A P-






3.3.1 Phantom validation of the skull effect 
The frequency response of the first pulse as recorded by the 60º-PCD and 90º-PCD 
configurations, with and without the presence of the skull in the wave propagation path is 
depicted in Fig. 3.5. Without the skull, the frequency spectra in the 60º-PCD and 90º-PCD 
cases are similar. As mentioned in Chapter 2, the frequency response shown in this study 
can be classified into two types125. The first response is generated by stable cavitation, i.e., 
at harmonic, sub-harmonic and ultra-harmonic frequencies. The second response is 
Figure 3.4 – Illustration of the inertial cavitation dose (ICD) calculation of the in vivo 
experiments. (a) The spectrogram of the first pulse from 0.02 to 0.15 ms after a 4 MHz 
high-pass filter (chebshev type 1) at 0.60 MPa. The harmonics and the broadband 
response could be observed in this figure. The corresponding VRMS was depicted in (b) 






generated by inertial cavitation, which will produce broadband acoustic emission. Here, the 
broadband response was detected when the pressure was at, or higher than, 0.45 MPa (Fig. 
3.5(a, c)). This broadband response was used to determine the threshold of inertial 
cavitation for Definity® within the 610-micron-diameter vessel. The skull presence led to a 
decrease in the peak amplitude of all harmonics, but the characteristic broadband response 
was still detected (Fig. 3.5(b, d)). This indicated that the threshold of inertial cavitation of 
0.45 MPa was not dependent on the skull presence. However, comparison of the results 
between the 60º-PCD and 90º-PCD configurations showed that the detection of acoustic 
emissions was influenced by the skull’s presence, i.e., part of broadband response was 
absorbed by the skull (Fig. 3.5(b)). 
The spectrogram of the first pulse as recorded by the 60º-PCD and 90º-PCD 
configurations in the presence of the skull in the wave propagation path is depicted in Fig. 
3.6, which shows that the pressure threshold of the broadband response (or, inertial 
cavitation) was the same between these two PCD configurations, i.e., 0.45 MPa. This 
indicated that the pressure threshold of the broadband response was not affected by the 
skull in vivo. At 0.30 MPa, however, the 90º-PCD could detect the ultra-harmonics but the 
60º-PCD could not, which indicated that the stable cavitation response was filtered by the 
skull. Also, the comparison of the results between the 60º-PCD and 90º-PCD configurations 
showed that the 2nd harmonic would be detected by the 60º-PCD without microbubbles at 
0.30 MPa and the acoustic emission amplitude was influenced by the presence of the skull, 
i.e., the response was partially absorbed by the skull.  
In order to assess the temporal behavior of the bubbles, the frequency response’s 




with and without the skull (Fig. 3.7). The spectrogram also indicated that the skull 
influences the signal at 60º-PCD. The amplitude around the fundamental frequency was 
enhanced by the skull (Fig. 3.7(b)). However, both Figs. 3.6 and 3.7 confirm the threshold 
of inertial cavitation to be 0.45 MPa. 
		
Figure 3.5 –   Frequency response of the first pulse (a,c) through no skull and (b,d) 
through an ex vivo skull at 5 distinct acoustic pressures. Acoustic emissions were 
collected with a PCD positioned at (a,b) 60º and (c,d) 90º from the longitudinal axis of 














Figure 3.6 – Spectrogram of the first pulse in the phantom study without and with the 
microbubbles at 5 distinct acoustic pressures. Acoustic emissions were acquired with a 
PCD positioned at 60º and 90º from the longitudinal axis of the FUS beam. No broadband 
acoustic emissions were detected without the microbubbles while with the microbubbles 
the broadband acoustic emissions were detected at pressure at or higher than 0.45 MPa. At 










Figure 3.7 –    The spectrogram (a,c) without the skull and (b,d) through an ex vivo skull at 
five distinct acoustic pressures. The duration of each sonication was 2 s, i.e., 20 pulses. 
Please note that the broadband acoustic emissions could only be detected at the first two 









Figure 3.8 – (a) Root mean square (VRMS) and (b) ICD at 5 distinct acoustic pressures 
are indicated here. In order to emphasize the difference between 5 distinct acoustic 
pressures, the limit of the y-axis is from 0 to 0.5 at 60º-PCD, with the presence of skull. 
ICD was quantified as the area below VRMS curve, at each pressure. Twenty pulses were 
applied for each sonication set. The ICD at 0.45 MPa was significantly larger than 0.30 








     The broadband response as detected by the PCD was quantified by using the VRMS at 
each pressure amplitude (Fig. 3.8(a)) and the ICD (Fig. 3.8(b)). The ICD, which is shown 
in Fig. 3.8(b), was calculated by taking the integral of the VRMS variation. The VRMS curve 
depicted no significant difference between different pressure amplitudes beyond 1 s. As 
indicated by the ICD calculations (Fig. 3.8(b)), the presence of the skull induced lower ICD 
and the ICD at 60º-PCD was lower than at 90º-PCD. The ICD at 0.45 MPa was statistically 
higher than at 0.30 MPa (P < 0.05), which confirmed that the threshold of inertial 
cavitation was around 0.45 MPa. 
B-mode images acquired after two seconds of sonication were used to depict the spatial 
distribution of microbubbles within the vessel at five different pressure amplitudes, with or 
without the presence of the skull (Fig. 3.9). As the pressure amplitude increased, an 
increasingly dark region in the center of the B-mode image coinciding with the FUS focus 
(Fig. 3.10(a)), representing loss of echogenicity, was observed in the focal region. 
	
Figure 3.9 – B-mode imaging provided a means of determining whether the microbubbles 
were present following sonication. Images were acquired after 2 seconds of sonication at 5 








Figure 3.10 – (a) The illustration of ROI and (b) the correlation between ICD and the 
intensity decrease ratio of B-mode imaging at 5 distinct acoustic pressures (0.30, 0.45, 
0.60, 0.75 and 0.90 MPa). The intensity decrease ratio at 0.45 MPa was significantly larger 






With the skull in place, the dark region appeared only when the pressure amplitude was 
at and above 0.45 MPa, which was consistent with the aforementioned threshold of inertial 
cavitation from the PCD (Fig. 3.8). The spatial maps were compared against the ICD 
measurements. The region of interest (ROI) around the focal region of FUS was traced and 
the intensity ratio (Eq. 3.1) decrease was calculated from the radio frequency (RF) signal 
corresponding to the B-mode images (Fig. 3.10(a)). The intensity ratio was found to be 
statistically different between 0.30 MPa and 0.45 MPa (P < 0.05) (Fig. 3.10 (b)). This was 
also consistent with the results of the ICD quantification.  
 
3.3.2 In vivo transcranial cavitation detection in mice 
The confirmation of BBB opening and the corresponding spectrogram are depicted in 
Fig. 3.11. As a result of the deposition of gadodiamide into the brain parenchyma through 
the BBB opening, the MRI indicated that the threshold of BBB opening was at 0.30 MPa 
(Fig. 3.11(a) and (c)), but the spectrogram showed that the broadband response occurred at 
0.45 MPa (Fig. 3.11(b) and (d)). After bubble administration, higher harmonics could be 
detected, including the 3rd harmonic at 0.15 MPa without BBB opening, the 3rd to 5th 
harmonics at 0.30 MPa with BBB opening, and the 3rd to 8th harmonics together with the 
broadband response and BBB opening at 0.45 MPa and 0.60 MPa. The threshold of inertial 
cavitation was consistent between the two systems (Fig. 3.6(b), (d)) and the duration of the 
broadband response was around 5 µs at 0.45 MPa. However, the duration of the broadband 
response detected from the 10-MHz P/E transducer at 0.60 MPa was 0.5 ms longer than the 
hydrophone, especially at higher frequencies. At 0.30 MPa, not only the 3rd to 5th but also 




harmonic peak between the 7th (10.5 MHz) and 8th harmonics (12 MHz) was detected as 






Figure 3.11 – BBB opening using confirmed by 3D-MRI images, using (a) System-A and 
(c) System-B. The corresponding spectrograms of the first pulse using (b) System-A and (d) 
System-B showed that the broadband acoustic emissions were detected at 0.45 MPa and 
0.60 MPa but not at 0.15 MPa and 0.30 MPa. The 3D-MR images confirmed that the BBB 









The broadband response as detected by the PCD was quantified using the ICD (Fig. 
3.12). As indicated by the ICD calculations, the ICD at 0.45 MPa and 0.60 MPa was 
statistically higher than at 0.30 MPa and 0.15 MPa (P < 0.05) (Fig. 3.12(a)), which 
confirmed that the threshold of inertial cavitation during the BBB opening was around 0.45 
MPa. The histological findings are shown in Figs. 4.13 and 4.14. In the cases of BBB 
opening at 0.30 MPa and no BBB opening at 0.15 MPa confirmed by 2D-MR horizontal 
images, no cell damage, e.g., red blood cell (RBC) extravasations or neuronal death 91, was 
observed after histological examination (Fig. 3.13 and 4.14, (a-f)). In the cases of BBB 
opening at 0.45 MPa, no extravasations were detected in the sonicated brain regions (Fig. 
3.13 and 4.14, (j-l)) even though a broadband response was detected (Fig. 3.11(b), (d)). 
Brain samples sonicated at 0.60 MPa showed higher incidence of microscopic damage at 
multiple distinct damaged sites (Fig. 3.13 and 4.14, (j-l)). The exposure pressures that 















Figure 3.12 – The inertial cavitation dose (ICD) at 4 distinct acoustic pressures (a) using 
the System-A and (b) using the System-B. ICD was quantified as the area under the 
VRMS curve from 0.095 ms to 0.145 ms, at each pressure. The signal used for 
quantification was from a focused hydrophone. For the System-A, the ICD at 0.45 MPa 
and 0.60 MPa was significantly higher than 0.15 MPa and 0.30 MPa (*: P < 0.05). For 
the System-B, the ICD at 0.60 MPa was significantly higher than at 0.30 MPa and 0.15 






























Figure 3.13 – 2D-MRI images and H&E-stained horizontal sections of the BBB-opened 
hippocampi at (a-c) 0.15 MPa, (d-f) 0.30 MPa, (g-i) 0.45 MPa, and (j-l) 0.60 MPa using the 
System-A with microbubbles administration. Sonicated brains at 0.15 MPa, 0.30 MPa and 
0.45 MPa showed no histological damage. Brain samples sonicated at 0.60 MPa (j-l) 
showed higher incidence of microscopic damage at multiple distinct damaged sites. Black 
arrows point to the RBC extravasations. Black boxes in the left and middle column indicate 
the enlarged regions shown in the middle column and right column, respectively. 
Magnifications and scale bars in (a,d, g, j) were 40x and 200 μm, in (b, e, h, k) 100x and 










Figure 3.14 – 2D-MR images and H&E-stained horizontal sections of the BBB-opened 
hippocampi at (a-c) 0.15 MPa, (d-f) 0.30 MPa, (g-i) 0.45 MPa, and (j-l) 0.60 MPa using the 
System-B with microbubbles administration. Sonicated brains at 0.15 MPa, 0.30 MPa and 
0.45 MPa showed no histological damage. Minor microscopic damage was noticeable in 
one location of the right hippocampus sonicated 0.60 MPa, constituting one distinct 
damaged site (g-i). Black arrows point to RBC extravasations. Black boxes inside the left 
and middle column showed enlarged regions in the middle and right columns, respectively. 
Magnifications and scale bars in (a,d, g, j) were 40x and 200 μm, in (b, e, h, k) 100x and 






3.4.1 Phantom validation of the skull effect 
The peak-rarefactional pressure threshold of inertial cavitation in the presence of 
preformed microbubbles in a vessel phantom by FUS in the absence or presence of a skull 
was investigated in this chapter. Qualitatively and quantitatively, the threshold of inertial 
cavitation was identified to be at the peak-rarefactional pressure of 0.45 MPa with or 
without an ex vivo skull in place (Figs. 3.4-3.10). The frequency spectrum of the first pulse 
showed that the broadband response appeared when the pressure was at, or higher than, 
0.45 MPa (Fig. 3.5). Spatial mapping using B-mode imaging provided further evidence of 
bubble disruption caused by inertial cavitation (Fig. 3.9). The decrease in echogenicity was 
consistent with the emergence of the broadband response shown in Fig. 3.5, which 
demonstrated that the microbubbles were disrupted by inertial cavitation. Quantitative 
results of spatial maps also showed that the image intensity ratio (Eq. (3.1)) at 0.45 MPa 
was larger than at 0.30 MPa (P < 0.05). Hence, both the PCD frequency response and the 
spatial information from B-mode imaging could be used to determine the threshold of 
inertial cavitation.  
This study also investigated the effect of the skull to predict feasibility in in vivo 
transcranial applications where transcranial cavitation detection is required. At the same 
pressure amplitude, the ICD was lower in the presence of the skull (Fig. 3.8(b)), which 
showed that the acoustic wave was distorted by the skull. In order to reduce skull thickness 
effects being responsible for the difference between the 0º and 60º cases, based on our 




was around 5 mm2 which would cover the ultrasound path for both the 0º and 60º cases. 
When the PCD was placed at 60º, the PCD signal amplitude was the lowest because the 
acoustic wave propagated through the skull twice (Fig. 3.5(b), Fig. 3.8(b)). However, the 
quantification showed that the significant broadband response could still be detected at 60º-
PCD (Fig. 3.8(b)). Hence, the PCD system used in this study might be suitable for the in 
vivo applications.  
The broadband response appeared when the microbubbles were sonicated at or above 
0.45 MPa. The broadband response at 0.90 MPa persisted for approximately 0.5 s, which 
was consistent with the VRMS curves (Fig. 3.8(a)). Inertial cavitation may have caused 
microbubble destruction, thus hampering the likelihood of subsequent inertial cavitation. 
However, harmonics were still detectable during the entire sonication at each pressure 
amplitude (Fig. 3.7) and these harmonics appears to have been due to microbubbles (Fig. 
3.15(b)), as they were absent in the degassed water filled vessel (Fig. 3.15(a)). Figure 8 
showed that only the 1st and 2nd harmonics appeared when degassed water was sonicated, 
while distinct 1st to 6th harmonics were observed in the presence of microbubbles. There are 
three possible explanations for this phenomenon. First, since the focal region of the PCD 
was larger than the focal region of FUS (Fig. 3.1), the harmonics may be due to the 
oscillation of microbubbles, which were near the focal region of FUS but had not 
experienced the full extent of the peak pressure amplitude. Second, some microbubbles 
may have adhered to the vessel wall and they continued to be acoustically driven. Third, 
the initial microbubbles may have been disrupted into smaller bubbles, which were not 
detectable on the B-mode images. These smaller bubbles could then be acoustically driven 





Quantitative results of the frequency response and spatial maps indicated the threshold 
of inertial cavitation (Fig. 3.10(b)). When the pressure was higher than 0.60 MPa, no 
significant difference was shown in the intensity ratio, since the microbubbles in the focal 
region might have completely disappeared after 2 s of sonication. In contrast, the ICD 
increased exponentially when the pressure exceeded the threshold of inertial cavitation.  
 Here, we provided a simplified method to show that the ICD was influenced by the 
skull unlike the threshold of inertial cavitation. This implied that, if the BBB is opened at 
0.30 MPa74, the mechanism involved at that pressure may be stable cavitation. However, 
some issues remain to be investigated further in order to understand the mechanism of BBB 
opening. The diameter of the vessel in this study was 610 μm, which was larger than most 
murine vessels. The internal carotid artery of the mouse brain has a diameter of 218±19 
μm126. The compliance or stiffness of the vessel also influences the bubble behavior 110. 
Therefore, a smaller diameter vessel phantom should be implemented to confirm the 
	
Figure 3.15 – Comparison between (a) water and (b) bubble experiments without skull 
for spectrogram from 90º-PCD at 0.90 MPa. Broadband acoustic emissions and the 





threshold of inertial cavitation of microbubbles within smaller vessels, such as 100 to 300 
μm, will not be affected by the skull. 
No flow effects were investigated in this study unlike in the in vivo case. The 
concentration of microbubbles may also affect the threshold of inertial cavitation, which 
has been shown to decrease with the concentration of microbubbles in the vessel 
phantom127. The effect of flow and concentration will be investigated in future 
implementations.  
The PCD sensitivity also needs to be considered. The broadband response captured by 
the PCD is dependent on its sensitivity. The results of this study showed that the threshold 
of inertial cavitation was equal to 0.45 MPa. However, it might be possible that the 
broadband response was not captured at 0.30 MPa because the PCD sensitivity was not 
high enough. However, based on the complementary results of the spatial maps from the B-
mode imaging, we believe that the sensitivity of the PCD used in this study is deemed 
sufficiently high. 
Two different angles of PCD were used to understand whether the results will be 
influenced by the presence of the skull. At 0.30 MPa without the skull, some signal at 60º-
PCD (Fig. 3.5(a)) was higher than at 90º-PCD (Fig. 3.5(c)). The signals obtained by 60º-
PCD may include some reflected signals from the surface of the phantom, which may not 
have been captured by 90º-PCD. The PCD used in this study had a cylindrical focus, which 
was ideal when the hydrophone was positioned perpendicular to the focused ultrasound 
transducer’s main axis. When positioned in this manner, the cylindrical focal region closely 
matches the ellipsoidal shape of the FUS focal spot (Fig. 3.1(b)). If the PCD is placed at a 




surface of the phantom and the effect of the skull will also be observed. Therefore, it may 
be better to place the PCD at 90 degrees for vessel phantom experiments. 
  
3.4.2 In vivo transcranial cavitation detection in mice 
The presented study noninvasively detected in vivo acoustic emissions during FUS-
induced BBB opening and showed that BBB could be opened without inertial cavitation or 
cell damage. The reliability, sensitivity, and transcranial capability of our PCD setup to 
detect acoustic emissions was validated first in a phantom119. Broadband emission, a 
signature of IC, could be detected transcranially (with the 60º-PCD configuration) and the 
IC threshold was identical to that at 90º-PCD (non-transcranial PCD). Hence, the PCD 
system used in this study was deemed suitable for transcranial in vivo detection of inertial 
cavitation. 
Both the phantom and in vivo studies indicated that the threshold of inertial cavitation 
during BBB opening was at the peak-negative pressure of 0.45 MPa. This was verified 
qualitatively and quantitatively. When the sonication was performed one minute after 
bubble administration, the bubble concentration in the mouse body would decrease because 
the increased circulation time would increase the probability of bubble disruption, 
dissolution, absorption and clearance. However, the threshold of the broadband response 
was not affected by this one-minute delay, which indicated that the variation of bubble 
concentration within one minute inside the capillaries of the brain does not significantly 
affect the threshold of inertial cavitation. 
Our findings indicated that the BBB remained intact at 0.15 MPa and opened at 0.30 




confirmed using fluorescence imaging74,91. In addition, a broadband response was not 
detected at the pressure of 0.30 MPa. Our findings were in good agreement with 
McDannold et al.’s findings that indicated that the BBB in the rabbit after craniotomy 
would be intact at 0.14 MPa and open at 0.29 MPa. The threshold of broadband response 
was also found to fall around 0.40 MPa in their study. On the other hand, they proposed 
that the second and third harmonics may be used to monitor BBB opening. However, in our 
study, the third harmonic could not be used to monitor BBB opening because it could still 
be detected at 0.15 MPa, which was shown not to induce BBB opening. Based on the 
results of our phantom study, at 0.30 MPa, the ultra-harmonics were effectively filtered by 
the skull (Fig. 3.6), which suggested that the stable cavitation might be responsible for 
BBB opening at 0.30 MPa in vivo and that the associated ultra-harmonics could not be 
detected by the broadband hydrophone, potentially due to sensitivity limitation and the 
skull presence (Fig. 3.11(b)). However, the signals from 10-MHz P/E transducer with in 
vivo implementation (Fig. 3.11(d)) showed that not only could higher harmonics be 
detected at 0.30 MPa but also the ultra-harmonics at 11.25 MHz. Therefore, both 
transcranial phantom and in vivo studies showed that BBB opening might be induced by 
stable cavitation only, at or near the opening threshold. 
 In the in vivo study, the fourth and fifth harmonics could be detected and associated 
with BBB opening at 0.30 MPa (Fig. 3.11(b, d)). This was also consistent with our 
phantom work, which indicated that the fourth and fifth harmonics were detected at 0.30 
MPa by the 60º-PCD (Fig. 3.6). At 0.30 MPa, nonlinear oscillations may induce the fourth 
and fifth harmonics, and bubble expansions may lead to BBB opening. In simulations, the 




the fourth and fifth harmonics of 1.5 MHz128,129. As a result, the fourth and fifth harmonics 
detected by the broadband hydrophone might serve as a reliable indicator for BBB opening. 
 The spectrogram used in this study could clearly elucidate the onset and duration of IC 
within a signal pulse. In this study, the IC occurred at the beginning of sonication and the 
longest duration was around 50 μs as detected by the hydrophone (Fig. 3.11(b)) and 500 µs 
as detected by the 10-MHz P/E transducer (Fig. 3.11(d)) at 0.60 MPa. The overlap of the 
focal regions of the FUS and the 10-MHz P/E transducers was larger than with the 
broadband hydrophone, hence the longer duration of inertial cavitation detected. Therefore, 
the System-B will be used in the following in vivo studies in mice. 
At 0.45 MPa, the broadband response was detected at the first but not the second pulse. 
However, at 0.60 MPa, a broadband response was detected in the first three pulses. A likely 
explanation for this may be that the pulse repetition frequency (PRF) used in this study was 
not low enough to allow blood reperfusion in the capillaries between pulses. As a result, the 
microbubbles were disrupted after the first pulse but not a sufficient number of 
microbubbles replenished the vessel within the interval of 80 ms (20% duty cycle, PRF = 
10 Hz). However, harmonics could be detected at each pulse. Since the focal region of the 
PCD was larger than the FUS focal region (Fig. 3.3), the harmonics may be due to the 
nonlinear oscillation of the microbubbles, which were near the FUS focal region but were 
not activated at the highest pressure amplitude. 
In the phantom study, the sub-harmonic and ultra-harmonics were clearly detected at 
0.30 MPa when the detection was performed without the skull in the PCD path, i.e., in the 
90º-PCD case, but it was masked by the skull at 60º-PCD. In the in vivo study, sub-




filtered by the skull. Since the broadband response is more commonly associated with 
inertial cavitation, inertial cavitation was detected and quantified through the measurement 
of broadband emissions at different pressures.  
The histological results in this study were consistent with existent literature that 
investigated the relationship between tissue damage and inertial cavitation113,130. Some red 
blood cell extravasations were induced at 0.60 MPa but no extravasations could be found at 
0.15, 0.30 or 0.45 MPa. Even with higher ICD estimated at 0.60 MPa, the extravasations 
were limited to 2-3 sections. However, in order to investigate more specific forms of 
cellular damage (i.e., apoptosis), more sensitive staining protocols, such as TUNEL, will be 
applied in future studies. 
Standing waves might also be generated due to the long pulse lengths used in our in 
vivo study that may lead to peak pressure variations within the mouse brain. However, in 
this study, the threshold of inertial cavitation was identical between the phantom and in 
vivo studies, which indicated that the standing wave effects might not be significant in vivo. 
This is in agreement with simulation findings predicting the standing wave effects 
intracranially131. Figure 3.11 also showed that the inertial cavitation occurred at the 
beginning of sonication. Therefore, our results on the IC threshold may be independent of 
the number of cycles and thus potential standing wave effects. Of course, we might have to 
take into account the fact that the in vitro (atmospheric) and in vivo (i.e., capillary) 
pressures were not the same. However, the identical threshold of BBB opening across all 





Since two systems and poly-dispersed microbubbles were used in this chapter, it is 
difficult to identify the role of stable cavitation. In order to determine the effect of stable 
cavitation with distinct microbubble diameter, the stable cavitation dose will be quantified 
in the next chapter. 
Because the bubble response could be detected through the skull, more parameters 
should be investigated to unveil the mechanism of BBB opening. Different PRF could be 
applied to obtain the blood velocity, which will affect the reperfusion rate of microbubbles. 
The microbubbles used in this study were commercial ultrasound contrast agents, which 
were poly-dispersed. Because the threshold of BBB opening was shown to be higher for 
the 1-2 µm than the 4-5 µm bubbles56, the size-dependent threshold of inertial cavitation 
will be investigated to identify the role of different bubble diameters on the inertial 
cavitation and BBB opening, which will be described in detail in Chapter 4.. Finally, a 
smaller pressure step size can be used to identify a more precise IC pressure threshold 
associated with BBB opening by using more sensitive instrumentation. 
 
3.5 Conclusion 
In summary, preliminary investigation on the in vivo transcranial cavitation detection 
and quantification of the inertial cavitation activity during BBB opening was presented. 
The bubble behavior was shown detectable in mice in vivo through the intact scalp and 
skull. The threshold of inertial cavitation using transcranial FUS and microbubbles in a 
vessel phantom was also investigated to provide complementary information to the in vivo 
findings. This novel system will allow us to investigate the role of microbubbles and 








Chapter 4  
Microbubble-Dependent Mechanism 
of Blood-Brain Barrier Opening Using 







In Chapter 3, an in vivo transcranial cavitation detection system was successfully 
developed. Then deeper investigations regarding the bubble property and acoustic 
parameters should be performed. Since microbubbles are the necessary agents to induce a 
safe BBB opening, their role needs to be thoroughly investigated. In this chapter, we aim at 
understanding how the interaction between microbubbles and ultrasound-induced BBB 
opening and corresponding permeability. Following the development of in vivo transcranial 
PCD system, this system was applied to order to unveil the physical effects of different 
microbubble properties, including diameter and shell component, responsible for FUS-
induced BBB opening, 
Typically, most reported studies in FUS-BBB opening use commercially available and 
poly-dispersed microbubbles, such as Definity®, Optison®, or Sonovue®. Thus, it has been 
difficult to determine the role of the microbubble properties in those applications. The 
bubble diameter is inversely proportional to the resonance frequency, when every other 
bubble parameter remains the same. For a bubble constrained in a vessel, regardless of the 
shell property, the resonance frequency increases when the bubble size decreases128,132. For 
example, when the bubble is confined in a compliant, 10-µm-diameter vessel, its resonance 
frequency at a diameter of 2 µm, 4 µm, 6 µm and 8 µm is 3.92 MHz, 1.93 MHz, 1.41 MHz 
and 1.26 MHz, respectively132. When microbubbles are confined within a vessel, the 
bubble behavior changes due to the vessel wall constraints. Some numerical studies have 
predicted how the vessel size and stiffness affect the bubble behavior. In rigid vessels, it 




diameter decreases128. The resonance frequency of microbubbles also decreases as the 
vessel compliance decreases132,133.  
Therefore, the frequency of the FUS used in this study (1.5 MHz) is close to the 
resonance frequency of 4-5 µm bubbles. High-speed camera findings have also indicated 
that the pressure threshold of bubble fragmentation increases with bubble size105. Recently, 
mono-dispersed microbubbles were shown as an important factor in high frequency 
ultrasound imaging134. It has also been shown that the pressure threshold of BBB opening 
is bubble-size dependent. The threshold of 1-2-µm bubbles was higher than that of 4-5-µm 
microbubbles56, which underlined the importance of the microbubble role in BBB opening. 
Hence, the physical mechanism of FUS-induced BBB opening may also be bubble-size 
dependent, so understanding the role of different microbubble sizes is very important to 
unveil the physical mechanism of BBB opening.  
Besides the diameter, the shell has been shown to dictate bubble behavior. The main 
shell constituent is lipid/surfactant, albumin, and lipid for the Definity®, Optison®, and 
Sonovue® bubbles, respectively. The pressure threshold of inertial cavitation has been 
shown to differ between the aforementioned contrast agents135. Because the shell and 
diameter range distribution of commercial microbubbles are different, both factors need to 
be investigated. Theoretical models have shown a clear dependence of the bubble wall 
velocity, attenuation coefficient in a bubbly liquid, and resonance frequency on the 
viscosity of the surface layer136,137. The increase in shell stiffness and shell friction would 
increase the damping coefficient, and affect the oscillation138. Therefore, it is expected that 
stiffer shells may undergo smaller expansion during oscillation. Recently, Marmottant et al. 




Moreover, it has been shown that the acyl-chain length (i.e., lipid hydrophobic chain) 
dictates the dissolution behavior of the lipid monolayer-coated microbubbles140 and the 
ultrasound-induced microbubble fragmentation141. The surface shear viscosity of the 
phospholipid monolayer-coated microbubbles has also been found to be acyl-chain length 
dependent142. In addition, some studies have shown that the polyethylene glycol (PEG), an 
additional component of the lipid shell composition, may affect the fraction of the bubble 
fragmentation induced by inertial cavitation143,144. Therefore, shell effects are expected to 
affect the acoustic response from microbubbles. Until now, however, most models or 
experimental studies were implemented on a single free bubble, i.e., not in vivo. The bubble 
behavior may be affected due to wall constraints when the bubble is confined within a 
vessel. It has been shown that the microbubble resonance frequency decreases, and the 
pressure threshold of inertial cavitation increases, as the vessel diameter or compliance 
decreases128,145. The expansion ratio (R(t)/R(0)) of a microbubble in a 8-µm capillary is 
half of a free bubble132. The shell effect is still unknown in vivo, especially in the brain 
vasculature. 
The objective of this chapter was to unveil the physical effects of microbubble diameter 
and shell properties responsible for FUS-induced BBB opening. First, the physical effects 
of different microbubble sizes were determined. Microbubbles were size-isolated into 1-2, 
4-5, and 6-8-µm diameter ranges and the acoustic response of different-sized microbubbles 
were transcranially detected during BBB opening. Second, we proposed a method to 
investigate the effect of lipid shell composition on the microbubble response in the brain 
vasculature. In order to exclude the impact of bubble size, the diameter of microbubbles 




MRI was used to determine the threshold of BBB opening and the BBB opening volume, 
as well as to generate the permeability maps based on the kinetic model determined from 
previous study (Appendix). Second, during BBB opening, the acoustic emission from 
microbubbles with three diameters or with three acyl-chain lengths was detected 
transcranially and noninvasively. The spectrogram, stable cavitation dose (SCD), and 
inertial cavitation dose (ICD) were then generated to identify the threshold of inertial 
cavitation and the bubble behavior of distinct bubble properties. Third, in each study, 
histology was used to detect any macroscopic effects of BBB opening and T2 images were 
used to assess the possibility of hemorrhage in the sonicated area.  In addition, in order to 
determine the precise PRP threshold of inertial cavitation of each microbubble diameter, 
simulation based on several theoretical models and phantom validation were implemented.  
 
4.2 Theoretical models for microbubble oscillation 
Microbubbles are the necessary agent to induce BBB opening within safe pressure 
ranges (i.e., by avoiding the thermal effects). Since the theoretical model about 
microbubbles can be used to explain the bubble behavior, including the radius, bubble wall 
velocity, and frequency response, an appropriate theoretical model will be used for the 
simulation to identify the behavior of lipid-shelled microbubbles under FUS. A variety of 
models have been developed to study bubble dynamics in liquids, Qin et al.146 provided a 
detailed description regarding bubble behavior simulation, including some main models, 
such as the classic Rayleigh-Plesset equation about unshelled bubble in incompressible 
unbounded liquid147, Keller and Miksis equation about liquid compressibility148, and shell 




shell property has been proposed in 1995139. Since the microbubbles used in our study, 
Definity® and mono-dispersed microbubbles, are phospholipids shell, this model will be 
used to explain the bubble behavior in our studies. 
 
4.2.1 Oscillation of a free air and a shelled microbubble 
Bubblesim, an ultrasound contrast bubble simulation codes, was used for estimating the 
radial oscillation and scattered sound from an ultrasound contrast bubble under acoustic 
field. Bubblesim was developed by Dr. Hoff and was in collaboration with the Acoustics 
Group at the Department of Telecommunications and with the Department of Physiology 
and Biomedical Engineering, both at NTNU, the Norwegian University of Science and 
Technology, in Trondheim, Norway149. 
It was implemented as a toolbox in MatlabTM program (Math Works, Natick, MA) on a 
PC to solve the model of microbubbles and to plot the variation of some parameters 
(velocity of bubble wall, radius, etc…). Fig. 4.1 showed the basic interface of the 
Bubblesim. Here the R-P with radiation damping equation was the main model for the 
response of a bubble behavior under the ultrasound pulse. Most parameters (Pulse 
Amplitude, Pulse Length, Pulse Center Frequency, Sample rate and Bubble Radius) were 
the same as the experimental situation. 
    The shell model was also considered in Bubblesim. Regarding the property of the 
shell material, most of them were in general not known. Therefore, in this experiment, 
several literatures were searched to find the related parameters about the shell. An optical 
method was developed to measure the resonance frequency of contrast agent. Under this 




set for 3 nm and the shell viscosity was 0.19 Pa•s150. The shell shear modulus of 
microbubble was measured based on the observation of effects of ultrasound radiation 
force. The shear modulus of phospholipid shell was 32 MPa150.  The aforementioned 
parameters will be then applied into Bubblesim to obtain the oscillation of shelled 
microbubbles. 
    
		
Figure 4.1 – The graphical user interface of bubblesim used to specify bubble, pulse and 




4.2.2 Oscillation of a lipid-shelled microbubble 
Fig. 4.2 shows three states during the oscillation of the lipid-shell bubble. When the 
lipid molecules are larger than the bubble surface area (i.e. bubble compression until	ܴ ൑
	ܴ௕௨௖௞௟௜௡௚), the surface tension will be equal to zero. The bubble surface tension will be 
equal to the water surface tension when	ܴ ൒ 	ܴ௥௨௣௧௨௥௘ௗ. The bubble will behave elastically 
between those two states. The main equations are as follows: 
	
















ۓ 0																																						݂݅	ܴ ൑ 	ܴ௕௨௖௞௟௜௡௚
	ݔ ൬ ோమோ್ೠ೎ೖ೗೔೙೒మ െ 1൰ 						݂݅	ܴ௕௨௖௞௟௜௡௚ ൑ 		ܴ ൑ 	ܴ௕௥௘௔௞ି௨௣
			ߪ௪௔௧௘௥																								݂݅	ݎݑ݌ݐݑݎ݁݀	ܽ݊݀	ܴ ൒ 	ܴ௥௨௣௧௨௥௘ௗ







R Bubble radius 
ሶܴ  The velocity of bubble wall 
ሷܴ  The acceleration of bubble wall 
P0 The hydrostatic pressure 
Pac The acoustic pressure  
ߪ surface tension 
ρ Liquid density, 103 kg/m3
ߛ Polytropic exponent, 
c Speed of sound in the liquid, 1500 m/s 
ߤ Liquid viscosity, 10-3 Pa 
k Shell viscosity 10
-9, 10-8, and 2.5 x 10-8 kg/s for 1-2, 4-5, and 6-8-µm 
microbubbles 





4.3 Materials and Methods 
4.3.1 Mono-dispersed microbubbles 
4.3.1.1 Microbubble size distribution  
In general, as shown in Fig. 4.3, the distribution of Definity® is not well centralized 
around a certain diameter. In this chapter, Lipid-shelled microbubbles with three different 
diameters (1-2, 4-5 and 6-8 µm) were in-house manufactured and size-isolated using 
differential centrifugation described by Feshitan et al.151. The concentration was diluted 
from a higher concentration to approximately 107 numbers / mL after microbubble 
administration and the sonication was performed immediately after microbubble 
administration. microbubble size distributions and concentrations were determined by laser 
light obscuration and scattering (Accusizer 780A; NICOMP Particle Sizing Systems, Santa 
Barbara, CA, USA). The number- and volume-weighted size distributions before and after 
	
Figure 4.2 – The illustration of dynamic surface tension of a lipid-coated bubble as 




(~8h later) the experiments (those were unused bubbles obtained from the same vial at 
those times) are shown in Fig. 4.4, which shows that the microbubbles used for BBB 
opening remain stable. In the study of the size effect, two sets of 1-2-µm diameter bubbles 
were found not to be stable after the experiments, i.e., the peak in the number distribution 
was still 1-2 µm, but the peak of the volume distribution had shifted to larger diameters 
(around 4-8 µm). However, the results of the two vials were statistically different from the 
4-5-µm and 6-8-µm diameter bubbles, which led to the conclusion that the number 








Figure 4.3 – The size distribution of the Definity® microbubbles (a) according to the 
number concentration and (b) volume fraction was characterized. This indicated that the 
size distribution of Definity® microbubbles was not well centralized. 







Table 4.1 Abbreviations, molecular weight, viscosity, and gel-liquid transition temperature 
of each acyl-chain length 
Property 
Acyl-chain Abbreviations M.W. Viscosity (mN s/m)142 Tm(°C)142 
C16 DPPC 734.05 1 41 
C18 DSPC 790.16 3 55 
C24 DLgPC 958.48 22 80 
 
Figure 4.4 – Size distributions of 3 mono-dispersed microbubbles are depicted as number-
weighted percent of the total concentration of bubbles and volume-weighted percent of the 
total volume of bubbles. Before in vivo experiment, the distribution is centralized at 1-2 
µm, 4-5 µm, and 6-8 µm (solid black). Distribution analysis is performed again at the same 




4.3.1.2 Microbubble shell materials 
In the study of the shell effect, lipid-shelled microbubbles with three different acyl-
chain lengths (C16, C18, and C24) were manufactured and size-isolated in-house with a 4-
5-µm diameter. The concentration was diluted from a higher concentration to 
approximately 8 x 108 bubbles / mL before microbubble administration and sonication was 
performed after microbubble administration. microbubble-size distributions and 
concentrations were determined by the electrical impedance sensing zone method 
(Multisizer 3, Beckman couter, Brea, CA, USA). The properties, including the molecular 
weight (M.W.), viscosity and get-to-liquid crystalline phase-transition temperature, of the 
three acyl-chain lengths are shown in Table 4.1.  
 
4.3.2 Sonication protocol 
4.3.2.1 In vivo study for BBB opening properties assessment 
Different numbers of mice are used in three distinct studies shown in this chapter. First, 
in the study of the bubble-size effect, 67 mice were sonicated at 0.15, 0.30, 0.45, or 0.60 
MPa. The number of mice used at each pressure and bubble size is shown in Table 4.2. 
Second, in the study of the shell effect, 0.15, 0.225, 0.30, 0.45, and 0.60 MPa peak-
rarefactional acoustic pressures were used on 31 mice. The number of mice used at each 
pressure and acyl-chain length was provided in Table 4.3. 
The experimental setup has been mentioned in section 3.2.2 (Fig. 3.3(b)) and the 
experimental timeline was shown in Fig. 4.5. The pulse length, pulse repetition frequency 
(PRF) and the total sonication duration were respectively 100 cycles, i.e., 67 µs, 10 Hz, and 




to obtain the baseline of acoustic response used in the quantification of cavitation dose. The 
mice were sacrificed 3 hrs or 7 days after sonication for histological analysis. The 
procedure has been described in section 4.2.2.3. 
 
Table 4.2 Number of mice studied at each pressure and each bubble size 
  Pressure (MPa) # of mice
Diameter 0.15  0.30 0.45 0.60  67
1-2 µm 3 6 6 8 23
4-5 µm 4 7 6 6 23 
6-8 µm 3 6 5 7 21 
 
Table 4.3 Number of mice studied at each pressure and each acyl-chain length 
 Pressure (MPa) # of mice
Acyl-chain 0.15 0.225 0.30 0.45 0.60 31
C16 1 1 2 2 3 9
C18 1 1 3 3 3 11 








4.3.2.2 Phantom validation for IC threshold determination 
As mentioned in section 3.2.1.1,   the same materials for the vessel phantom are used 
here for 3 different microbubble diameters.  Each sonication set includes a pulse length of 
100 cycles (67 μm) and a pulse repetition frequency (PRF) of 10 Hz. The total duration of a 
sonication set is 2 seconds (i.e. 20 pulses). Five sonications are done in a row with a space 
of 5 mm in between each focus, and repeated for three times with fresh microbubble 
administration. Acoustic signals emitted from microbubbles are obtained for each pulse. 
The peak rarefactional pressure amplitude ranges between 0.15 and 0.60 MPa at a 0.05 
MPa step size as calibrated in previous studies40,41 
 
4.3.3 MRI protocol 
All the mice were imaged in a 9.4 T microimaging MRI system (DRX400, Bruker 
Biospin, Billerica, MA, USA). Each mouse was scanned 30-40 minutes after sonication, 
using a 30-mm-diameter single resonator. Isoflurane gas (1-2%) was used to keep the 
mouse anesthetized at 50-70 breaths/min during the entire MRI procedure. Dynamic 
contrast-enhanced MR imaging (DCE-MRI) was performed using a 2D FLASH T1-
weighted sequence of a 192×96 matrix size (reconstructed to 256×128), a spatial resolution 
of 130×130 μm2 (reconstructed to 98×130 μm2), a slice thickness of 600 μm (no interslice 
gap), a flip angle of 70°, TR/TE=230/2.9 ms, NEX=4 and a scan time of 88 s. Forty 
dynamic acquisitions were made over a total period of 60 min. Each acquisition produced 
20 horizontal slices that covered the entire mouse head. Upon completion of the second 
dynamic acquisition, a 0.30 mL non-diluted bolus of gadodiamide (Gd-DTPA) was 




relatively large dosage of contrast agent was preferred in order to secure the presence of a 
bolus peak in the vascular system, which is essential for the AIF determination, but also to 
have a clearer depiction of the extent of BBB opening. Gd-DTPA has been shown to 
reduce the longitudinal relaxation time when excreted in the extravascular extracellular 
space (EES), thus enhancing the T1 signal intensity, where the BBB opening has occurred. 
Upon completion of DCE-MRI, a 2D FLASH T1-weighted sequence (TR/TE=230/3.3 ms; 
flip angle: 70°; NEX=18; scan time: 9 min 56 s) with higher spatial resolution (matrix size: 
256×192; spatial resolution: 86×86 μm2; slice thickness: 500 μm with no interslice gap) 
and a 2D RARE T2-weighted sequence (TR/TE=3300/43.8 ms; echo train: 8; NEX=10; 
scan time: 9 min 54 s; matrix size: 256×192; spatial resolution: 86×86 μm2; slice thickness: 
500 μm with no interslice gap) were acquired. 
The kinetic model used here to generate permeability map was developed by Vlachos et 
al. and is summarized in Appendix A. The volume of BBB opening was quantified using 
Medical Image Processing, Analysis, and Visualization software (MIPAV, Center for 
Information Technology, National Institutes of Health, Bethesda, MD, USA). In each 2D 
horizontal image, an intensity threshold was determined from the left hippocampal region. 
A levelset volume of interest (VOI) was then used to analyze the intensity values and 
identify the contour boundary of the BBB opening, where the intensity was higher than a 
pre-specified threshold. After defining the area and the thickness of each slice, the BBB 






4.3.4 Acoustic emission signal processing 
The acoustic emission detected by the PCD was sampled at 100 MHz and a customized 
spectrogram function (24-cycles, i.e., 16 µs, Chebyshev window; 98% overlap; 4096-point 
FFT) in MATLAB® (2007b, Mathworks, Natick, MA) was used to generate a time-
frequency map, which provided the spectral amplitude in time and frequency. The 
spectrogram can then clearly indicate how the frequency content of a signal changes over 
time. Therefore, the duration of the broadband response can be demonstrated using the 
spectrogram. In order to obtain the stable cavitation dose, the root-mean-square (RMS) 
spectral amplitude with a 100-kHz bandwidth of each ultra-harmonic frequency (2.5f to 
7.5f) was calculated. The quantification of ICD has been shown in section 3.2.1.4. In 
general, the cavitation dose was defined as the area under the time-amplitude curve of the 




4.4.1 Bubble size dependent BBB opening properties 
4.4.1.1 In vivo BBB opening investigation 
The qualitative results, including 3D T1-weighted MR images, spectrogram of the first 
pulse permeability maps, and histological analysis of each pressure and microbubble 
diameter are depicted in Fig. 4.6. Here, only the second harmonic is present at 0.60 MPa in 
the spectrogram without microbubble administration, which has been shown in chapter 3. 




microbubble effects (Fig. 4.6). 3D coronal, sagittal and horizontal T1-MR images were 
used to identify the location of BBB opening. As a result of the deposition of the MRI 
contrast agent induced by BBB opening, the MR images indicate that the threshold of BBB 
opening is at 0.45 MPa for the 1-2-µm diameter bubbles and at 0.30 MPa for the 4-5-µm 
and 6-8-µm diameter bubbles. The corresponding spectrogram  shows that only lower 
harmonics (1st to 4th) are detected at 0.15 MPa and higher harmonics (up to 8th) can be 
detected at 0.30 MPa and beyond at each bubble size. However, the broadband response, 
i.e., the inertial cavitation, occurs at 0.45 MPa and 0.60 MPa for all microbubbles used in 
this study. Therefore, the BBB opening can be induced by nonlinear oscillation (i.e., with 
harmonics but without broadband emissions) at 4-5-µm and 6-8-µm diameter but not 1-2 
µm diameter bubbles. The permeability maps assessed both the efficacy of the targeting 
and the spatial extent of the opening. The corresponding histological analysis (methods is 
shown in section 3.2.2.3) shows indicates that no damage was detected in any of these 
cases shown in Fig. 4. 6 (damaged cases are shown in Fig. 4.11). 
The quantitative results, including the SCD, ICD, BBB opening volume, and 
permeability are shown in Figs. 4.7-4.9. Stable cavitation based on the 2nd to 7th ultra-
harmonic (3.75 – 11.25 MHz) with three distinct diameters is quantified as the SCD and 
depicted in Fig. 4.7.  The SCD at the 6-8-µm diameter was significantly higher than at the 
1-2-µm diameter (*: P < 0.05, compared to 1-2-µm diameter) in most cases, and at the 4-5-
µm diameter in two cases (#: P < 0.05, compared to 4-5-µm diameter). At 0.30 MPa, the 
SCD at the 4-5-µm or 6-8-µm diameter was significantly higher than at the 1-2-µm 







Figure 4.6 – The BBB opening with 3 bubble diameters confirmed by 3D-MRI images 
with coronal (top left), sagittal (top right), and horizontal (middle left) views. The 
corresponding spectrogram (middle right) of the first pulse from 95 to 135 µs with 
microbubbles administration shows the acoustic response from microbubbles. The 
corresponding H&E sections (40x magnifications, bottom left) and permeability maps 
(bottom right) are also provided. In the case of 1-2 µm bubbles, the broadband acoustic 
emissions are detected at 0.45 and 0.60 MPa but not at 0.15 and 0.3 MPa. The 3D-MR 
images confirmed that the BBB is opened at 0.45 and 0.60 MPa, with inertial cavitation. In 
the case of 4-5 and 6-8 µm bubbles, the broadband acoustic emissions are detected at 0.45 
and 0.60 MPa but not at 0.15 and 0.3 MPa. The 3D-MR images confirmed that the BBB is 
opened at 0.30 MPa without inertial cavitation or 0.45 MPa and 0.60 MPa with inertial 
cavitation. In each H&E image, its center indicated the focus as viewed on the MRI. No 






Figure 4.7 – Statistical analysis of the stable cavitation dose (SCD) at the ultra-harmonics 
3.75 MHz (2.5f), 5.25 MHz (3.5f), 6.75 MHz (4.5f), 8.25 MHz (5.5f), 9.75 MHz (6.5f), and 
11.25 MHz (7.5f) against three distinct pressures at three microbubble diameters.  The SCD 
at the 6-8-µm diameter was significantly higher than at the 1-2-µm diameter (*: P < 0.05, 
compared to 1-2-µm diameter) in most cases, and at the 4-5-µm diameter in two cases (#: P 
< 0.05, compared to 4-5-µm diameter). At 0.30 MPa, i.e., no inertial cavitation occurrence, 
the SCD at the 4-5-µm or 6-8-µm diameter was significantly higher than at the 1-2-µm 





The ICD, BBB opening volume of different bubble diameters, and their relationship are 
shown in Fig. 4.8. The ICD 6-8-µm is larger than at 1-2-µm-diameter bubbles (*: P < 0.05) 
at 0.45 and 0.60 MPa, as well as larger than at 4-5-µm-diameter bubbles at 0.45 MPa (#: P 
< 0.05), which shows that the ICD is also bubble-size dependent [Fig. 4.8(a)]. The 
statistical analysis results of the BBB opening volume at different bubble diameters are 
	
Figure 4.8 – The quantification of (a) the inertial cavitation dose (ICD), (b) BBB opening 
volume and (c) the correlation in between. Statistical analysis indicates that the ICDs and 
BBB opening volume are both pressure and bubble-size dependent. [*: P < 0.05, compared 
to 1-2-µm diameter, #: P < 0.05, compared to 4-5-µm diameter]. Regression analysis 
shows a linear correlation between the ICD and the BBB opening volume with three bubble 
diameters. It also shows that inertial cavitation is necessary for 1-2 µm bubbles to induce 
BBB opening. The intercept indicates that the BBB can be opened without inertial 






shown in Fig. 4.8(b). The volume with 4-5- and 6-8-µm-diameter bubbles is larger than 
with 1-2-µm-diameter bubbles (*: P < 0.05) at 0.45 and 0.60 MPa. In the cases of 0.30 and 
0.45 MPa, the BBB opening volume with 6-8 µm is statistically larger than with 4-5-µm-
diameter bubbles (#: P < 0.05). The correlation between the BBB opening volume and ICD 
is shown in Fig. 4.8(c), which a linear correlation with all bubble diameters. The intercept 
indicates that the BBB can be opened without inertial cavitation in the case of 4-5 and 6-8-
µm diameter bubbles as configured by Fig. 4.7.  
The 1-2 μm bubbles exhibited no uptake of Gd-DTPA at 0.30 MPa and a small uptake 
at 0.45 MPa. At 0.60 MPa a Ktrans was found higher than 0.005 min-1. Similar Ktrans 
distributions were found between the 4-5 μm/0.30 MPa and 6-8 μm/0.30 MPa cases, 
resulting in mildly permeable BBB openings. The quantitative measurements provided 
numerical permeability values of the BBB opening (Fig. 4.9). The opening threshold for 
the 1-2 μm bubbles was found to be at 0.45 MPa, yielding a Ktrans value of 0.011 ± 0.004 
min-1, while at 0.60 MPa Ktrans reached a value of 0.039 ± 0.008 min-1. The 4-5 μm bubbles 
exhibited higher Ktrans values, i.e. 0.028 ± 0.013 min-1, 0.044 ± 0.011 min-1 and 0.052 ± 
0.007 min-1, for the pressures of 0.30, 0.45 and 0.60 MPa, respectively. Similar results with 
the 4-5 μm bubbles were found for the 6-8 μm, where the estimated Ktrans was 0.033 ± 
0.007 min-1, 0.049 ± 0.001 min-1 and 0.049 ± 0.006 min-1 for the pressures of 0.30, 0.45 and 
0.60 MPa, respectively. The statistically significant p-values for each acoustic pressure and 
microbubble size using a two-tailed Student’s t-test with unequal variances are depicted on 
the corresponding graphs (Fig. 4.9). The permeability of the epicranial muscle was also 
measured in every mouse and the mean Ktrans value throughout the entire group of mice 





Figure 4.9 – Mean quantitative Ktrans measurements. The results are presented in two 
different ways in order to demonstrate the dependence of the BBB opening Ktrans on both 
the acoustic pressure and the microbubble size. The mean Ktrans in the epicranial muscle (no 
barrier) is also presented for comparison. One asterisk (*) refers to a statistical significance 
of P < 0.05 and two asterisks (**) refer to a statistical significance of P<0.01. 
		
Figure 4.10 – Histology at the BBB opening threshold. The mouse was sacrificed either 
3 hrs or 7 days after sonication. In both cases, no red blood cell extravasations and dark 
neurons were found with H&E staining, which means that safe BBB opening can be 





Two histological analyses were performed. First, the histological analysis at the BBB 
opening threshold at both the 3-hours and 7-day time points was shown in Fig. 4.10. In 
both cases, no cell damage, e.g., red blood cell (RBC) extravasations or dark neurons91, was 
detected after histological examination, which signifies that safe BBB opening can be 
achieved at all bubble diameters. Second, the damaged cases were inspected and shown in 
Fig. 4.11. The histological findings showed that only three out of all mice used in this study 
revealed some structural neuronal damage and cell loss in the sonicated hippocampal area. 
In two of these mice, which were sonicated at 0.45 and 0.60 MPa, using 4-5 μm 
microbubbles (Fig. 4.11(c-h) and (k-p), respectively), cell loss was detected in the granule 
cell layer of the right dentate gyrus (GrDG). Moreover, the presence of dark neurons in the 
layer could be an indication of apoptosis. More serious damage was found in the 6-
8μm/0.60 MPa case (Fig. 4.11(v-x)), which underwent a major deformation of the structure 
of the CA3 field of the right hippocampus, followed by cell loss and multiple dark neurons. 
However, the H&E slices of all the mice showed no red blood cell extravasations that could 
indicate hemorrhage. The regular T1 images (Fig. 4.11(a, i, q)) and the permeability maps 
(Fig. 4.11(b, j, r)) of the corresponding mice, acquired approximately 1.5 h after sonication 
are presented along with the histological findings, but no direct correlation could be found 






T2 imaging was used as a complementary tool for the assessment of any physiological 
changes in the sonicated region. Dark regions were detected in the sonicated region in most 
of the cases of higher pressures and larger microbubbles (Fig. 4.12), but a distinct 
correlation with the histological findings could not be established, since H&E staining 
showed no signs of erythrocyte extravasations. This led to the conclusion that the dark 
regions in T2 imaging were the result of susceptibility artifacts from the excessive Gd-
DTPA excreted in the EES, rather caused by hemorrhage. 
 
	
Figure 4.11 – Permeability and histological findings of the only three mice that exhibited 
neuronal damage and cell loss. (a) T1 image, (b) corresponding permeability map and (c-h) 
H&E sections of the first mouse, sonicated at 0.45 MPa using 4-5 µm bubbles. (i) T1 
image, (j) corresponding permeability map and (k-p) H&E sections of the second mouse, 
sonicated at 0.60 MPa using 4-5 µm bubbles. (q) T1 image, (r) corresponding permeability 
map and (s-x) H&E sections of the third mouse, sonicated at 0.60 MPa using 6-8 µm 
bubbles. The black boxes in (c, f, k, n, s, v) refer to the regions of interest depicted in (d, g, 
l, o, t, w), respectively. The black boxes in (d, g, l, o, t, w) refer to the regions of interest 





4.4.1.2 IC threshold determination of mono-dispersed microbubbles 
In 4.4.2.1, we have found that the BBB opening properties, including the pressure 
threshold, permeability, and volume are bubble size dependent. However, the pressure 
threshold of IC lay between 0.30 and 0.45 MPa within all bubble sizes, which was different 
from theoretical interpretation105 and optical observation104. Therefore, a channel phantom 
was used to determine the pressure threshold of IC for mono-dispersed microbubbles used 
		
Figure 4.12 – Transverse T2 images of the brain from each mouse cohort. Dark areas in 
the sonicated regions (indicated by white arrows) were detected at higher pressures for 
the larger bubbles as a result of susceptibility artifacts from the excessive Gd-DTPA 




in our in vivo studies. The SC was also quantified to compare the in vivo results. Figures 
4.13-4.15 showed the spectrum and the ICD at pressures from 0.15 to 0.60 MPa, as well as 
the SCD at pressures from 0.15 to 0.35 MPa, of 1-2, 4-5, and 6-8 µm diameter bubbles, 
respectively. The IC threshold lay between 0.30 and 0.35 MPa for 1-2 and 4-5 µm diameter 
bubbles, and it lay between 0.35 and 0.40 MPa for 6-8 µm diameter bubbles. This 
confirmed our in vivo results which showed that the IC threshold lay between 0.30 and 0.45 
MPa for all microbubbles used in this chapter. The SC did not occur at pressures of 0.15 - 
0.35 MPa for 1-2-µm diameter bubbles (Fig. 4.13), but occur at 0.30 MPa for 4-5- and 6-8-
µm diameter bubbles (Figs. 4.14, 4.15). 
The oscillation of a 1.5-µm diameter bubble simulated by three bubble conditions, an 
unshelled and a shelled bubble using Bubblesim, as well as a shelled bubble using the 
Marmottant model, was shown in Fig. 4.16. The result of the Marmottant model was 
implemented on Matlab. Here, the “compression-only” behavior, i.e. the bubble only 
compresses and hardly expands beyond its initial diameter, observed by DeJong152 was 
successfully simulated. The expansion ratio (Rmax/R0), which can be used to determine the 
IC threshold, at 0.30, 0.35, and 0.40 MPa for each diameter and each theoretical model was 
shown in Table 4.4.  
 
Table 4.4 Expansion ratio (Rmax/R0) for each diameter and each theoretical model 
Diameter 1-2 µm 4-5 µm 6-8 µm  
Bubble\PRP 0.30 0.35 0.40 0.30 0.35 0.40 0.30 0.35 0.40 
Unshelled 4.48 5.11 5.78 2.69 2.99 3.34 2.60 2.69 2.84 
Shelled 1.51 1.83 2.24 2.35 2.70 3.01 1.91 2.12 2.29 







Figure 4.13 – The frequency spectrum and ICD of the 1-2-µm diameter bubbles. The IC 
threshold is determined to lie between 0.30 and 0.35 MPa (***: P < 0.001). The SC does 
not occur between 0.15 and 0.35 MPa. 
	
Figure 4.14 – The frequency spectrum and ICD of the 4-5-µm diameter bubbles. The IC 
threshold is determined to lie between 0.30 and 0.35 MPa (**: P<0.01), but the SC 






Figure 4.15 – The frequency spectrum and ICD of the 6-8-µm diameter bubbles. The IC 
threshold is determined to lie between 0.35 and 0.40 MPa (***: P<0.001), but the SC 
occurs at 0.30 MPa. 
		
Figure 4.16 – Simulation of the oscillation of a 1.5 µm diameter bubble at 0.20 MPa 
PRP using Bubblesim (unshelled, shelled), and Marmottant model.  The “compress-




4.4.2 Shell effect on bubble behavior during BBB opening 
Since no BBB opening was induced at 0.15 or 0.225 MPa, the results at these two 
pressures are not shown here. The T1-weighted MR images, permeability maps, 
histological sections and corresponding spectrograms of the first pulse of each acyl-chain 
length case are depicted in Fig. 4.17 and four main observations can be made: 1) the BBB 
opening pressure threshold is 0.30 MPa at all acyl-chain lengths, which means that the 
BBB opening pressure threshold is not affected by the acyl-chain length; 2) the 
corresponding permeability map clearly shows that the BBB opening region at high Ktrans 
(> 0.03 min-1) increases with the pressure amplitude, but no difference is observed across 
all acyl-chain lengths; 3) the spectrogram shows that the threshold of inertial cavitation 
with the 4-5-µm bubbles lies between 0.30 and 0.45 MPa for all acyl-chain lengths, which 
is the same as what was shown in our previous study on the effect of microbubble diameter; 
4) histological findings showed that some dark neurons or red blood cell (RBC) 
extravasations are generated at 0.45 and 0.60 MPa (Fig. 4. 17). The number of damaged 
cases at each acyl-chain length and applied pressure are shown in Table 4.5. Despite the 
fact that a high damaged rate (6/9) at 0.60 MPa or with C24 microbubbles were obtained, 
no significant damage difference between acyl-chain lengths was noted. 
Table 4.5 Safety assessment (damaged / BBB-opened mice) at each pressure and each 
acyl-chain length 
 Pressure (MPa)
Acyl-chain 0.15 0.225 0.30 0.45 0.60
C16 0/0 0/0 0/2 1/2 1/3
C18 0/0 0/0 0/3 1/3 2/3
C24 0/0 0/0 1/3 2/3 3/3






As used in the investigation on the effect of microbubble diameter, T2 imaging was also 
used as a complementary tool for the assessment of any physiological changes in the 
sonicated region here. Dark regions were detected in the sonicated region in most of the 
cases of higher pressures and larger microbubbles (Fig. 4.18), including one case at 0.30 
MPa with the C24 microbubbles. This is the only case with corresponding hemorrhage in 
the absence of inertial cavitation. 
	
Figure 4.17 – The 2D horizontal T1-weighted MR image (top left), corresponding 
spectrogram of the first pulse (top right), 2D horizontal permeability map (bottom left), and 
H&E sections of the hippocampus (bottom right) in each table entry at 3 bubble diameters 
and 3 peak-rarefactional pressures. Few histological damage cases were noted and shown 
here (black arrow: dark neuron, red arrow: red blood cell extravasations) were observed 




Stable cavitation based on the 2nd to 7th ultra-harmonic (3.75 – 11.25 MHz) with three 
applied pressures is quantified as SCD and depicted in Fig. 4.18. In most cases, no 
difference was observed among the three acyl-chain lengths studied. As a result, the acyl-
chain length does not seem to have an effect on the ultra-harmonic response emitted by the 
microbubbles during BBB opening. At 0.30 MPa and above, however, all SCDs were 
statistically higher than zero (i.e., more ultramonics were generated in the presence of 
microbubbles than with the skull alone), which confirms the results shown in Fig. 4.7.  
		
Figure 4.18 – Transverse T2 images of the brain from each mouse cohort. Dark areas in 
the sonicated regions (indicated by white arrows) were detected at all pressures for the 







Figure 4.19 – Statistical analysis of the stable cavitation dose (SCD) at the ultra-harmonics 
3.75 MHz (2.5f), 5.25 MHz (3.5f), 6.75 MHz (4.5f), 8.25 MHz (5.5f), 9.75 MHz (6.5f), and 
11.25 MHz (7.5f) with three acyl-chain lengths at three distinct pressures. No significant 
difference was observed across the different acyl-chain lengths in most cases. However, at 
9.75 MHz and 11.25 MHz, the SCD of the C16 microbubbles was significantly higher than 
the C24 microbubbles (*: P < 0.05). Since the center frequency of the PCD is 10 MHz, the 
sensitivity may be higher when the ultra-harmonic is close the 10 MHz.  At 0.30 MPa, i.e., 
no inertial cavitation occurrence, the SCD was statistically higher than the background 





Figure 4.20 – Statistical analysis of the (a) inertial cavitation dose (ICD), (b) BBB 
opening volume, and (c) permeability between three acyl-chain lengths at three distinct 
pressures. The ICD of C24 microbubbles was significantly lower than the C16 and C18 
microbubbles at 0.60 MPa (*: P < 0.05). In the rest cases, however, no statistically 







The inertial cavitation dose (ICD), BBB opening volume, and Ktrans are shown in Fig. 
4.20. The threshold of inertial cavitation is identified to lie between 0.30 and  0.45 MPa for 
all acyl-chain lengths but, at 0.60 MPa, the ICD with the C24 microbubbles is statistically 
lower than with the C16 and C18 microbubbles (P < 0.05, Fig. 4.9(a)). The quantification 
of BBB opening volume and permeability are shown in Fig. 4.9(b) and (c), and no 
significant difference is observed between the three acyl-chain lengths at all pressures, 
although the ICD is lower with the C24 microbubbles. Similar to our previous studies, 
however, the ICD and BBB opening increase with pressure, and the permeability reaches 
an upper limit around 0.05 min-1 at 0.45 and 0.60 MPa.  
 
4.5 Discussion 
4.5.1 Bubble size dependent BBB opening properties 
4.5.1.1 In vivo BBB opening investigation 
The objective of this study was to investigate the physical effects of the systematically 
circulating microbubbles on the FUS-induced BBB opening and corresponding 
permeability. The pressure threshold of BBB opening, determined by the MRI contrast 
enhancement, was 0.45 MPa for the 1-2-µm and 0.30 MPa for both the 4-5-µm and 6-8-µm 
bubbles. However, the spectrogram showed that the broadband response occurred at 0.45 
MPa for all microbubbles. The uncorrelated threshold between BBB opening and inertial 
cavitation implied that the physical effects responsible for the BBB opening may be bubble 
size dependent. The inertial cavitation may be necessary for BBB opening with smaller 




For larger diameter (4-5 and 6-8 µm) microbubbles, at 0.45 and 0.60 MPa, with the 
occurrence of inertial cavitation, both the volume and the shape of the contrast 
enhancement region was different from the case at 0.30 MPa. In the sagittal images, the 
shape of the contrast enhancement region at 0.45 MPa and 0.60 MPa with 4-5 µm and 6-8 
µm bubbles indicated enhanced shielding effects induced by the bubbles and potential 
inertial cavitation occurrence (Fig. 4.6). However, at 0.30 MPa without inertial cavitation 
occurrence, the contrast enhancement region, which covered the hippocampal formation 
(Fig. 4.21(a)), was more homogeneous and was similar in shape and geometry to the -6 dB 




Figure 4.21 – Comparison between (a) sagittal section of 3D-T1-MR images and (b) -
6dB focal region of the FUS transducer in the case of 6-8 µm bubbles at 0.30 MPa. The 
consistence between the contrast enhancement region and focal region of the FUS 







The capillary diameter in the murine brain ranges between 4-8 µm153, which is 2-8 
times larger than the 1-2-µm diameter bubbles. It has been shown that the microbubble will 
be fragmented when the radius expands to higher than three times the initial radius at rest 
(i.e., Rmax / Rrest > 3)104. However, the ratio of expansion of the 4-5-µm and 6-8-µm 
diameter bubbles needed not to be as high as for the 1-2-µm diameter bubbles to enter into 
contact with the capillary wall. BBB opening may thus be induced through nonlinear 
oscillation only in the case of larger bubbles. In addition, the bubbles of 6-8-µm in diameter 
are even closer in size to the diameter of the capillary, increasing the probability of opening 
in a larger number of locations. 
The spectrogram used in this study clearly elucidated the onset and duration of inertial 
cavitation within the first pulse. Here, the inertial cavitation occurred at the beginning of 
sonication (Fig. 4.6). At the highest pressure (0.60 MPa), the broadband response 
corresponding to the first pulse, lasted throughout the entire duration of the pulse length at 
all bubble sizes (Fig. 4.6), which indicated that the highest pressure may fragment the 
microbubbles to smaller bubbles that serve as cavitation nuclei. In the case at 0.15 and 0.30 
MPa at all bubble sizes, only harmonics without broadband emissions, were detected. 
However, the BBB opened at 0.30 MPa only in the 4-5 and 6-8 µm cases. Despite the fact 
that up to the 8th harmonic could be detected by our PCD, no BBB opening was induced at 
0.30 MPa with the 1-2 µm bubbles. Therefore, the nonlinear oscillation of smaller bubbles 
would not induce BBB opening. The harmonics which corresponded to the nonlinear 
oscillation of microbubbles thus may not be used as an indicator of BBB opening in the 




In chapter 3, we showed that the BBB was opened at 0.30 MPa using FUS and 
Definity® 120. Despite the fact that the mean bubble diameter was within 1.1-3.3 µm, close 
to 1-2 µm, they were not considered as mono-dispersed because the maximum diameter 
was 20 µm and 98% was under 10 µm. It has also been shown that Definity® are poly-
dispersed microbubbles based on the size distribution119. Therefore, the BBB opening may 
be induced by the larger (4-10 µm) bubbles rather than the smaller (1-3 µm) Definity® 
bubbles at 0.30 MPa.  
According to previous reports on Definity® and Optison®, Optison® appeared to 
produce larger effects than Definity® when applied at the same pressure amplitude with 
respect to the magnitude of the BBB opening63. Here, our findings using both ICD and 
BBB opening volume confirmed this conclusion. The mean diameter range of Optison® 
and Definity® was 2.0-4.5 µm and 1.1-3.3 µm, respectively. Both the effects to the 
vasculature and the acoustic emission detection were different at distinct microbubble sizes.  
It has been shown that the active vesicular transport is more pronounced in arterioles 
than in capillaries and venules after BBB opening5, which provided evidence that opening 
is not restricted to the capillaries. Since the size of the arterioles was around 10 – 20 µm99, 
bubble expansion may not be the factor inducing BBB opening in arterioles. According to 
multiphoton imaging findings, a vasoconstriction induced after microbubble administration 
was previously reported99. Vasoconstriction may be induced by bubble aggregation caused 
by a secondary radiation force154. Therefore, larger bubbles may induce vasoconstriction 
with higher probability than smaller bubbles. After vasoconstriction is induced by bubble 
aggregation, the shear stress surrounding the microbubble may be high enough to enhance 




strength of the tight junctions and the shear stress amplitude will be considered in future 
investigations to unveil the mechanical effect onset of FUS-induced BBB opening. 
Similar to the threshold of BBB opening, the SCD, ICD and BBB opening volume 
were also bubble size dependent (Figs. 4.7 and 8). At 0.30 MPa, the SCDs at the 4-5- or 6-
8-µm diameter bubbles were significantly higher than at the 1-2-µm diameter bubbles at 
frequencies of 3.75, 5.25, 9.75, and 11.25 MHz (Fig. 4.7). Also, at the same pressure, mean 
ICD was almost zero for all microbubble diameters (Fig. 4.8(a)). As a result, both SCD and 
ICD indicated that the BBB was opened via stable cavitation in the cases of larger bubbles. 
A good linear correlation between the ICD and BBB opening volume was also observed 
(Fig. 4.8(c)), thus the PCD may serve as a good indicator to estimate the BBB opening 
volume based on the ICD calculation. 
According the histological analysis at the BBB opening threshold, the BBB opening 
can be induced without RBC extravasations or neuronal damage (Fig. 4.10). Despite the 
fact that the inertial cavitation occurred at 0.45 MPa with the 1-2-µm diameter bubbles, a 
small opening volume was induced without any damage. In this case, inertial cavitation did 
not induce cell death but was sufficient to change the permeability of endothelial cell or 
ruptured the tight junctions.  
The histological findings of this study revealed that no significant damage was induced 
in the majority of the sonicated mice, proving that the permeability can increase, but not at 
the expense of safety. Three out of forty mice (7.5%) showed signs of neuronal damage 
under histological examination or cell loss in the sonicated hippocampus seven days after 
sonication at pressures higher than 0.45 MPa and microbubble sizes larger than 4-5 μm 




one particular case a significant deformation of the right hippocampal anatomical structure 
was observed. The presence of dark regions in T2 imaging (Fig. 4.12) in the cases of 
sonications with higher pressures using larger-sized bubbles was found not to correlate 
with hemorrhage, since no red blood cell extravasations were found in the H&E sections of 
any of the mice that underwent the FUS procedure. Thus, the dark regions were assumed to 
be directly related to the field inhomogeneities as a result of the excessive Gd-DTPA 
presence in the EES. Liu et al42 have suggested that susceptibility-weighted imaging (SWI) 
can detect massive hemorrhagic regions after FUS at the acoustic pressure of 3.47 MPa, but 
the detection of a few erythrocyte extravasations that low acoustic pressure sonications may 
induce is limited by the spatial resolution that MRI can offer.  
As mentioned in the Materials and Methods section, the stability of the 1-2-µm bubbles 
is being improved in ongoing investigations. During our experiments, mono-dispersed 
microbubbles were generated on the same day or one day before our experiments. The 
number-weighted distribution was always centered around 1-2 µm. In every case of the 1-
2-µm diameter bubbles, the BBB was not opened at 0.30 MPa. Therefore, it would also be 
expected that the threshold of BBB opening might be higher than 0.45 MPa, if the 1-2 µm 
bubbles are still stable after our experiments.  
Based on a quantitative summary of findings of this study, the BBB opening pressure 
threshold, BBB opening volume, inertial cavitation dose, and the percentage of mice with 
dark neurons are all bubble size dependent but the inertial cavitation threshold is not. In this 
study, the pressure interval was 0.15 MPa which may not be small enough to determine the 
real pressure threshold of inertial cavitation. Regarding the neuronal damage, the inertial 




the mechanism of BBB opening may also be bubble size dependent. The highest 
percentage of mice with dark neurons is in the case of 4-5 µm bubbles. Since the resonance 
frequency of 4-5 µm bubbles embedded in a compliant vessel is close to 1.5 MHz, i.e., the 
FUS frequency used in this study, the inertial cavitation at this bubble size may induce 
more damage. 
 
4.5.1.2 IC threshold of lipid-shelled mono-dispersed microbubble 
Since the IC threshold of mono-dispersed microbubbles with three distinct diameters 
was observed within the same range from our in vivo investigation, which is different from 
previous reports about the relationship between the IC and bubble diameter104,105, a 
phantom validation, together with theoretical models implementation, was performed to 
identify the IC threshold of the microbubbles used in this chapter. As shown in Figs. 4.19-
21, the IC threshold was determined as 0.35, 0.35, and 0.40 MPa for the 1-2, 4-5, and 6-8-
µm diameter bubbles, respectively. The largest microbubbles (6-8-µm diameter) were 
shown having higher threshold than the other two microbubbles, which is similar as 
previous report105. The IC threshold, however, was identical between 1-2 and 4-5-µm 
diameter bubbles. This may be resulted from the effect of the resonance frequency. Since 
the resonance frequency of 4-5-µm bubbles lies between 1.25 MHz and 1.61 MHz, where 
our insonation frequency lies in, the IC threshold may hence be lower than expected. 
However, the results of our phantom validation confirmed our in vivo investigation, which 
indicated that the IC will not occur below 0.30 MPa using 1.5-MHz insonation. 
A theoretical model can be used to estimate the microbubble oscillation. From previous 




defined as 3104. The ratio of each diameter microbubble at 0.30, 0.35, and 0.45 MPa with 
three bubble conditions was shown in Table 4.4. In the case of the 1-2-µm microbubbles, 
the estimation of an unshelled bubble was considered not proper since the ratios (4.48-5.78) 
were twice than the threshold, which can be clearly observed from Fig. 4.16. Compared 
with the unshelled bubble, the other two conditions, Shelled and Marmottant, provided 
more accurate ratio corresponding to our phantom validation. Furthermore, the Marmottant 
model not only estimated the correct ratio (2.40 at 0.35 MPa), but also described the 
“compression-only” behavior which has been observed in previous reports152,155. Therefore, 
in the case of 1-2-µm microbubbles, the Marmottant model was concluded to be more 
appropriate.  
However, the ratio estimated by the Marmottant model became inaccurate (> 5 at 0.40 
MPa) compared to the other two models. Till now, the oscillation of larger microbubbles at 
the pressure higher than 0.3 MPa using Marmottant model has not been reported. In this 
model, the fitting of experimental radius-time curves for lipid-shelled microbubbles reveals 
that the shell material parameters are found to be dependent on the initial bubble radius137. 
In our simulation, the shell viscosity and elasticity were determined based on previous 
reports at much lower pressure (40 kPa), which may not be applicable at higher pressure up 
to megaPascal level. Also, “compression-only” behavior was only observed in the case of 
small microbubbles (< 2-µm diameter), which can be explained by this model mainly based 
on the “buckling behavior” within narrow range of radii change137. If, during expansion, the 
bubble radius exceeds the threshold value Rbreak-up, the shell ruptures, which will affect the 
estimation of the next bubble expansion. Therefore, larger microbubbles with the 




In comparison with the theoretical model and phantom validation, the simulation of a 
shelled bubble using Bubblesim may hence be suitable for the case of 4-5 and 6-8-µm 
diameter bubbles. Therefore, this model and corresponding shell parameters will be 
implemented to estimate the bubble oscillation in Chapter 5, which will use 4-5-µm 
diameter bubbles and relative low pressure (0.18 MPa) to determine the BBB opening 
mechanism triggered by the stable cavitation. However, this is an approximate simulation 
in order to estimate possible bubble oscillation in vivo. More accurate models, such as 
taking into account red blood cells156, should be investigated to provide more accurate 
estimation in the future. 
 
4.5.2 Shell effect on bubble behavior during BBB opening 
In this study, the effect of the acyl-chain on the BBB opening characteristics and 
corresponding microbubble behavior was investigated. The threshold of BBB opening was 
found to be identical across all acyl-chain lengths. According to the qualitative and 
quantitative analysis, four cases of microbubble oscillation can be determined in this study. 
First, at 0.15 and 0.225 MPa, the microbubble expansion or the shear stress induced by 
microbubble oscillation did not induce BBB opening. Second, at 0.30 MPa, when no 
inertial cavitation was detected, the BBB could be opened through stable cavitation (Fig. 
4.19), at a lower permeability (Ktrans ~ 0.03 min-1). The microbubble expansion, at this stage, 
may thus not be affected by the capillaries. Third, at 0.45 MPa, i.e., the threshold of inertial 
cavitation, the bubble expansion ratio may reach the threshold of inertial cavitation, which 
would lead to larger BBB opening volume and higher permeability than at 0.30 MPa. At 




the ICD, most likely because the capillary wall may have a larger effect on the bubble 
expansion. Finally, at 0.60 MPa, i.e., the pressure at which a 66% damage rate was noted, 
the ICD of the C24 microbubbles was statistically lower than with the C16 and C18 
microbubbles, but no difference in the BBB opening volume and permeability was noted. 
The bubble expansion may exceed the wall strength at this stage, which induced similar 
BBB opening volume and permeability. The permeability at 0.60 MPa did not exceed the 
value at 0.45 MPa, since the well-known upper limit had been reached (Ktrans ~ 0.05 min-)64.  
The plateau in the permeability (Fig. 4.20) was reached at 0.45 and 0.60 MPa, which 
was the same as our previous studies64. The permeability reached the upper limit when the 
inertial cavitation occurred, even if the ICD with the C24 acyl-chain was significantly 
lower than with the C16 and C18 acyl-chains. Therefore, it was expected that, since 
different acyl-chain lengths have no effect on the threshold of the inertial cavitation, the 
permeability will not be affected.   However, because of the upper limit, the permeability 
may not be used to estimate the BBB opening volume. According to the findings of our 
previous study regarding the physical mechanism of the BBB opening with three 
microbubble diameters, the ICD can be used towards the estimation of the BBB opening 
volume. The shell, however, was shown to have an effect on the ICD but not on the BBB 
opening volume. Thus, the correlation between the ICD and the BBB opening volume 
changes both pressure and shell types.  
In terms of the acoustic response from microbubbles, a previous study has shown that 
shell composition influences microbubble response in ultrasonic imaging157. Larger 
molecular-weight shell was shown to have lower imaging intensity since the elasticity of 




in vivo. The ICD from the C24 microbubbles was significantly lower than from the C16 
and C18 microbubbles at 0.60 MPa. As shown in Table 4.1, the molecular weight, viscosity, 
and phase transition temperature were comparable between the C16 and C18 microbubbles. 
In the case of the C24 microbubbles, the molecular weight was 170 Da higher than the C18 
microbubbles, and the viscosity was 22 times higher than the C16 microbubbles. Thus, as 
previously mentioned, since the bubble expansion was not affected by wall strength at 0.60 
MPa, the expansion ratio of the C24 microbubbles may be lower, thereby inducing lower 
ICD. Regarding the BBB opening characteristics, however, the shell composition did not 
have any effects on the BBB opening volume, BBB opening threshold, or permeability. 
Since the microbubble diameter in this study was 4-5 µm, which was similar to the 
diameter of a capillary, a stable oscillation at 0.30 MPa was sufficient to open the BBB 
regardless of the acyl-chain lengths.  Therefore, the bubble size effect may override the 
bubble shell effect on the BBB opening.  
Histological findings (Table 4.5) revealed that the damage ratio was 1/8, 4/8, and 6/9 at 
0.30, 0.45, and 0.60 MPa, respectively, which means that the probability of inducing 
damage increased with pressure, especially correlated with the occurrence of inertial 
cavitation. T2 images also showed dark region in the damage cases (fig. 4.18). This finding 
was different from previous studies using 4-5-µm microbubbles. Only few damaged cases 
were observed in that study because the mice were sacrificed 7 days as opposed to 3 hours. 
Because certain damage may be reversible after 7 days, more damage cases were observed 
in this study.  
Interestingly, In the case of the C24 microbubbles, five out of six brains were observed 




ICD was the lowest at 0.60 MPa. It was expected that the ICD was lower with the C24 
microbubbles due to the moderate expansion. However, most studies reported that the 
damage was correlated with the ICD107,113,114. This study therefore provided another insight 
into the shell effect. Borden et al. have shown that buds and strings build up to form large 
lipid particles several microns in diameter after few pulses insonification in the case of 
DBPC (i.e., C22 acyl-chain length) microbubbles141. Compared with the C24 
microbubbles, the C16 and C18 microbubbles mostly experienced acoustic dissolution, 
which resulted in diameter decrease. Thus, larger contact area between the aforementioned 
large lipid particles and endothelial cells may be reached in the case of the C24 
microbubbles, which may increase the probability of inducing damage with inertial 
cavitation (i.e. at 0.45 and 0.60 MPa). The effect of buds or strings formed due to the 
ultrasonic pulses may not be sufficiently reflected by the ICD. However, since this is a 
preliminary study regarding the effects of the acyl-chain length, we cannot safely conclude 
that the acyl-chain length will have effect on the RBC extravasations or dark neurons 
observed. Further studies need to be performed in order to investigate the effect of the acyl-
chain length on safety.  
Here, three acyl-chain lengths (C16, C18 and C24) were used to identify the shell 
effects. In the composition of the lipid-coated microbubbles, however, polyethylene glycol 
(PEG) is frequently used as the emulsifier to prevent coalescence and nonspecific 
adsorption of blood plasma proteins140. PEG has been considered as a tuning parameter 
with respect to the cavitation events. The pressure required to yield 50% fractional 
destruction of the microbubble population was affected by PEG, despite the fact that the 




PEG-5k used in this study, PEG-40 stearate (PEG 40s) was used as the emulsifier in our 
previous studies on the effect of bubble size. Therefore, the effects between PEG-40s and 
PEG-5k could now be studied here with identical acyl-chain length and the bubble size 
(C18 and 4-5-µm diameter, respectively). The threshold of inertial cavitation and BBB 
opening lied between 0.30 and 0.45 MPa for PEG-40s and PEG-5k microbubbles. In terms 
of quantitative parameters, such as the ICD, BBB opening volume and permeability, no 
statistical difference was noted between the PEG-40s and PEG-5k. Hence, following the 
findings on the acyl-chain length reported here, the threshold of inertial cavitation, 
threshold of BBB opening, BBB opening volume, and permeability were concluded not to 
be affected by the microbubble shell (PEG and acyl-chain length) in the brain vasculature.  
In addition, in the brain vasculature, the acoustic emission was found to be affected by 
the acyl-chain length, but the BBB opening characteristics were not. In terms of BBB 
opening, combined with our previous studies, the microbubble size was concluded to be the 
most important parameter compared to the shell properties. In order to adequately control 
the contact area between the microbubbles and the endothelial cells, smaller acyl-chain 
length would be preferable. For example, C18 microbubbles will be recommended as the 
agent to induce BBB opening. On the other hand, since the vibration of microbubbles in the 




This chapter has revealed the microbubble-dependent effect on FUS-induced BBB 




microbubble size and shell properties. First, we have investigated the relationship between 
permeability, cavitation response, the diameter of the administered microbubbles and the 
peak rarefactional pressure of the focused ultrasound-induced blood-brain barrier opening. 
The volumetric, quantitative permeability measurements and inertial cavitation dose 
showed that Ktrans, SCD, and ICD in the sonicated region are increasing with the bubble 
size and the acoustic pressure. Inertial cavitation was observed to be required for smaller 
bubbles to induce BBB opening. Based on our findings on the SCD and ICD, however, the 
interaction between larger bubbles (4-5-µm and 6-8-µm) and the FUS beam could induce 
the BBB opening through nonlinear oscillation, without inertial cavitation. No significant 
damage was detected at the BBB opening threshold, at all bubble sizes. Therefore, larger 
diameter bubbles and lower pressure amplitudes (0.20 – 0.30 MPa) were determined to be 
safe and consistent in BBB opening. Second, in order to characterize the microbubble 
behavior during BBB opening, three distinct acyl-chain lengths were used in the fabrication 
of mono-dispersed microbubbles (4-5-µm diameter). Our findings indicated that the BBB 
opening characteristics, such as the pressure threshold of BBB opening, the BBB opening 
volume, and permeability were not affected by the acyl-chain lengths. In addition, the BBB 
was opened through stable cavitation at 0.30 MPa at all acyl-chain lengths. The 
quantification of SCD in both studies on microbubble size and shell properties provided the 
evidence that the stable cavitation, i.e., ultra-harmonics, occurred in the absence of inertial 
cavitation at 0.30 MPa. The microbubble behavior, however, was affected by the acyl-
chain length at 0.60 MPa. The C24 microbubbles might also have higher probability to 
induce RBC extravasations and dark neurons. Further studies need to be performed to 








Chapter 5  
The Cavitation-Dependent Tight-
Junction Integrity of Blood-Brain 
Barrier Opening Using Focused 







In Chapter 4, the role of microbubbles in FUS-induced BBB opening has been 
determined. Also, based on our findings in Chapter 3, the cavitation type can be monitored 
and controlled for the BBB opening. As mentioned in Chapter 2, several physiological 
responses to the FUS-induced BBB opening have been studied. The corresponding physical 
mechanism, however, has not been investigated. Therefore, in this chapter, we will focus 
on the cavitation dependent mechanism of the FUS-induced BBB opening. Meanwhile, the 
conditions for BBB opening induced by different cavitation types will also be investigated.  
In Chapter 2, two types of cavitation have been defined for the microbubbles activated 
in the acoustic field: inertial cavitation (IC) and stable cavitation (SC). Under IC, the 
collapse of microbubbles, in association with microjets and shockwaves, was shown 
responsible for the perforation of cell membranes158 or hemolysis107. Under SC, 
microbubbles expand and contract in the negative and positive acoustic fields, 
respectively103. The mechanical index (MI), defined as the peak rarefactional pressure 
(PRP, negative pressure) divided by the square root of the center frequency, was used for 
the determination of IC likelihood. It has been shown that the IC is not required to induce 
BBB opening and MI = 0.37 was able to induce the IC during BBB opening120. Therefore, 
real-time modulation of treatment pressures on the basis of acoustic emissions from the 
exposed microbubbles is capable of monitoring and controlling the cavitation during BBB 
opening159. 
As shown in Fig. 2.4, tight junction (TJ) plays an important role in the formation of the 
BBB. Therefore, understanding the TJs response to the specific cavitation type can be 




microbubble oscillation in the acoustic fields. The MI, however, used in the studies shown 
in Chapter 2 about the TJs integrity of BBB opening was above the IC threshold (0.37), 
and the microbubbles were poly-dispersed. Since the pressure threshold of BBB opening is 
bubble size-dependent56,57, using poly-dispersed microbubbles at high MI would raise the 
difficulty of unveiling the physics of FUS-induced BBB opening.  
To date, the physical mechanism of causing the disruption of the TJ proteins after FUS-
induced BBB opening is unclear. Therefore, the purpose of this study is to investigate the 
TJ response and corresponding cavitation during BBB opening. In order to exclude the 
bubble size effect, 4-5-µm diameter bubbles are used in each sonication and the 
concentration remained the same. SC-induced BBB opening is generated at a PRP of 0.18 
MPa using various pulse lengths (PLs). In contrast, IC-induced BBB opening is generated 
at a PRP of 0.45 MPa using a burst sequence based on our previous study53. Although, as 
mentioned in Chapter 2, IC occurs along with SC occurrence, the IC dominates BBB 
opening while the PRP is higher than the IC threshold. In both cases, the TJ integrity is 
studied with respect to SC- and IC-induced BBB opening.  
 
5.2 Materials and Methods 
5.2.1 Sonication protocol 
The system of focus ultrasound and cavitation detection was shown in Fig. 3.3(b). A 
total of thirty-three (n=33) adult male mice (strain: C57BL/6, weight: 23.35 ± 1.93 g, 
Harlan Sprague Dawley, Indianapolis, IN, USA) were sonicated in this chapter. The right 




precise grid-targeting procedure40. The focus was placed 3 mm beneath the skull so that the 
focal region overlapped with the right hippocampus as in previous studies41. 
In the study of SC-induced BBB opening, a PRP of 0.18 MPa accounting for tissue 
attenuation was used40. The pulse repetition frequency (PRF) was 5 Hz. Six sets of acoustic 
parameters were used to investigate the effect of pulse length (PL), exposure energy, and 
duty cycle. The number of mice used at each set of acoustic parameters is provided in 
Table 5.1. A PRP of 0.45 MPa was used in the study of the IC-induced BBB opening. As 
employed in our previous study160, a burst of 100 short-cycle pulses (3 cycles, PRF = 5, 25, 
or 100 kHz) was applied at 5-Hz burst repetition frequency. The method of the 
quantification for the ICD has been proposed in section 4.3.4. 
Lipid-shelled microbubbles of 4-5-µm in diameter were manufactured and size-isolated 
in-house using differential centrifugation as described in Feshitan et al.151. The 
concentration was diluted from a higher concentration to approximately 8 x 108 bubbles / 
mL before microbubble administration and sonication was performed 5 s after microbubble 
administration. Microbubble-size distributions and concentrations were determined by the 
electrical impedance sensing zone method (Multisizer 3, Beckman couter, Brea, CA, USA). 
Table 5.1 Acoustic parameters for SC-induced BBB opening 
Protocol (a) (b) (c) (d) (e) (f) 
PL (cycles) 150 750 3000 7500 30000 150 
PL (ms) 0.1 0.5 2 5 20 0.1 
PRF 5 5 5 5 5 100 
Duty cycle (%) 0.05 0.25 1 2.5 10 1 
Duration (s) 300 300 300 300 30 300 
Exposure time (s) 0.15 0.75 3 7.5 3 3 




5.2.2 BBB opening confirmation 
In this study, MRI and fluorescence microscopic examination of dextran delivery was 
used to confirm the BBB opening. A vertical-bore 9.4T MR system (Bruker Biospin, 
Billerica, MA, USA) was used to confirm and quantify the BBB opening in the murine 
hippocampus. The procedure and volume quantification method were then used as 
previously described in Chapter 457. The average MR intensity within the opening volume 
was also measured simultaneously.  
Lysine-fixable dextran at a molecular weight of 3 kDa and fluorescently tagged with 
Texas Red® (Invitrogen, Carlsbad, CA, USA, excited wavelength: 568±24 nm.) were used 
as the model drug. Dextran was dissolved (concentration: 40 µg/g) in phosphate-buffered 
saline (PBS). A 100 µl volume was injected into the tail vein during 30 s after sonication. 
Brains were prepared for fluorescence microscopy and image analysis by serial dilution of 
10%, 20%, and then 30% sucrose at 30 min, 1 h, and overnight time increments, 
respectively. They were then embedded in a formulation of water-soluble glycols and 
resins (Sakura Tissue-Tek O.C.T. Compound; Torrance, CA, USA), frozen in a square 
mold, and then sectioned using a cryostat into 80-µm and 10-µm slices in the horizontal 
orientation. Images of all frozen sections were then acquired using an upright fluorescence 
microscope (BX61; Olympus, Melville, NY, USA). 
 
5.2.3 Immunofluorescence Staining 
Immunofluorescence staining of the frozen brain sections was performed according to 
the manufacturers’ instructions.  Briefly, sections were prewashed once in PBS for 3 min, 




temperature. The antigens were unmasked by incubating the sections in 10 mM sodium 
citrate buffer (pH 6.0) and heating them just below the boiling temperature (95-99 ºC) for 
20 min. The slides were then cooled down at room temperature for 30 min, rinsed in PBS 
for 3 min and then followed by immunofluorescence staining. Sections were blocked with 
blocking buffer (PBS/0.3% Triton-X-100/5% goat serum) for 1 hr at room temperature and 
then incubated with rabbit anti-ZO-1 antibody (Invitrogen) diluted with antibody dilution 
buffer (PBS/0.3% Triton-X-100/1% BSA) overnight at 4 ºC. After washing sections with 
PBS 3 times, they were incubated with Alexa Fluor 488 conjugated goat anti-rabbit IgG 
(Invitrogen) for 1 hr in the dark at room temperature. Sections were then washed and 
covered with vectashield mounting medium containing DAPI (Vector Lab; Burlingame, 
CA) and cover slips. The final fluorescence images were captured with an Olympus 




5.3.1 SC- and IC-induced BBB opening  
The BBB opening confirmed by MRI of each parametric set is depicted in Fig. 5.1. In 
the case of low PRP (0.15 MPa), three main observations can be concluded. First, at 5-Hz 
PRF, the BBB is not opened with a 0.1-ms PL, but is opened at PLs of 0.5, 2, 5, and 20 ms 
(Figs. 5.1(a-e)). Second, BBB opening is not observed at 0.1-ms PL and 100-Hz PRF (Fig. 
5.1(f)). Third, the histological analysis shown in Figs. 5.1(g-i) depicts that no damage is 




duration). The quantitative analysis depicted in Fig. 5.2 shows that both the BBB opening 
volume and the normalized MR intensity reach a plateau when the PL surpassed 2 ms (Fig. 
5.2(a)). In the investigation on the effect of exposure time (2-ms PL and 5 min duration as 
well as 20-ms PL and 0.5 min duration), no significant difference was observed in the BBB 
opening volume (Fig. 5.2(b), left axis), but the normalized MR intensity is significantly 
higher at longer sonication durations (*: P < 0.05, Fig. 5.2(b), right axis).  
		
Figure 5.1 – The 2D T1-weighted MR image of each acoustic parameter set shown in 
Table 1. At 5-Hz PRF, sonications were (a-d) at PLs of 0.1, 0.5, 2, and 5 ms at 300-s 
duration, or (e) at 20-ms PL and 30-s duration. In addition, identical duty cycle as set (c), 
sonication was at (f) 0.1-ms PL and 100-Hz PRF. The BBB was not opened in protocol (a) 
and (f), but was opened in protocol (b-e). Histological analysis (g-i) showed that no red 
blood cell extravasations were observed in protocol (d), i.e., the longest exposure time. The 






Emission of the burst sequence at the PRFs of 5, 25, and 100 kHz is capable of opening 
the BBB (Fig. 5.3(a-c)). No significant difference was observed between the three different 
PRFs in the BBB opening volume and normalized MR intensity. The inertial cavitation 
dose (ICD) at 100-kHz PRF is significantly higher than 5- and 25-kHz PRF (Fig. 5.3(d), *: 
P<0.05).  
 
5.3.2 Fluorescence imaging and Tight Junction integrity 
Fluorescence images (Fig. 5.4) and the corresponding frequency response show that, in 
the case of the longest exposure time (5-ms PL and 5-min duration) of the SC-induced 
BBB opening, fluorescently tagged 3-kDa dextran was contained in the vessel (Fig. 5.4(b)) 
and only the harmonics were observed (Fig. 5.4(f)), while the dextran is diffuse into the 
hippocampus region in the case of IC-induced BBB opening at 100-kHz PRF (Fig. 5.4(d)) 
together with the presence of the broadband response (Fig. 5.4(h)).  
 
Figure 5.2 – Statistical analysis of the BBB opening volume and normalized MR intensity 





The immunofluorescence staining of ZO-1 protein for SC- and IC-induced opening is 
shown in Fig. 5.5. However, no difference is observed on the expression of ZO-1 between 
the unsonicated (Figs. 5.5(a,c,e,g)) and sonicated sites (Figs 5.5(b,d,f,h)), neither between 
the opening induced by SC (Figs. 5.5(b,d)) and IC (Figs. 5.5(f,h)).  
 
Figure 5.3 – The 2D T1-weighted MR image of IC-induced BBB opening sonicated at 
PRFs of (a) 5 kHz, (b) 25 kHz, and (c) 100 kHz. The BBB opening volume, normalized 
MRI contrast enhancement, and inertial cavitation dose of 3 PRFs were measured (d). No 
significant difference was observed between all cases in terms of volume and intensity. The 





Figure 5.4 – Fluorescence images and the corresponding frequency spectrum in the case of 
(a,b,e,f) SC- and (c,d,g,h) IC-induced BBB opening.  The right hippocampus (b,d,f,h) was 
sonicated in the presence of microbubbles and fluorescently tagged 3-kDa dextran, whereas 
the left side was the control (a,c,e,g). The dextran molecules were restricted in the vessel in 
the case of SC-induced BBB opening (b), together with the occurrence of harmonics, while 
they were diffused to the hippocampus in the case of IC-induced BBB opening (d), together 






Here, the cavitation-dependent TJ integrity in the presence of the FUS-induced BBB 
opening was investigated. The TJ protein ZO-1 was examined to evaluate the relation 
between TJ and cavitation. In the SC-induced BBB opening, to our knowledge, a PRP of 
0.18 MPa has not been used in transcranial BBB opening using FUS and microbubbles. 
This study also investigated the effect of pulse length, duty cycle, and total exposure energy 
to explore the conditions required for SC-induced BBB opening at low PRP. In IC-induced 
BBB opening, the effect of PRF in the burst sequence was also determined based on the 
cavitation response recorded by our trascranial PCD. 
	
Figure 5.5 – Immunofluorescence staining in the cases of (a-d) SC- and (e-h) IC-induced 
BBB opening. The ZO-1 expression was indicated in green. No significant difference can 
be observed between the left (a,c,e,g) and the right (b,d,f,h) hippocampus, in both SC- and 




5.4.1 Cavitation-dependent mechanism of BBB opening 
The TJs were found not to be disrupted by either SC or IC under the FUS and 
microbubble pore formation used in this study (Fig. 5.5). This is different from the findings 
reported by Sheikov et. al 6, where ZO-1 was disassembled, leading to the loss of junctional 
barrier functions in brain microvessels, inspected by the immunoelectron   microscopy, 
after sonication. The variations could be linked to the different PRPs applied in that study 
(1.1 MPa) comparing to ours (0.45 MPa for IC and 0.18 MPa for SC), suggesting that the 
TJs may not be disrupted until a sufficiently high pressure is reached. For the delivery of 
macromolecules (3-kDa dextran) across the BBB in our study, it is possible that 
transcellular transport was preferred over the paracellular at the pressures used (Fig. 5.4). 
Similar results have previously been reported using other lipid-coated microbubbles161,162.  
Juffermans et al. showed that the uptake of fluorescent di-4-
aminonaphtylethenylpyridinium (di-4-ANEPPS, ~500 Da) was facilitated through 
endocytosis and macropinocytosis after rat cardiomyoglast cells were sonicated using 1 
MHz at 0.25 MPa PRP with Sonovue® microbubbles161.  Using fluorescence microscopy, 
Meijering et al. also showed homogeneous distribution of 4.4- and 70-kDa dextrans 
through the cytosol, using 1 MHz at 0.22 MPa PRP with Sonovue® microbubbles, which 
was linked to ultrasound and microbubble-mediated delivery of macromolecules through 
endocytosis in vitro162.  Although the type of cavitation was not determined in the 
aforementioned two studies, the MIs were calculated to be 0.25 and 0.22, respectively, 
which was lower than the IC threshold (0.37, Chapters 3, 4)120. Therefore, it is concluded 





Furthermore, we observed that a sufficient PL (0.5 ms) was required for SC to induce 
BBB opening (Fig. 1). It has been shown that an increases in intracellular calcium occurs 
when subjected to mechanical stretching on keratocytes163. Also, the opening of stretch-
activated ion channels in response to repeated mechanical deformation may lead to an 
increase in calcium concentration in visceral sensory neurons164. The vessel invagination 
has also been observed due to the ultrasound-driven microbubble165. A longer PL may thus 
increase probability and number of interactions between the microbubbles and the 
endothelial cells or surrounding neurons. Therefore, the duration of the repeated 
deformation of the endothelial cells, dictated by the pulse length (PL), may play an 
important role in the SC-induced endocytosis.  
As mentioned in Chapter 4, the theoretical model can be a tool for estimation of 
microbubble oscillation. In this chapter, compared with our previous studies56,57, the BBB 
was opened at 0.18 MPa but was not opened at 0.15 MPa, even at a PL of 20 ms. In order 
to have the possible explanation, Bubblesim was used to estimate the microbubble 
oscillation. As shown in Fig. 5.6, the maximum diameter of microbubble is over 9 µm at 
0.18 MPa, but is less than 7 µm at 0.15 MPa based on the parameters decided in Chapter 4. 
As a result, 0.15 MPa may not be sufficient for microbubbles to have enough contacts on 
the endothelial cells. Using 0.18 MPa, the expansion of 4-5-µm diameter bubbles may be 
able to reach the capillary wall of the endothelial cells, and then induce BBB opening via 






In Chapter 4, the stable cavitation dose quantified in vivo (Fig. 4.7) and in phantom 
(Fig. 4.14) showed that the SC occurred at 0.30 MPa. Here, we also quantified the SCD at 
0.18 MPa PRP, but no significance was observed between the peaks at ultra-harmonics and 
the background noise. Despite the fact that the skull may mask the detection of ultra-
harmonics, the phantom results in Chapter 4 also showed that SC did not occur at 0.18 
MPa. Therefore, using 4-5-µm diameter bubbles, the BBB may be opened via short PL (67 
µs, Chapter 4) in the presence of ultra-harmonics, or long PL (5 ms) in the absence of ultra-
harmonics. 
		
Figure 5.6 – Simulation of the oscillation of a 4.5-µm-diameter bubble at PRPs of 0.18 
MPa and 0.15 MPa using Bubblesim. The shell viscosity was 0.19 Pa.s and the shear 
modulus was 32 MPa. The maximum diameter lies in 8-10 µm at 0.18 MPa, but in 5-7 µm 




The mechanism of IC-induced BBB opening was also investigated in this study. Our 
results indicate that observable BBB opening was induced using 3-cycle PL and 4-5-µm 
diameter bubbles(Fig. 5.3(a-c)), which confirmed the previous works using short cycles 
and Definity® bubbles53,62. Also, the ICD at 100-kHz PRF was significantly higher than at 
5-kHz and 25-kHz PRF (Fig. 5.3(d)). Because of lower microbubble depletion through 
uninterrupted pulsed sonication in short pulse interval durations, 100-kHz PRF may 
increase the probability of disrupting a larger number of microbubbles, thereby causing 
higher ICD. However, no significant difference was observed in terms of the BBB opening 
volume and normalized intensity. Since the permeability plateau is reached at 0.45 MPa 
using 4-5-µm diameter bubbles64, the PRF may not affect the BBB opening properties with 
identical conditions. 
Interestingly, in the case of SC-induced BBB opening at the longest exposure time, 
detectable BBB opening was observed in the MR images (Fig. 5.1(d)), but not in the 
fluorescence images (Fig. 5.5(b,d)). Since the molecular weight of MRI contrast agent, 
Omniscan®, is 573 Da, while the fluorescently-tagged dextran is 3 kDa, this finding could 
imply that the size of SC-induced BBB opening is between 573 Da and 3 kDa. However, 
the uptake mechanism between them may be distinct. In addition, comparing with the IV 
injection for the dextran, the administration of Omniscan® was IP. It is difficult to compare 
the uptake of different molecules with distinct administration routes. Future studies will be 





5.4.2 Safe BBB opening using low mechanical index 
The thresholds of MI used in previous studies (0.46 or 0.37) were determined not to be 
necessary and sufficient for BBB opening12,51. The results of this study indicate that low MI 
(0.15) is capable of inducing detectable BBB opening at PLs of 0.5 ms or above. The PL 
threshold of inducing BBB opening has been previously identified at 10 ms using Optison® 
at MI = 0.652 and 2 ms using Definity® at MI = 0.312. In this study, however, it was 
identified between 0.1 and 0.5 ms. Compared with other studies of the PL effect, 4-5-µm 
mono-dispersed microbubbles were used in this study. The effect of bubble size has been 
investigated in our previous studies56,57. The BBB opening was induced without IC using 
larger microbubbles at 0.067-ms PL. Therefore, the PL-threshold may be also bubble-size 
dependent. The histological analysis showed that no RBC extravasation was observed 
using the longest exposure time, i.e., 5-ms PL and 5-min duration (Fig. 5.1(g-i). Also, 
compared with our previous study, comparable BBB opening volume (20.92 ± 2.65 mm3) 
could be reached using long PL (5 ms) at relatively low pressures (0.18 MPa) instead of 
100 cycles at 0.45 MPa. Therefore, equivalent therapeutic effects may be induced at low 
pressures and sufficient PL, which will effectively reduce the probability of damage caused 
by the IC.  
In this study, sonication duration was observed having effects on the MR intensity. As 
shown in Fig. 5.2, the BBB opening volume was similar but the normalized MR intensity 
of the 300-s duration was found significantly higher than that of the 30-s duration. As 
shown in Fig. 5.1(g), since the BBB opening volume reached the plateau at 2-ms PL, 
longer PL may not increase the opening volume. However, longer durations may increase 




due to the reperfusion of microbubbles; thereby increasing the amount of gadolinium 
diffusion to the brain tissue. 
The effect of the duty cycle was also investigated in this study. In order to keep the 
duty cycle identical, 100-Hz PRF and 0.1-ms PL was applied to compare with the results of 
5-Hz PRF and 20-ms PL. Even if the duty cycle is fixed at 1%, no BBB opening was 
induced using 100-Hz PRF and 0.1-ms PL. Therefore, the duty cycle does not play a role in 
the FUS-induced BBB opening.  
 
5.5 Conclusion 
In this chapter, for the first time, MI = 0.15 was shown to be capable of transcranially 
opening the BBB. A sufficient PL was required to induce BBB opening at this MI, and 
higher MRI contrast enhancement was induced at longer sonication durations. The TJ was 
not disrupted at PRPs lower than 0.45 MPa, therefore longer PLs (2 ms) at lower acoustic 
pressure (0.18 MPa), in combination with larger (4-5-µm diameter) microbubbles, may be 
sufficient to deliver therapeutic molecules by changing the permeability of endothelial cells 










Chapter 6  
Translation of the Focused Ultrasound 
Induced Blood-Brain Barrier Opening 








In previous chapters, we have shown that a passive cavitation detector (PCD) can be 
used to transcranially acquire the acoustic emissions stemming from the interaction 
between the microbubble and the brain tissue during BBB opening in mice. During 
sonication, the cavitation response, which was found to be pressure- and bubble-dependent, 
provided real-time feedback regarding the opening occurrence and its properties, thereby 
determining the physical mechanism of FUS-induced BBB opening. As a result, the 
passive cavitation detection can serve as a useful tool for monitoring the microbubble 
response to predict the occurrence and volume of BBB opening, as well as the possibility 
of inducing damages. However, to test the potential of this technique to be applied in 
humans, it is very important to first translate this system of the FUS in combination with 
cavitation monitoring from mice to larger animals and preferable non-human primates. 
Contrary to rodents, the primate brain consists of sulci (fissures) and gyri (lobes). In 
addition, due to the thicker skull, discrepancies in sound velocity and density combined 
with high absorption can lead to poor focusing quality and high energy loss, especially at 
higher frequencies166. Therefore, in non-human primates, the pressure threshold of BBB 
opening and inertial cavitation as well as the safety window and the physical mechanism of 
FUS-induced BBB opening may be distinct from that in mice. 
In this chapter, we aim at establishing a cavitation-guided BBB opening system in non-
human primates. This study will be a major step towards the clinical translation of this 
emerging technology that can be combined with any type of pharmacological treatment to 
the brain. Based on our previous studies on the capabilities and limitations of this technique 




microbubble size and acoustic pressure for BBB opening. Second, different parameters will 
be applied to determine the reproducibility and reversibility of BBB opening. Finally, the 
correlation between the cavitation response, the BBB opening volume and targeted brain 
structure will be established to achieve the real-time cavitation-guided BBB opening in 
monkeys. 
 
6.2 Materials and Methods 
6.2.1 Sonication protocol 
Initial feasibility studies were performed on five male rhesus macaques over the course 
of 12 sessions (a total of 25 sonications). Either the mono-dispersed 4-5-µm bubbles were 
manufactured in-house and size-isolated using differential centrifugation, as used in 
Chapter 4 and 5,151 or the Definity® microbubbles, as used in Chapter 3, were used in this 
study. The PRP, PL, PRF, microbubble types, and targeting region were described in Table 
6.1. The experimental setup was shown in Fig. 6.1. The single-element transducer used in 
our previous ex vivo study was mounted on a standard monkey stereotaxic frame for 
accurate positioning (Fig. 6.2), and the corresponding targeting region was shown in Fig. 
6.3. The global attenuation (absorption, reflexion and scattering) of the skull and the skin 
was assumed to be -5.7 dB and -4.5 dB at 500 kHz, respectively167. The attenuation in the 
monkey brain tissue was assumed to be around -0.5 dB.cm-1 and the thickness of this layer 
was estimated to be equal to 2 cm. Therefore, the emission amplitude was raised by 7.15 
dB (approximately a factor of 2.28) compared to the calibration measurements obtained in 






Table 6.1 Acoustic parameters and corresponding targeting region # denotes the number of 
sonications. N is the number of monkeys. VC: Visual Cortex.   HC: Hippocampus  Ca: 
Caudate Pu: Putamen. 
Protocol PL PRF (Hz) microbubble PNP (MPa) Targeting (#) N
A 100 cycles 10  Definity® 
0.20 VC (1) 1 
0.25 VC (1) 1 
0.30 VC (1) 1 
B 5000 cycles 2  
Definity® 
0.30 HC (3) 2 
0.45 HC (3) 2 
0.60 HC (1) 1 
4-5 µm 
0.30 VC (2), Ca (2), Pu (1) 4 
0.45 VC (4), Ca (1), HC (1) 4 





Figure 6.1 – Experimental setup for in vivo FUS-induced BBB opening in the operating 
room. (a) A single-element, circular focused ultrasound transducer with a hole in the center 
was driven by a function generator (Agilent Technologies, Palo Alto, CA, USA) through a 
50-dB power amplifier (ENI Inc., Rochester, NY, USA). The center frequency, focal depth, 
outer radius and inner radius of FUS were 500 kHz, 90 mm, 30 mm and 11.2 mm, 
respectively. (b) In vivo of the transducer mounted on the stereotactic frame with a 
manipulator allowing precise positioning of the transducer in the stereotactic referential. (c) 
Monkey placed in the stereotactic frame. The monkey is shaved and a degassed 
echographic gel container is placed on the top of its head to insure maximal acoustic 
transmission. 
 











Figure 6.2 – Targeting procedure for in vivo FUS-induced BBB opening. (a) A positioning 
rod (black arrow), indicating the position of the focus (5 cm away from the edge of the 
transducer), was used to target. (b) This positioning rod was mounted on the manipulator in 
order to locate the origin of the stereotactic coordinates. (c) The origin of the stereotactic 
coordinates indicated by the engraved cross on the metal piece between the ear-bars is 





Figure 6.3 – Targeting region and corresponding view from three dimensional views, 
adapted from a web-based brain atlas168.  
 






Figure 6.4 – Experimental timeline of in vivo BBB opening in NHPs. Two targets at 0.30 
MPa (purple circle) and 0.45 MPa (orange circle) are also illustrated. 
 
 
The experimental timeline is shown in Fig. 6.4. For the application of the FUS, all 
animals were anesthetized with 2% isoflurane (carrier gas: oxygen). The heart rate was 
held at approximately 120 beats per minute and the respiratory rate at around 60 breaths per 
minute.  Prior to sonication, the scalp hair was removed with a depilatory cream to ensure 
maximal acoustic transmission. The animal’s head was then placed in a stereotactic frame 
to enable careful targeting of the ultrasound. The sonication was performed immediately 
after intravenous (IV) injection of a 500-μL microbubble bolus in all experiments (5x109 
numbers/mL for customized microbubbles and 1.2x1010 numbers/mL for Definity®). 
Targeting was ensured using a manipulator and a positioning rod indicating the position of 





6.2.2 MRI and acoustic emission detection 
MRI was used to confirm BBB opening using gadiodiamide contrast agent. 3D Spoiled 
Gradient-Echo (SPGR) T1-weighted sequences (TR/TE=20/1.4 ms; flip angle: 30°; 
NEX=2; spatial resolution: 500×500 μm2; slice thickness: 1 mm with no interslice gap) 
were applied after intravenous (IV) injection of gadodiamide (Omniscan®, molecular 
weight 573.66 Da, GE Healthcare, Princeton, NJ, USA) 1 h after sonication. The dose 
applied was 0.2 mL/kg and the IV injection was performed 2 minutes before the SPGR T1-
weigthed scan (scan duration: 18 minutes). Gadodiamide presence in the brain parenchyma 
was induced by BBB opening, similar to the mice shown in Chapters 3-5. 3D T2-weighted 
sequence (TR/TE=3000/80; flip angle: 90°; NEX=3; spatial resolution: 400×400 μm2; slice 
thickness: 2 mm with no interslice gap) and 3D Susceptibility-Weighted Image (SWI) 
sequence were applied (TR/TE=19/27 ms; flip angle: 15°; NEX=1; spatial resolution: 
400×400 μm2; slice thickness: 1 mm with no interslice gap) and were used to assess brain 
damage.  In the session of closing timeline and accuracy, FSL, a comprehensive library of 
analysis tools for MRI brain imaging data, was used to perform the image registration to 
keep the brain orientation at identical location for the closing timeline determination, and 
the focal shift identification169,170. 
A single-element passive cavitation detector (center frequency: 7.5 MHz, focal length: 
60 mm, Olympus NDT, Waltham, MA, USA) was positioned through the center hole of the 
FUS transducer. The two transducers were aligned so that their focal regions fully 
overlapped within the confocal volume. The PCD and spectrogram method were 





6.3.1 BBB opening and corresponding cavitation response 
Two protocols were implemented in this study. First, in the protocol A (Table 6.1), we 
used Definity® microbubbles and short PL (100 cycles) at 0.20 – 0.30 MPa. The results 
were shown in Fig. 6.5, which showed that no BBB opening was induced in any case of 
protocol A (Table 6.1), although inertial cavitation, i.e., broadband response, occurred in 
each case. However, microbubble response was detected through the monkey skull for the 
first time36.  
Second, in the protocol B (Table 6.1), Long PL (5000 cycles) and higher pressure (0.30 
– 0.60 MPa) were applied with Definity® or 4-5-µm diameter bubbles. Figure 6.6 shows 
that no BBB opening was induced at 0.45 MPa using Definity® but a broadband response 
was detected. In the case of 4-5-µm microbubbles, however, the BBB was successfully 
opened at 0.30 and 0.45 MPa. The MR images and the corresponding spectrogram of the 
first pulse are depicted in Fig. 6.7. As a result of the deposition of the MRI contrast agent in 
the brain tissue after ultrasound exposure, the MR images indicated that the BBB was 
opened at 0.30 MPa (Fig. 6.7(d,e,g)) and 0.45 MPa (Fig. 6.7 (f,h)) using the 4-5-µm 
bubbles. The white matter, compared with the gray matter, was observed easier to be 
opened (Fig. 6.7). The peak MR intensity enhancement at the BBB-opened region relative 
to the average value in the parenchyma was increased by 119% and 48% at 0.3 MPa and 
0.45 MPa, respectively. The volume of the BBB disruption was equal to 24.6 mm3 and 30.5 





Figure 6.5 – (a) The spectrogram without microbubbles administration show that all the 
harmonics and broadband response are from microbubbles. Spectrograms during FUS 
sonication with monkey 2 at (b) 0.20 MPa, (c) 0.25 MPa, (d) 0.30 MPa, and MR images 
with (e) coronal and (f) sagittal planes show that the broadband response occur with all 
pressures, but no BBB opening is induced (dashed circle). 
 
	
Figure 6.6 – (a) The spectrogram without microbubbles administration show that all the 
harmonics and broadband response are from microbubbles. The spectrogram during FUS 
sonication with monkey (b) 0.45 MPa shows that the broadband response takes place. The 






Figure 6.7 – The BBB opening confirmed by 3D-MRI images. No higher harmonics and 
broadband response are present at 0.30 MPa in (a) the spectrogram without microbubbles 
administration. The corresponding spectrogram of the first pulse with microbubbles 
administration shows that the broadband acoustic emissions are detected at (b) 0.30 MPa 
and (c) 0.45 MPa. The 3D-MR images confirm that the BBB is opened at (d, e, g) 0.30 
MPa and (f, h) 0.45 MPa with inertial cavitation. The yellow box in the sagittal plane in (d) 
defines a region of interest from which images in (e) and (f) were acquired. The coronal 
plane with BBB opening is provided at (g) 0.30 MPa and (h) 0.45 MPa. The white arrow in 
(c) indicates that the time-point of occurrence of the second harmonic coincides with the 
travel distance to the skull. 
 
The corresponding spectrogram (Figs. 6.7 (b) and (c)) showed that the broadband 
response, i.e., the inertial cavitation, occurred at 0.30 MPa and 0.45 MPa. No harmonics 
were present at 0.30 MPa in the spectrogram without microbubble administration (Fig. 6.7 
(a)), which confirms our findings in mice (Chapter 3)120. The spectrogram can also be used 
to determine the position of the focus. The white arrow in Fig. 6.7 (c) indicates that the 
time-point of occurrence of the second harmonic coincides with the travel distance to the 
skull. Therefore, harmonics higher than the 3rd harmonic and any broadband response are 





Figure 6.8 – Damage assessment. (a,c,d) 3D T2-weighted sequence. Edemas should appear 
brighter in these images. (b,e,f) 3D Susceptibility-Weighted Image (SWI) sequence was 
applied. Hemorrhages, as well as large vessels should appear in black in these images. (a,b) 
Same reconstructed coronal slice as shown in Fig. 6.7. The two opening sites are circled 
with the corresponding colors. There is no difference between the two hemispheres. 
(c,d,e,f) Corresponding reconstructed sagittal slices for the two opening sites. No edemas or 
hemorrhages are visible in the sonicated regions (dashed contour). 
 
The same MRI sequence and IV contrast agent injection were repeated six days after 
BBB opening. No intensity enhancement was observed indicating that the BBB was closed 
or reinstated. Two other MRI sequences (T2-weighted and susceptibility-weighted) were 
used to assess potential brain damage after ME-FUS and both of them indicated absence of 
detectable damage such as edema or hemorrhage (Fig. 6.8). The same protocol was 
repeated for the two following sessions applying 0.6 MPa and two different kinds of 
microbubbles. The results are shown in Fig. 6.9 and 6.10. T1-weighted MR sequences were 
used to track the diffusion of gadodiamide. The peak MR intensity enhancement at the 
BBB-opened region relative to the average value in the parenchyma was increased by 68% 
and 41% using customized and Definity® microbubbles, respectively. The volume of the 
BBB disruption was equal to 285.5 mm3 and 116.3 mm3, respectively. The BBB opening 
regions at the caudate and the hippocampus were shifted from the targeted location by 




MR sequences were also used to assess potential damages in the brain. An edematous 
region was detected on the T2-weighted MRI in one case using custom made microbubbles 
while no damage was detected using Definity® with all acoustic parameters being the same. 
All the animals have been survived and therefore histological findings are not available at 
this time. Even though no in-depth cognitive tests have been performed thus far, qualitative 
assessment of basic the animal behavior has been monitored. Normal cognitive behavior 
has been noted following ME-FUS procedures at moderate pressures and using Definity®. 
In the case of 0.6 MPa and customized microbubbles, the animal with the edema exhibited 
a weakness in the contra-lateral arm over four days after treatment, but then fully recovered 
after that four-day period. The corresponding spectrogram showed that a large broadband 
signal was recorded for both customized and Definity® microbubbles. 
		
Figure 6.9 – BBB opening experiment targeting hippocampus using Definity® 
microbubbles and applying 0.6 MPa (yellow dashed line shows region of interest). 3D 
Spoiled Gradient-Echo (SPGR) T1-weighted sequence was applied after intravenous (IV) 
injection of gadodiamide 1 h after sonication. No damage was detected using Definity® 





Figure 6.10 – BBB opening experiment targeting hippocampus using custimized 
microbubbles and applying 0.6 MPa (yellow dashed line shows region of interest). 3D 
Spoiled Gradient-Echo (SPGR) T1-weighted sequence was applied after intravenous (IV) 
injection of gadodiamide 1 h after sonication. An edema was visible using Definity® 
microbubbles from T2-weighted sequence. 
 
Here, a total of 11 BBB openings were induced at 0.30 and 0.45 MPa (Table 6.1) using 
4-5-µm diameter bubbles. The correlation between the ICD and the BBB opening volume 
was shown in Fig. 6.11. At 0.60 MPa, because the BBB opening volume was the 
combination of four sonications (two in the visual cortex and two in the hippocampus), this 
opening volume (285.5 mm3) is not including the Fig. 6.11. The SCD at all ultra-harmonics 
of difference regions at 0.30 and 0.45 MPa is shown in Fig. 6.12. At 0.30 MPa, the 
amplitude at ultra-harmonics was the largest in the putamen and the lowest in the visual 





Figure 6.11 – The correlation between the ICD and the BBB opening volume at 0.30 and 
0.45 MPa at 4-5-µm diameter bubbles (a total of 11 openings). The volume at 0.60 MPa is 





































Figure 6.12 – The region dependent SCD at 0.30 and 0.45 MPa. The amplitude level is 
putamen > caudate > visual cortex at 0.30 MPa, as well as visual cortex > caudate > 






6.3.2 Closing timeline and accuracy 
The duration of BBB opening and the corresponding opening volume of each scan 
were shown in Fig. 6.13. At 0.30 MPa, the BBB was opened in the caudate and lasted two 
days. On day 4, the opened BBB was completely recovered. The targeting precision was 
also investigated. Figures 6.14 and 6.15 show the estimated focal region (yellow area) and 
the BBB opening region (blue area) from the coronal, sagittal, and horizontal plane. The 
axial shift of the focus was found to vary in 6.9 mm. The corresponding spectrogram for all 
duration (120s) is also presented. The focal shift, BBB opening volume, and MRI contrast 
enhancement of the visual cortex and caudate are quantified in Table 6.2.  
		
Figure 6.13 – An example of BBB closing in the NHP caudate using 0.30 MPa and 4-5-
µm microbubbles. The blue region indicates the opening region and it is no longer visible 
in day 4. The corresponding quantification of BBB opening volume indicates that the BBB 
is nearly closed on day 2. The error bar denotes the stander deviation of the MR intensity of 







Table 6.2 The axial focal shift, BBB opening volume, and MRI contrast enhancement of 
two opening regions. The focal shift is as our expectation shown in Appendix B. 
 
Region Caudate Visual cortex 
Pressure (MPa) 0.30  0.45  
Axial focal shift (mm) 3.4 6.9 
Volume (mm3) 72.5 112.3 







Figure 6.14 – The discrepancy between focal region (yellow area) and BBB opening 
region (blue area) at the caudate at 0.30 MPa. Corresponding spectrogram shows the 





Figure 6.15 – The discrepancy between the focal region (yellow area) and the BBB 
opening region (blue area) at the visual cortex at 0.45 MPa. Corresponding spectrogram 




In this chapter, the FUS-induced BBB opening, combined with the transcranial 
cavitation detection, in non-human primates is reported for the first time. A total of four 
locations were disrupted in five animals (Table 6.1). Pressures ranging from 0.3 MPa to 0.6 
MPa were investigated. Previous studies have shown that a pressure increase results in a 
larger BBB opening extent and higher BBB permeability while a safety window exists 
within the pressure range of 0.30 MPa and 0.60 MPa91,120. For all experiments, T1-
weighted MRI at 3.0 T was used to confirm the BBB disruption, tracking the diffusion of 
IV-injected gadodiamide in the brain. Since this cavitation response was capable of being 




further information could be obtained in this study to investigate the cavitation-guided 
BBB opening in NHP. 
Understanding the discrepancy of physical mechanism between mice and monkeys is 
helpful for clinical translation. Here, except for one case sonicated at 0.60 MPa, no BBB 
opening was induced using Definity® microbubbles and 10-ms pulse length, despite the 
occurrence of inertial cavitation (Figs. 6.5 and 6.6). Therefore, lower pressures (0.20 - 0.30 
MPa) and shorter pulse length (0.2 ms) shown in protocol A (Table 6.1) may not be 
sufficient to induce BBB opening. However, in our previous studies, the BBB was opened 
at 0.45 MPa and PLs of 0.1, 0.2, 1, 2, and 10 ms, using the same microbubbles in mice. 
Therefore, higher pressures may be required to open the BBB in monkeys using Definity®. 
Also, given that the medial areas were targeted (Fig. 6.5), the focus included the 
superior sagittal sinus that, due to the large volume of microbubbles circulating, resulted in 
larger amplitude of the cavitation spectrum. Measuring the cavitation spectrum may, 
therefore, be helpful to determine whether a large vessel is in the path of the FUS beam and 
thus predict or avoid its effects on inducing BBB opening. This is important as this 
likelihood may be hard to exclude otherwise: 1) due to the interference from the skull, the 
exact location of the focus in the brain is difficult to predict; 2) the exact location of large 
vessels in the brain relative to the beam is not known a priori. Hence, the relationship 
between the amplitude of the cavitation spectrum, the area of BBB opening, and the BBB 
opening threshold will provide valuable additional information regarding the presence of 
large vessels close to the focus. This information can thus be used to predict whether 




subsequent shielding and adjust the targeting accordingly to achieve BBB opening, i.e. 
avoid shielding by large vessels. 
Those preliminary results have also indicated the dependence of the BBB opening on 
the microbubble types. In protocol B (Table 6.1), at 0.30 and 0.45 MPa, BBB opening was 
only observed with the 4-5-µm bubbles (Figs. 6.7 and 6.8). At 0.60 MPa, larger BBB 
opening area was obtained with the 4-5-µm bubbles (Figs. 6.9 and 6.10). This is mainly 
because by increasing the peak pressure, a larger portion of the brain reaches the disruption 
threshold. We have shown that the 4-5-µm bubbles result in a larger BBB opening region 
in mice. Based on this finding, which complements our previously reported studies on the 
bubble size in mice57, it is believed that the bubble size also plays an important role in the 
BBB opening in primates. 
In Chapter 4, we showed that the BBB was opened at 0.3 MPa and the inertial 
cavitation occurred at 0.45 MPa using 1.5-MHz FUS and 4-5-µm diameter bubbles. Here, 
the BBB was also opened at 0.30, 0.45, and 0.60 MPa with the presence of inertial 
cavitation. The mechanical index was 0.25, 0.37, and 0.49 at 1.5 MHz, as well as 0.42, 0.64 
and 1.02 at 500 kHz for 0.3 MPa, 0.45 MPa and 0.6 MPa, respectively. Since the MI 
threshold of the broadband response was close to 0.451 and the broadband response was 
observed in most cases of BBB opening, lower pressures will be applied and the stable 
cavitation dose will be quantified to determine whether the BBB can be opened without 
inertial cavitation using 4-5-µm diameter bubbles. 
In our previous studies, the cavitation response was shown capable of estimating the 
BBB opening volume (Chapter 4)57. By taking into account 11 openings performed with 




in Fig. 6.11. More openings will be performed in the future to determine the relation 
between the ICD and the BBB opening volume. If successful BBB opening and the 
corresponding opening volume can be predicted using the PCD system, MRI is not 
required for monitoring BBB opening during sonication, thereby expanding the application 
of FUS while maintaining its low cost and real-time capability for the clinical application. 
In the cavitation response, not only the ICD, but also the spectrogram can provide very 
useful information on the microbubble behavior in real-time. Figure 6.16 shows three 
spectrograms. First, the spectrogram of total duration (120s) (Fig. 6.16(a)) indicated the 
duration for microbubbles to reach the brain after the IV-injection. For instance, it takes 10 
seconds for Definity® microbubbles to reach the brain (Fig. 6.16(a)). In clinical application, 
the patient may have a circulation problem, which may be indicated by the spectrogram of 
total duration. The microbubble persistence can also be identified. Compared with the 
response of 4-5-µm bubbles shown in in Fig. 6.15, the 4-5-µm bubbles is shown more 
robust during 120s. Second, the spectrogram of one pulse (red line in Fig. 6.16(a)), 
showing a pulse length of 10 ms (Fig. 6.16(b)), can determine the duration of inertial 
cavitation. This duration may be microbubble dependent and correlated to the ICD. If 
insufficient microbubbles are sonicated at each pulse, the duration of inertial cavitation 
may be shorter, thereby inducing lower ICD and BBB opening volume.Third, the first few 
hundred microseconds of one pulse (Fig. 6.16(c), 0-0.4 ms of the Fig. 6.16(b)), can indicate 
the location of the focus based on the starting point of harmonics and broadband response. 
This might be useful to estimate the actual focus, thereby determining the axial shift 







Figure 6.16 – Three spectrograms of the cavitation response. (a) The spectrogram of all 
pulses provides the information about the microbubble persistence and the duration for 
them to reach the brain after the IV-injection. (b) The spectrogram of one pulse (red line in 
(a)) indicates the duration of inertial cavitation. (c) The actual location of the focus may be 
determined by the first 0.4 ms of one pulse, i.e., the red square in (b). 
 
Since the primate brain is inhomogeneous, the BBB opening properties may be distinct 
between different areas. As shown in Fig. 6.7, the intensities of MRI contrast enhancement 
in the BBB opening region at 0.30 MPa was 2.3 times higher than at 0.45 MPa. These 
differences may be due to a higher concentration of microbubbles in the sonicated region 
during the 0.30 MPa stimulation. This would explain both, the enhanced MRI contrast and 
the stronger broadband response.  
 In addition, the cavitation response may also be region dependent. The SCD at distinct 
regions at 0.30 and 0.45 MPa was depicted in Fig. 6.11. The higher sensitivity lied near the 
center frequency of the PCD (7.5 MHz). Four different locations were shown having 
distinct cavitation response. In Fig. 6.11, at 0.30 MPa, the amplitude level in the putamen is 
the largest and the visual cortex is the lowest. In comparison between the caudate 
(Fig.6.12) and the virtual cortex (Fig. 6.13), the visual cortex is deeper than the caudate. 
This might be one of the reasons why lower amplitudes are detected in the visual cortex. 
The comparison between the caudate and putamen can be seen in Fig. 6.3. The putamen is 




deeper than caudate in the sagittal view, but is roughly the same depth in the coronal view. 
Also, because of only one sonication in the putamen, more sonications will be implemented 
to determine the region dependent cavitation response. In the comparison between the 
visual cortex and hippocampus, the hippocampus is deeper than visual cortex from the 
sagittal and coronal view (Fig. 6.3). Therefore, the amplitude was lower in the 
hippocampus. Although the depth of the targeting regions would have an effect on PCD 
amplitude, the region dependent cavitation response might be used to characterize the BBB 
opening properties in different location in NHP.  
 
6.5 Conclusion 
In this chapter, we successfully translated the in vivo transcranial BBB opening system 
together with real-time passive cavitation detection from mice to NHPs. First, initial 
feasibility of noninvasive, highly selective, drug-independent and reversible BBB opening 
was demonstrated in non-human primates in vivo. High spatial selectivity of this technique 
was also shown.  Compared to the mouse application (Chapters 3-5), the BBB in monkeys 
was considered more difficult to be opened, and the larger microbubbles facilitated BBB 
opening. Ongoing investigations entail optimization of the procedure including safety and 
efficacy of the trans-BBB drug delivery. Second, the noninvasive and transcranial 
cavitation detection during BBB opening in non-human primates was achieved. The ICD 
can be used to estimate the BBB opening and corresponding opening volume. In addition, 
the MRI contrast enhancement and cavitation response were shown to be region and/ or 
microbubble-size dependent. Therefore, this technique might be used for a cavitation-




MRI. Further studies will be performed to optimize the application in primates and 
determine the correlation between the location of BBB opening and the cavitation 
spectrum. This study is a major step toward clinical translation of this emerging technology 









Chapter 7  






In this dissertation, the physical mechanism and corresponding safety assessment have 
been fully investigated. The safety window, including the threshold of the inertial 
cavitation and the damage (here is red blood cell extravasations), in terms of microbubble 
types and peak rarefactional pressure, was determined in mice and shown in Fig. 7.1. First, 
the BBB was opened in the absence of inertial cavitation and damage using Definity® 
microbubbles at 0.30 MPa (Chapter 3) as well as using 4-5-µm diameter bubbles at 0.18 
and 0.30 MPa (Chapters 4 and 5), considered as the safest window (green rectangular). 
Second, using Definity® or 1-2-µm diameter bubbles, although the inertial cavitation 
occurred at 0.45 MPa, no damage was observed. As a result, another safety window 
(orange rectangular) lies between 0.45 and 0.60 MPa using Definity® (Chapter 3) or 1-2-
µm diameter bubbles (Chapter 4).  
Figure 7.1 – Safety windows in terms of peak rarefactional pressure and microbubble types 
in mice. The safest window (green rectangular), in the absence of inertial cavitation (IC) 
and damage, lies between 0.15 and 0.30 MPa using 4-5- or 6-8-µm diameter bubbles, as 
well as between 0.30 and 0.45 MPa using Definity®. Another safety window, in the 
absence of damage with the IC occurrence (orange rectangular), lies between 0.30 and 0.45 
MPa using 1-2-µm diameter bubbles or Definity®. However, the pressure threshold of the 




A major step toward the clinical application was the successful BBB opening in 
monkeys using our noninvasive and transcranial cavitation-guided BBB opening system. 
The probability of opening the BBB in monkeys was 100% using 4-5-µm diameters 
bubbles at 0.5 MHz and at pressures of 0.30 – 0.60 MPa (Chapter 6). Therefore, 
microbubbles in diameters of 4-5-µm or 6-8-µm were suggested for future application in 
monkeys or human.  
In this dissertation, the physical mechanism was determined based on the cavitation 
response, combined with theoretical model simulation and the phantom validation. In mice, 
harmonics at 0.18 MPa (Chapter 5), ultra-harmonics, i.e. SCD, at 0.30 MPa (Chapter 4), 
and broadband response, i.e. ICD, at 0.45 and 0.60 MPa (Chapters 3,4) were detected and 
the corresponding BBB opening properties was obtained. Therefore, the conclusions of our 
main findings were as follows: 
1) The transcranial cavitation response, including the SCD and ICD, during BBB 
opening was successfully detected and calculated for the first time (Chapters 3-6). 
2) The BBB can be opened in the absence of inertial cavitation or any cellular damage 
in mice (Chapters 3-5). 
3) A sufficiently long pulse length was required to induce BBB opening in mice via 
stable cavitation, without disrupting the tight junction (Chapter 5).  
4) The physical mechanism may be distinct between mice and monkeys (Chapter 6).   
5) Cavitation response can serve as a decent indicator to estimate the BBB opening 
occurrence (SCD, Chapter 4), the BBB opening volume (ICD, Chapter 4),  
microbubble persistence (Spectrogram, Chapter 6), and the location of focus 




7.2 Future directions 
This dissertation has revealed the physical mechanism of FUS-induced BBB opening 
and achieved the feasibility of cavitation-guided BBB opening in non-human primates. 
However, in order to achieve the goal of safe delivery of therapeutic drugs, several studies 
are recommended.  
Successful delivery of therapeutic agents (BDNF) in mice has been reported by our 
group4. The acoustic pressure, however, was at 0.46 or 0.60 MPa along with the IC 
occurrence. Although the IC in conjunction with Definity® microbubbles at 0.45 MPa was 
still within the safety window, until now, the capability of brain drug delivery using the SC 
has not been investigated. As shown in Chapter 5, fluorescently tagged 3-kDa dextran was 
contained in the vessel in the case of SC-induced BBB opening at 0.18 MPa. Thus, the 
BDNF, with a total molecular mass of 27 kDa, may not be delivered at 0.18 MPa. Choi et 
al. have shown that the FUS combined with microbubbles opened the BBB sufficiently to 
allow passage of compounds of at least 70 kDa, but not greater than 2000 kDa into the 
brain parenchyma, using 0.46-MPa sonication, i.e. the inertial cavitation threshold of 
Definity®. Therefore, identifying the range of molecular mass of the agents across the SC- 
or the IC-induced BBB opening will be important to assess the efficacy of this approach. 
Based on the findings in Chapter 3, microbubbles in the diameter of 4-5- or 6-8-µm were 
able to induce sufficient BBB opening in the absence of the inertial cavitation.  Also, at 
relative low pressure (0.18 MPa), a sufficiently long PL (5 ms) was capable of enhancing 
the MR contrast in the BBB opening region. On this ground, we suggest using those 
microbubbles in combination with sufficient pressure and PL to determine the maximum 





A long term study, in combined with the cognitive monitoring, is obligated to be 
investigated in order to determine the effect of repeated sonication with intervals of few 
days to few weeks. If any injury was induced by the repeated sonication, the corresponding 
behavior may be different from the normal mice. This study will provide useful 
information for the clinical application in the future. 
In Chapter 6, the feasibility of BBB opening using FUS and microbubbles, along with 
transcranial cavitation detection, was achieved. More aspects should be investigated: 
1) Safety windows determination, including the wide investigates on pressures, pulse 
length, microbubble sizes, and behavior monitoring after BBB opening. 
2) Delivery of pharmacological compounds in monkeys.  
3) Successful prediction of BBB opening occurrence and the BBB opening volume at 
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The general kinetic model (GKM) was used to measure the BBB permeability in the 
targeted region. Previous studies66 have validated the reliability of GKM in the FUS-





t                                                (A.1)	
where Ktrans, Kep are the transfer rate constants from the blood plasma to the EES and 
from the EES to the blood plasma, respectively, and Cp, Ct are the concentrations of Gd-
DTPA in the blood plasma and the EES respectively. GKM assumes prior knowledge of 
the arterial input of the contrast agent over time, which is model fitted to a bi-exponential 
equation, typically referred to as the arterial input function (AIF): 
  tm2tm1p 21 eAeAtC                                                (A.2) 
where Ai, mi (i=1, 2) are the amplitude and decay rates of Cp respectively and t is time. 
The plasma concentration Cp is calculated as a fraction of the blood concentration Cb, 
bctp )CH(1C  , where Hct=0.45 is the hematocrit level for wild-type mice. The difficulty 
in obtaining an accurate AIF from a detectable vessel in the dynamic images has been 
reported and assessed with various estimating models172. However, recent studies172 have 
demonstrated that selecting a population average from a large group of the same strain of 
animals in order to determine the AIF can be both accurate and robust. In this study, the 
entire cohort of mice was used to determine the AIF, by averaging the Gd-DTPA 
concentration changes in the internal carotid artery (ICA), as shown in previous studies66.  
Signal intensity in T1 images is translated to tracer concentration, using the Solomon-




concentration of the contrast agent ([Gd]) and the relaxation rate difference (ΔR1). Relating 
the relaxation rate to signal intensity (S) in the gradient echo MR images yields a linear 







                                                (A.3) 
where T1,pre is the longitudinal relaxation time of the corresponding tissue before the 
contrast agent administration, r1 is the longitudinal relaxivity of the contrast agent and Spre, 
Spost are the signal intensities before and after Gd-DTPA injection respectively. Phantom 
experiments in the 9.4 T MRI system have shown that the r1 relaxivity of gadodiamide 
(Omniscan®, molecular weight of 530 Da) is approximately 2.6 mM-1s-1, while the 
longitudinal relaxation times of the brain tissue (0.9 s) and the arterial blood (1.5 s) in mice 
have been reported in previous studies, using arterial spin labeling techniques174. 
Prior to the quantitative Ktrans measurements, all the images were smoothed using the 
N-D filtering algorithm of the Image Processing Toolbox® of Matlab (MathWorks, Inc., 
Natick, MA, USA). In addition, since the actual Gd-DTPA injection time occurred 
approximately 3 min after the beginning of DCE-MRI, exclusion criteria were set for the 
estimated Gd-DTPA injection time (t<0 or t>30 min) in order to avoid any fitting 
divergences. The spatial permeability distribution was estimated by counting the voxels 
that exhibited a Ktrans value over a predefined threshold (0.005 min-1). The threshold was 
selected in the mouse that showed the smallest BBB opening, using the quantification 
method described below. The estimations represented the volume area in the sonicated 
region where there was a clear permeability increase. The Ktrans values were measured both 




mouse brain, and for a circular region of interest (ROI) of 1 mm in diameter in the targeted 
hippocampal area and the control side. The ROI was applied on the slice with the highest 
T1 signal enhancement due to BBB opening and the ROI size was selected so it matched 
the axial full-width-at-half-maximum intensity area dimension of the beam. If the temporal 
Gd-DTPA concentration profile of a pixel fitted the AIF curve (Fig. A.1), then that pixel 
was excluded and the remaining pixels within the ROI were averaged to extract the Ktrans 
value. 
The general kinetic algorithm determined both the Ktrans and Kep values, but this study 
emphasized only on Ktrans, which represents the Gd-DTPA leakage from the systemic 
circulation and is mostly influenced by the concentration changes immediately after the 
Gd-DTPA injection. Kep values are mostly influenced by the “steady-state” time points of 
the concentration curves (Fig. A.1), when equilibrium is reached between the EES and the 
blood plasma concentrations175,176. 
		
Figure A.1 – The arterial input function, averaged from a population of all 40 mice, by 





























 A single-element, circular focused ultrasound transducer (Riverside Institute, New 
York, New York, USA) with a hole in its center was driven by a function generator 
(Agilent Technologies, Palo Alto, CA, USA) through a 50-dB power amplifier (ENI Inc., 
Rochester, NY, USA). The center frequency, focal depth, outer radius and inner radius of 
FUS were 500 kHz, 90 mm, 30 mm and 11.2 mm, respectively. A single-element passive 
cavitation detector (PCD) (center frequency: 7.5 MHz, focal length: 60 mm, Olympus 
NDT, Waltham, MA, USA) was positioned through the center hole of the FUS transducer. 
The two transducers were aligned so that their focal regions fully overlapped within the 
confocal volume. This transducers assembly is suspended to a 3D axis positioning system 
(Velmex Inc., Bloomfield, NY, USA) to be able to aim the desired target through the skull. 
A hydrophone (HGN-0200, Onda Corp, Sunnyvale, CA, USA) is attached to a second 
similar 3D axis positioning system in order to scan the transcranial pressure field.  
 
Skull preparation 
Two human and two non-human primate skulls were used for this study. For these 
skulls, two hemispheres were used for each location. Prior to the experiment, the skulls 
were degassed during one day in a sealed jar. Vacuum was made using a custom made 
pump. For in vitro experiments, the transducer was connected to the first 3D positioning 
system and immersed in a large water tank filled with degassed water. The human or NHP 
skull is also immersed in water. The hydrophone was then placed inside the skull cavity at 






Targeting was performed using a pulse-echo transducer and utilizing the distinct 
landmarks on the skull. The 7.5 MHz pulse-echo transducer embedded through the central 
bore hole of the therapeutic transducer was used to map the surface of the targeted skull. 
The occipital protuberance (OP) that lines the inferior dorsal region and the lambda 
anatomical landmarks in both primates and humans (Fig. B.1) was identified using time-of-
flight and power spectral density measurements, whose product indicates the reflectivity of 
the skull. To this purpose, the pulse-echo transducer was moved using the positioning 
system in the lateral and ventro-dorsal directions of the skull and the time of occurrence of 
the peak in the power spectrum of the received RF signals will be calculated in each 
location. The OP and lambda landmarks were then identified (Fig. 6.2) due to their distinct 
reflectivity and texture and then mapped onto a preexisting brain atlas. For each target, the 
orientation of sonication was chosen to be similar to the previous simulation study 
performed in our lab131. In this previous work, optimal orientations for the ultrasound focus 
to match anatomical shapes of targets were calculated. Also, as the NHP OP seemed to be 
hindering the ultrasonic propagation for putamen and caudate targeting, alternative 
orientations were defined. These alternative orientations for caudate and putamen are very 
similar and studying the benefit of this choice in vitro is relevant, therefore for NHP skulls 





Figure B.1 – Targeting images for monkey and human skulls based on combined 
reflectivity and time-of-flight measurements. Anatomical landmarks are clearly 
identified such as the occipital protuberance or lambda. 
 
Acoustic measurements 
In order to quantify the focusing quality, pressure field measurements are realized 
around the geometric focus. Once the transducer is set to aim a particular region through 
the skull using the procedure described in the previous section, the hydrophone is set at this 
location using the second 3D positioning system. This second positioning system is used to 
move the hydrophone to scan the pressure field along one plane. The scan field of view is 2 
cm along lateral dimensions and 6 cm along axial dimension, the spatial step is 0.167 mm 
for the lateral dimensions and 0.5 mm for the axial. For each point, the acoustic response is 
acquired on a PC workstation with an 80‐MHz digital acquisition board (model 14200, 
Gage applied technologies Inc., Lachine, QC, Canada). For each location, the peak 




pressure profiles are compared with water pressure profiles enabling quantification 
comparison in peak pressure amplitude, position shift and focal shape. In the previous 
simulation work131, two other parameters were evaluated to quantify the quality of the 
target coverage by the ultrasound focus. For every case we calculated the percent-of-target-
overlapped, which depicts the volume fraction of the target above half-pressure threshold, 
and the percent-of-beam-overlapping-target, which represents the volume fraction of the 
beam that falls inside the targeted region.  
 
Results 
Figures B.2 & B.3 show typical beam plots of examples the transcranial ultrasonic 
pressures measured in the horizontal and transverse planes of the focus of the transducer. 
According to previous reports51,91,120, the ratio between the pressure threshold for damage 
and the pressure threshold for BBB disruption is always less than 2 or 6dB. These pressure 
fields have been thresholded at -6dB in order to represent the maximum extent of induced 
BBB opening without inducing damage. The contour of the targeted region is depicted 
using a blue dashed line. For each target and each skull type, these pressure profiles were 
acquired four times (two skulls and two hemispheres). For each acquisition, the quality of 
the focusing is assessed using the following parameters: attenuation compared to that of the 
water, lateral and axial resolution of the focus (for the lateral, small and large axis are 
measured to quantify the distortion of the focus), shift of the position of the focus compared 
to that of the water, resolution of the focus (-6 dB dimensions, roughly equivalent to half-
pressure threshold) and angle tilt of the focus. Using NHP skulls, the values of these 




targeting. The overall attenuation was found to be around -6 dB (respectively -5.66 ± 0.77 
dB, -6.18 ± 0.30 dB and -5.57 ± 0.47 dB for the hippocampus, caudate and vertex). The 
resolution of the focus was found acceptable compared to that of the water (lateral 
dimension 3.6 ± 0.1 mm, axial dimension 31.2 ± 1.2 mm). The difference in between the 
two main axis of the focus in the focal plane was also investigated in order to quantify the 
distortion of the focus. For the hippocampus, caudate and vertex respectively, the lateral -6 
dB dimensions were 3.9 ± 0.2 mm, 4.0 ± 0.1 mm and 3.7 ± 0.1 mm for the small axis and 
4.2 ± 0.2 mm, 4.2 ± 0.3 mm and 4.0 ± 0.2 mm for the large axis. Corresponding axial 
resolutions were found to be 38.5 ± 1.7 mm, 39.2 ± 2.3 mm and 38.9 ± 1.7 mm. The 
displacement of the focus compared to the geometrical focus was also quantified. The shift 
of the focus was found to be, respectively, 0.6 ± 0.2 mm, 0.8 ± 0.1 mm and 0.5 ± 0.3 mm in 
the focal plane and -4.4 ± 1.3 mm, -4.1 ± 0.7 mm and -3.9 mm ± 1.0 mm along the 
geometric axis of propagation. Finally the tilt of the focus induced by presence of the skull 
was measured, the angle between axial dimension of the focus and the principal axis of 
propagation. The respective measurements were 1.21 ± 0.11°, 1.43 ± 0.64° and 1.03 ± 
0.18°.   
For the initial orientation calculated for targeting the putamen, the effects of the skull 
were stronger. The total attenuation was found to be -6.91± 0.88 dB. The resolution of the 
focus was more altered and the difference between small axis resolution (4.3 ± 0.3 mm) 
and the large axis resolution (5.2 ± 0.7 mm) was increased. The axial resolution (41.2 ± 1.8 
mm) was also increased but compared to the previous orientations this change was less 
sensitive. The shift of the focus was increase by a factor three in the lateral dimension (2.0 





Figure B.2 – Examples of -6 dB pressure profiles obtained through a NHP skull for the 
four different orientations. Blue dashed lines represent the contour of the target (as 






Figure B.3 – Examples of -6 dB pressure profiles obtained through a human skull for the 
four different orientations. Blue dashed lines represent the contour of the target as indicated 





In the human skulls, the same measurements were also performed. Even though the 
overall effects induced by the skull are sharper, the findings were very similar. The total 
attenuation was measured to be -9.31 ± 0.62 dB, -9.02 ± 0.69 dB, -9.37 ± 0.65 dB and -9.05 
± 0.86 dB for the hippocampus, caudate, putamen and vertex, respectively. The lateral -6 
dB resolution was found to be 4.2 ± 0.2 mm, 4.2 ± 0.2 mm, 4.1 ± 0.2 mm and 4.0 ± 0.1 mm 
for the small axis in  the hippocampus, caudate, putamen and vertex, respectively, and 4.5 ± 
0.3 mm, 4.6 ± 0.2 mm,  4.4 ± 0.2 mm and 4.3 ± 0.1 mm for the large axis in  the 
hippocampus, caudate, putamen and vertex, respectively,. Corresponding axial resolutions 
were found to be 40.5 ± 1.1 mm, 42.0 ± 1.6 mm, 40.7 ± 1.3 mm and 40.3 ± 1.2 mm, 
respectively. The displacement of the center of the focus was found to be, respectively, 1.1 
± 0.6 mm, 1.3 ± 0.5 mm, 1.4 ± 0.3 mm and 1.2 ± 0.4 mm in the focal plane and -5.7 ± 0.6 
mm, -6.5 ± 0.9 mm, -7.0 ± 0.5 mm and -6.6 mm ± 0.5 mm along the geometric axis of 
propagation. Tilt angles were measured to be 1.56° ± 0.64°, 2.13° ± 0.91°, 2.18° ± 0.80° 
and 1.39° ± 0.57°. Figure B.4 summarizes all the measurements with their means and 
standard deviations.   
Target coverage estimations were calculated in each case. Table B.1 summarizes the 
findings. For NHP skulls, the percent-of-target-overlapped was found to be 42.1 ± 1.4 %, 
31.0 ± 0.9 % and 21.8 ± 5.4 % for the hippocampus, caudate and putamen respectively 
while the percent-of-beam-overlapping-target was found to be 62.3 ± 2.4 %, 45.1 ± 2.3 % 
and 27.2 ± 6.7 %. For human skulls, for the hippocampus, caudate and putamen, the 
percent-of-target-overlapped was found to be 12.3 ± 2.1 %, 13.8 ± 2.5% and 16.6 ± 1.7 % 
while the percent-of-beam-overlapping-target was found to be 71.2 ± 1.7 %, 54.4 ± 3.0 % 




Table B.1 Targeting coverage for the different anatomical aims through NHP and human 
skulls. 
 %-of-target-overlapped %-of-beam-overlapping-target 
NHP hippocampus 42.1 ± 1.4  62.3 ± 2.4 
NHP caudate 31.0 ± 0.9 45.1 ± 2.3 
NHP putamen 21.8 ± 5.4 27.2 ± 6.7 
Human hippocampus 12.3 ± 2.1 71.2 ± 1.7 
Human caudate 13.8 ± 2.5 54.4 ± 3.0 
Human putamen 16.6 ± 1.7 82.1 ± 2.8 
 
		
Figure B.4 – Focusing performance assessment through human and NHP skulls. 
Attenuation represents the energy loss crossing the skull interface compared to that of the 
water. Tilt represents the angle between the axial dimension of the focus and the geometric 
axis of propagation. Lateral resolution and axial resolution represents the dimension of the 
focus (-6 dB cutoff). Lateral and axial shift represents the displacement of the center of the 
focus. 
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